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Abstract 
 
Salmonella and other pathogens have evolved systems to avoid the innate 
mammalian immune response. Little is known about how Salmonella survive the 
mammalian gastrointestinal tract during early infection and aspects of Salmonella 
metabolism in relation to virulence have yet to be studied, despite earlier work on 
virulence determinants (Darwin and Miller 1999; Wallis and Galyov 2000; Zhang, 
Kingsley et al. 2003). 
Since the gastrointestinal tract is largely anaerobic with microaerobic niches 
(Jones, Chowdhury et al. 2007), nitrate can act as a terminal electron acceptor 
(Lundberg, Weitzberg et al. 2004). In conjunction with this, previous data (Alston 
et al.) found that SPI-1 genes, required for invasion of epithelial cells, are co-
expressed with genes of the nap operon. We hypothesised that the nap operon 
is important in the early stages of Salmonella infection and postulated that 
bacterial infection, colonisation of the mammalian gastrointestinal tract and 
nitrate dissimilation are connected 
In this study we elucidate the role of the three nitrate reductase systems of 
Salmonella, NR-A, Nap and NR-Z, during infection. We also characterised the 
role of NO detoxification by NorV, NrfA and HmpA in the growth and/or survival 
of Salmonella in the gastrointestinal tract. This project provides the first 
integrated view of the importance of nitrate reduction on gut colonization by 
Salmonella. 
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1.1 The Salmonella story 
The Salmonella bacterium was isolated in 1885 by a veterinary surgeon, 
D.E.Salmon, and his research assistant, T.Smith, himself a respected 
epidemiologist and pathologist, in the course of their work on pigs. The disease 
which it was thought to cause at that time was known as ‘hog-cholera’, so they 
named this Gram negative bacillus Hog-cholerabacillus. Later, Joseph Léon 
Marcel Ligniéres honoured Salmon by re-naming the bacteria Salmonella 
choleraesuis. This bacterium ultimately turned out to be commensally present in 
pigs, the causative agent of hog cholera being a virus. We now recognise two 
discrete species of Salmonella, Salmonella enterica (S. enterica) and 
Salmonella bongori (S. bongori); all of the different serological variants 
(serovars, or sv.), of which there are now over 2500, fall into one of these two 
species. 
 
1.1.1 Classification 
 
Classification of species has variously been based on factors such as host 
specificity, susceptibility to phage and the presence of cell surface antigens like 
lipopolysaccharide (LPS). The different serovars of Salmonella are defined by 
the different combinations of O, H1 and H2 antigens present on their bacterial 
cell surface. In 1952, Edwards and Kaufmann developed a method for 
classification in which flagellar (H) antigens of two different types (H1 – 
monophasic and H2 – diphasic) were used (Edwards and Kauffmann 1952). 
Depending on the oligosaccharide arrangement, there are also 50 different 
types of LPS antigen which can be identified. Subsequently, Kauffmann further 
refined the system by including classification based on cell surface LPS 
antigens (O or somatic antigen). Consequently, the Kauffmann-White schema 
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now applies the rule that each discrete combination of O, H1 and H2 identifies a 
different serovar. Further work has produced new proposals for improvements to 
the Kauffmann-White schema (Le Minor, Veron et al. 1982; Le Minor and 
Bockemuhl 1988), with the resulting identification of further serovars (Popoff, 
Bockemuhl et al. 2003; Popoff, Bockemuhl et al. 2004). Names given to the 
serovars often indicate the host and disease symptoms, such as with 
Salmonella choleraesuis explained earlier, or where they were first identified, for 
example Salmonella dublin.  
Use of DNA hybridisation showed that all the Salmonella serovars have a single 
hybridization group, so form a single species comprising seven subspecies 
(Crosa, Brenner et al. 1973; Stoleru, Le Minor et al. 1976). The species name 
Salmonella enterica (S. enterica)(sub-species (I))is now further defined by 
salamae (II), arizonae (IIIa), diarizonae (IIIb), houtenae (IV), bongori (V) and 
indica (VI). Still, the common serovar names, such as ‘Salmonella enterica 
serovar Typhimurium’ (S. Typhimurium) have been kept in use for subspecies (I) 
strains. 60% of all serotypes reside in subspecies (I), and over 90% of those 
cause human salmonellosis (Neidhardt 1996). 
Salmonella classification remains extremely complex. The use now of genome 
based identification technology has negated the need for earlier methods. 
Genome sequencing has importantly revealed that two pathogenically important 
variants are so closely related in their DNA that they cannot be considered 
separate species. These are S.Typhimurium LT2 (McClelland, Sanderson et al. 
2001) and Salmonella Typhi (S. Typhi) (Parkhill, Dougan et al. 2001), which 
have up to 99% sequence homology (Edwards, Olsen et al. 2002). This has led 
to the current classification of only two Salmonella species, Salmonella enterica, 
which contains former subspecies I, II, IIIa, IIIb, IV, and VI, and Salmonella 
bongori (formerly subspecies (V) (Selander, Beltran et al. 1990; Boyd, Wang et 
al. 1996; Chan, Baker et al. 2003). 
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Most members of the Salmonella genus are fermentative facultatively anaerobic 
intracellular pathogens of humans, birds and/or animals, and although there is a 
high degree of similarity in DNA between different serovars, they infect a variety 
of hosts to different extents. Most serovars are also highly motile, carrying 
peritrichous flagella distributed over their entire surface. As emphasised here 
earlier, most of the pathogenic variants belong to the Salmonella enterica 
species, including Typhimurium, Typhi, Paratyphi and Enteritidis serovars, 
although the degree of host speciation affects the type and levels of 
pathogenicity displayed in different hosts; for example, while S. Typhimurium 
causes a serious systemic infection in mice, it is more likely to result in a 
troublesome, though relatively minor, infection of the gastrointestinal tract in 
humans.  
 
1.1.2 Salmonella physiology 
The Salmonellae are classified as γ-proteobacteria, confirmed by their ribosomal 
RNA sequences, and included in the taxonomic family Enterobacteriacae 
(Cohen, Mechanda et al. 1996; Bohnert, Hubner et al. 2000; Lupp, Robertson et 
al. 2007).As a Gram negative bacterium, Salmonella is surrounded by a 
complex membrane structure. Around the plasma membrane is an additional 
thin layer of peptidoglycan which is itself surrounded by an outer membrane 
covalently attached to the peptidoglycan layer by lipoproteins. The outer 
membrane houses the O, H1 and H2 antigens which dictate the serological 
differences between serovars. Since they are facultative anaerobes, they are 
able to survive and grow either aerobically or anaerobically (Neidhardt 1996). In 
addition, a high level of motility may aid the ability of the bacterium to evade 
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some host defences (Stecher, Barthel et al. 2008), making Salmonella a 
formidable pathogen in a wide range of species. 
1.1.3 Salmonella enterica epidemiology 
 
There were 9,079 human infections reported in England and Wales during 2009 
which were attributed to Salmonella (HPA 2010). This number is probably under-
reported by a considerable margin, due to the self-limiting nature of most 
Salmonella infections (Oosterom 1991). It has also been estimated that there are 
between 16 million and 33 million cases of Typhoid Fever per year around the 
World (DeRoeck, Jodar et al. 2007), and overall, Salmonella infections kill 
around 1 million people each year (Galanis, Lo Fo Wong et al. 2006; Hendriksen, 
Mikoleit et al. 2009). However, the epidemiology of salmonellosis infection is 
difficult to measure precisely, due to differences in disease recording and 
presentation of patients between countries. Often, those areas most affected, 
such as south-central and south-east Asia, Africa, the Caribbean, and Oceania, 
also have the least effective recording systems for infectious diseases (Crump, 
Luby et al. 2004). Typhoid Fever is rare in Europe, but widespread in other parts 
of the World where water sanitation is less efficient. In sub-Saharan Africa and 
Asia in particular, prevalence of typhoidal salmonellosis is high, mainly due to 
poor sanitation; the death rate is also very high, since medical intervention may 
be difficult to access. The annual frequency has been estimated to be around 
twenty-seven million new cases of Typhoid Fever worldwide (Crump, Luby et al. 
2004).  
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1.1.4 Potential sources of infection 
 
Infection of humans by Salmonella often arises from consumption of 
contaminated food as well as water, although direct human to human, and 
animal to human transmission can occur. In this sense, Salmonella infections 
can be considered zoonotic. The most common food sources of Salmonella are 
poultry and egg products; beef and pork have also been found to be a 
Salmonella reservoir (Adak, Meakins et al. 2005).Indeed, in 2003, Salmonella 
was isolated from the caeca of 23.4% of British pigs in a survey carried out by 
D.E.F.R.A. The most common serotype found in pigs was S. Typhimurium, also 
often associated with human infections. Pork is also the most consumed meat in 
Europe (Fosse, Seegers et al. 2008). Of even more concern perhaps is the 
finding that in the United States, 90% of the Salmonella strains isolated from pig 
carcasses are multidrug resistant (Hoelzer, Soyer et al. 2010). In contrast, only 
1.4% of cattle carcasses carried predominantly S. Dublin, which itself only rarely 
causes human infection. In sheep S. Enterica subspecies diarizonae appeared 
with highest frequency, though still in only 1.1% of carcasses (D.E.F.R.A. 2005). 
The European Food Safety Authority also concluded that the lymph nodes of 
21% of British pigs were infected with Salmonella, (13.8% S. Typhimurium and 
4.8% S. Derby) (E.F.S.A. 2008). 
In contrast to the picture for Salmonella in the United Kingdom food production 
industry, Campylobacter species were discovered in 54.6% of cattle, 43.8% of 
sheep and 69.3% of pigs at slaughter. C. jejuni accounted for 81% and 65% of 
the Campylobacter presence in cattle and sheep respectively. Interestingly, 90% 
of the  Campylobacter isolated from pigs was C. coli (D.E.F.R.A. 
2005).Campylobacter infections are responsible for most of the instances of 
human food poisoning reported in the United Kingdom, although it is C. jejuni 
that causes most cases of infection (Tam, O'Brien et al. 2003); this suggests 
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that most infections may not originate from the ingestion of pork products. Still, 
cases presenting with C. coli infection account for about four times more cases 
of indigenously acquired food borne disease (IFD) than those arising from S. 
Typhimurium infection. However, S. Typhimurium is responsible for more human 
deaths (Tam, O'Brien et al. 2003). Verotoxigenic Escherichia coli (VTEC 0157) 
was present at much lower levels, 4.7% in cattle, 0.7% in sheep and only 0.3% 
in pigs. Verotoxin, also referred to as Shiga-like toxin, is one of a class of toxins 
that inhibit protein synthesis by blocking the interaction of ribosomal RNA. This 
toxin is generated by some strains of Escherichia coli. It is named for its 
similarity to the AB5-typeShiga toxin produced by the bacteria Shigella 
dysenteriae. A variety of shiga-like toxins are produced by pathogenic strains of 
E. coli, in particular E. coli O157. The toxins are particularly interesting since 
they require highly specific receptors on the cells' surface in order to attach and 
enter the cell; species such as cattle, swine and deer which do not carry these 
receptors may harbour toxigenic bacteria without any ill effect, shedding them in 
their faeces, from where they may be spread to humans. 
In December 2007, the United States Department of Agriculture was forced to 
issue a public health warning when 38 people became ill after eating ground 
beef, apparently purchased from a supermarket chain (CIDRAP 2007). An 
additional concern was that the strain involved proved to be the multi-drug 
resistant S. Newport, with the – MDR-AmpC phenotype. This incident serves to 
show that Salmonella infection of humans is not restricted to the developing 
world, and may become increasingly difficult to deal with effectively, as levels of 
antibiotic resistance increase. In January 2006, the United Kingdom-based 
chocolate manufacturer Cadbury withdrew many of its products when about 60 
cases of salmonellosis were traced to the ingestion of Cadbury products. The 
problem was identified as a leaking pipe which had become contaminated with 
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Salmonella at a factory in Herefordshire. It was estimated that the cost of this 
error amounted to some £10M to the company. Fruit and vegetables  also 
provide a reservoir for infection (Adak, Meakins et al. 2005) and in June 2008, 
the United States Food and Drug Administration (FDA) warned of a serious 
outbreak of salmonellosis initially connected to raw tomatoes. Subsequently, 
jalapeño peppers were found to be the culprits, probably as a result of the plants 
being watered with contaminated water. According to the Centre for Disease 
Control (C.D.C.), a total of around 1500 confirmed cases of salmonellosis were 
attributed to this outbreak (C.D.C 2008). In January 2009, an outbreak of S. 
Typhimurium infection in the United States was traced to a factory making 
peanut butter, and owned by the Peanut Corporation of America (PCA).  The 
FDA recommended avoidance of commercially-prepared or manufactured 
peanut butter-containing products and institutionally-served peanut butter. S. 
Typhimurium was identified in peanut-butter based products as diverse as 
crackers, energy bars, ice cream and cookies across 46 states in the US, which 
had been manufactured by over 300 different food companies. Around 700 
people became ill as a result, and nine deaths were attributed to this outbreak 
over the next three months. The peanut butter and peanut paste manufactured 
by PCA had been distributed to hundreds of other food producing companies for 
use as an ingredient in many different products, all of which were recalled. 
Outbreaks of this nature, where an ingredient which may be used in many 
different products, present an extra challenge in terms of detection, tracing and 
limiting the potential damage which may arise (Cavallaro, Date et al. 2011). 
The CDC also later reported another outbreak associated with ingestion of raw 
vegetables, this time alfalfa sprouts, (C.D.C. 2009). In fact, it is thought in this 
outbreak, it was a batch of the alfalfa seeds which had become contaminated 
from the seed grower. Thus, the economic costs and impact potential of 
Salmonella should not be underestimated. Recent assessment in the United 
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States concluded that the annual costs associated with Salmonella infections 
there amounts to an estimated $2.65Billion (CIDRAP 2010). 
Foodborne Salmonella infections are not the only source; as previously alluded 
to, zoonotic transmission can also occur and this commonly happens in 
households where reptiles of various species are kept as pets. The Salmonella 
serovars may vary, but the disease outcome, an episode of acute enteritic 
symptoms, is characteristic (Sanyal, Douglas et al. 1997). This work found 
evidence of two different Salmonella strains in one household in which two 
different reptilian species were kept, Salmonella chameleon in an iguana, and 
Salmonella arizonae in four snakes. 
1.1.5 Host specificity and Types of Disease 
 
Salmonella serovars may be either host specific, in which case they are 
restricted to infection of only one specific host species, host adapted which 
allows for the infection of a few different species, or generalists, which infect a 
wide range of hosts (Maskell 2005).However, the type of disease and symptoms 
vary between host species, even where the same serovar is involved. An 
example of such variation arises in infections caused by S.Typhimurium, which 
is usually limited to causing gastroenteritis infections in humans. In contrast, in 
mice, S. Typhimurium results in a systemic infection similar to Typhoid Fever, 
ultimately causing the death of the affected animal. These differences have 
attracted much interest in the pathogenetic attributes of the variants, since 
identification of the various virulence factors provides targets for either vaccine 
or antibiotic intervention (Germanier and Furer 1975; Galan and Curtiss 1989; 
Morgan, Campbell et al. 2004; Becker, Selbach et al. 2006).A host specific 
example is Salmonella enterica serovar Typhi (S. Typhi), which causes Typhoid 
Fever specifically in humans (Meltzer and Schwartz 2010). Chimpanzees may 
also be a closely enough related species to human for the specificity to also 
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apply to them, and this is supported by the observation that a disease which 
closely mimics that in humans  can be caused in chimpanzees by challenge with 
S. Typhi (Gaines, Sprinz et al. 1968).  
 
1.1.5.1 Typhoid Fever 
 
S.Typhi and Salmonella enterica sv. Paratyphi (S. Paratyphi) are transmitted in 
contaminated water and cause Typhoid or Paratyphoid fever in humans 
respectively. These systemic infections are acquired via the faecal-oral route, 
and involve organs other than the gastrointestinal tract, in the reticuloendothelial 
system which includes the liver and spleen. Paratyphoid fever resembles 
Typhoid Fever but presents with a more abrupt onset, milder symptoms and a 
shorter course (Bhan, Bahl et al. 2005). 
Infections are usually the result of ingesting contaminated water, or food which 
has been washed using contaminated water (Sears, Ferreccio et al. 1984; 
Mahle and Levine 1993; Huang and DuPont 2005). S. Typhi causes Typhoid 
Fever, in which the symptoms are wide-ranging and serious. If Typhoid Fever 
goes untreated, the course of the disease takes four discrete stages over about 
a month (Azad, Islam et al. 1997). Initially, there is an increase in body 
temperature, slow heart rate, headache, cough and general malaise (Ivanoff, 
Levine et al. 1994). Occasionally, there is bleeding from the nose and abdominal 
pain (Borries 1930). A reduction in the number of white blood cells and 
eosinophils is observable (Wang, Gu et al. 1989); blood cultures test positive for 
S. Typhi or Paratyphi. The classic Widal test is usually negative in the first week. 
However, results of this test must be interpreted cautiously; although it is a 
serological test for enteric or undulent fever, it is not very specific (Pang and 
Puthucheary 1983; Parry, Hoa et al. 1999). The Widal test uses agglutination of 
antibodies against O-somatic and H-flagellar antigens in the blood, and as 
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patients may have been exposed to other species of bacteria which cause 
cross-reactivity a false-positive result can be indicated (Senewiratne and 
Senewiratne 1977; Pang and Puthucheary 1983). Also, any past history of 
enteric fever, typhoid vaccination, and the general level of antibodies in the 
populations in areas of the World in which typhoidal infections are endemic can 
influence the result. In the second week, the fever plateaus at around 40 °C 
(104 °F) (Parry, Hien et al. 2002; Nsutebu, Martins e t al. 2003).Delirium 
frequently occurs, and rose spots appear on the lower chest and abdomen in 
30% of cases (Wang, Gu et al. 1989). There are rhonchi (rattling sounds) from 
the lungs, (Neva 1950) which can lead to an initial  misdiagnosis of upper 
respiratory tract infection. The abdomen may distend and become painful in the 
right lower quadrant where borborygmi (rumbling noises) can be heard 
(Morgenstern and Hayes 1991; Hohmann, Oletta et al. 1996). Diarrhoea can 
occur in this stage (more common in children) although constipation (more 
common in adults) may also do so (Abdool Gaffar, Seedat et al. 1992; Khan, 
Coovadia et al. 1999). Hepatosplenomegaly (enlargement of liver and spleen) 
develops (Hosoglu, Celen et al. 2006). The Widal reaction is by now strongly 
positive with antiO and antiH antibodies. Complications may begin to manifest 
during the third week; these can include intestinal haemorrhage, intestinal 
perforation in the distal ileum (frequently fatal) (Everest, Wain et al. 2001; 
Hosoglu, Aldemir et al. 2004; Hosoglu, Celen et al. 2006), encephalitis, 
metastatic abscesses (Gremillon, Geckler et al. 1977), cholecystitis 
(inflammation of the gall bladder), endocarditis(inflammation of the heart valves 
and/or endocardium) and (rarely) osteitis (bone inflammation) (Allal, Kastler et 
al. 1993; du Plessis, Govendrageloo et al. 1997; Malik 2002; Rayan, Mukundan 
et al. 2009).The fever remains very high and dehydration follows. The fever 
finally reduces after four weeks if the patient survives. 
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1.1.5.2 Gastroenteritis 
 
Several Salmonella serovars cause acute but self-limiting gastroenteritis in 
humans, primarily sv. Enteriditis and sv. Typhimurium. For S. Typhimurium, an 
incubation period of 6 to 72 hours is followed by varying combinations of 
headache, abdominal pain, diarrhoea and vomiting. The diarrhoea can contain 
blood, lymphocytes and mucus. Fever, malaise and muscle aches may also be 
experienced (Darwin and Miller 1999). In gastroenteritis infections, epithelial 
cells respond to infection by first increasing their intracellular calcium 
concentration (Pace, Hayman et al. 1993). This, in combination with the action 
of specific Salmonella virulence factors, activates the transcriptional regulator 
NF-κB (Rogler, Brand et al. 1998), resulting in the production and secretion of 
pro-inflammatory cytokines, such as Interleukin 8, a chemo-attractant for 
polymorphonuclear (PMN) leukocytes such as neutrophils (Elewaut, DiDonato et 
al. 1999; Gewirtz, Rao et al. 2000). These PMNs migrate to the gut lumen and, 
in combination with an increased level of epithelial cell death, cause fluid 
secretion, breakdown and detachment of the epithelial cell layer, which is 
manifested symptomatically as bloody diarrhoea (Haraga, Ohlson et al. 2008). 
These aspects of the immune response are covered in more detail later.  Most 
sufferers of Salmonella-induced gastroenteritis infection recover within a week; 
however, the elderly, young children and immuno-compromised individuals may 
suffer more severe infections, such as a non-typhoidal bacteraemia (Velge, 
Cloeckaert et al. 2005), and unfortunately some of these victims do not recover. 
More severe infections may also result if a particular strain of Salmonella, such 
as DT104, is involved. 
Gastroenteritis infections caused by Salmonella are also typified by the 
continued faecal shedding of bacteria for up to 18 weeks after the illness was 
first manifested. Occasionally, some patients become carriers, and despite 
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being asymptomatic themselves, the faecal shedding of the bacteria continues 
for periods in excess of one year (Scherer 2001). Carriers present the risk of 
causing new infections, so their treatment regime must be effective to ensure 
that further spread of the disease is prevented. 
 
1.2 The biology of Salmonella infection 
1.2.1  Mammalian Host Gastrointestinal Physiology 
 
It has been suggested that the gastrointestinal system is the largest part of, and 
the major contributor to, the immune system in the human body (Hart, Lammers 
et al. 2004).Upon ingestion, the first challenge encountered by enteric 
pathogens occurs within the oral cavity, where saliva, which contains lysozyme, 
is produced by the salivary glands. Lysozyme threatens the integrity of many 
bacterial membranes; it is a bacteriolytic enzyme present in several animal 
secretions (Peeters and Vantrappen 1975; Jones and Bevins 1992) . 
Having passed to the stomach, the bacteria experience a dramatic change in 
pH, due to the increasingly acidic environment of the stomach. Here, acidity may 
become as high as pH1 in the immediate post-prandial period (Levy, Koeppen 
et al. 2005; Rychlik and Barrow 2005). In addition, the presence of digestive 
enzymes and compounds, intended to break down whatever may be in the 
stomach, would contribute to the defence system of the host. If the bacterial 
defences fail, host proteases and peptidases could attack their proteins, 
reducing them to their component amino acids, carbohydrases break down 
starch and sugars, such as those found in bacterial membranes, while 
nucleases will reduce bacterial DNA to base nucleotides. 
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Upon leaving the stomach via the pyloric sphincter, the gut contents are met by 
a much more alkaline environment in the small intestine. Here, pancreatic juices 
and bile salts are secreted into the gut lumen, ensuring that the small intestine is 
maintained at an alkaline pH, (Levy, Koeppen et al. 2005), which prevents 
physiological damage to this part of the gastrointestinal tract and also allows for 
correct absorption of nutrients, vitamins and minerals which would be disrupted 
by an acidic environment. 
The epithelial surface of the mammalian small intestine comprises mainly 
columnar absorptive enterocytes, interspersed with Paneth cells, and goblet 
cells (Sansonetti 2004). The enterocytes are polarised cells, with a serosal or 
baso-lateral surface, and a brush border membrane facing into the lumen. The 
brush border surface is formed into microvilli which project into the gut lumen. 
Paneth cells are known to be operational in the immune response, since they 
secrete lysozyme and defensins to the gastrointestinal lumen as a defence 
compound (Peeters and Vantrappen 1975; Ganz 2000). Paneth cells are 
located towards the bases of the crypts of Lieberkühn which are invaginations of 
the surface of the small intestinal surface (Porter, Bevins et al. 2002). Goblet 
cells secrete mucus which forms a protective and lubricating barrier around the 
epithelial surface which is constantly exposed to ‘foreign’ molecules, whether 
they be food or foe (Deplancke and Gaskins 2001). Work in rats has shown that 
mucus is present in two layers, the outer one being easily removed, while the 
inner layer is firmly attached to the epithelium (Johansson, Phillipson et al. 
2008). While the outer layer may provide a nutritive resource for some 
commensal bacteria, the inner layer is impenetrable and prevents contact 
between the bacteria and the epithelium, (Backhed, Ley et al. 2005), which 
should also exclude pathogens. This also means that bacteria, whether 
commensal or pathogenic, are prevented from making contact with cells of the 
immune system, which could otherwise result in the initiation of an inflammatory 
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response, including that seen in Salmonellosis, which is evidenced by diarrhoeal 
symptoms. The physiology of the epithelial surface combined with such an array 
of defences, in addition to the peristaltic action of the gut and the competition for 
access to the surface with commensal bacteria which are also present in greater 
numbers in the gut presents a formidable hurdle to invading pathogens. 
Supplementing the barrier effect of the intestinal epithelium, the immune system 
here is supported further by the presence of gut associated lymphoid tissue 
(GALT), which comprises the appendix, lymphoid follicles, mesenteric lymph 
nodes and Peyer’s patches. Peyer’s patches are organized lymphoid follicles 
which are located in the wall of the small intestine, and their numbers increase 
towards the terminal ileum, just prior to the large intestine (Cornes 1965). These 
structures are dome-shaped follicles covered with mostly columnar epithelial 
cells. The lack of goblet cells results in a reduced mucus layer over the follicles 
(Owen and Ermak 1990).However, the Peyer’s patches also contain specialized 
cells called microfold-cells (M-Cells) which are unique to the patches (Bockman 
and Cooper 1973; Owen and Jones 1974; Jones, Ghori et al. 1994). The M-
Cells are adapted from enterocytes and do not have the microvillous brush 
border membrane which is characteristic of enterocytes (Owen 1994). M-Cells 
play an important role in the uptake of antigen which then stimulates the 
mucosal immune response (Wassef, Keren et al. 1989). They achieve this by 
sampling the microorganisms present in the lumenal environment (Bockman 
and Cooper 1973; Owen and Jones 1974; Owen and Ermak 1990; Jones, Ghori 
et al. 1994; Owen 1994). Structurally, M Cells contain a cavity on their serosal 
side, which is populated by cells of the innate immune system which are ready 
to pick up microorganisms translocated from the lumen via the M-Cells. By their 
uptake of bacterial cells for this sampling function, M-cells provide a route 
through the intestinal epithelial barrier (Zoetendal, Vaughan et al. 2006) which 
some pathogenic bacteria, like Salmonella, can and do, use to their advantage.  
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It has also been suggested that intestinal dendritic cells (DCs) sample bacteria, 
such as Salmonella, by extending cellular processes into the gut lumen to 
capture bacteria and draw them back to the serosal side of the epithelium to be 
dealt with by other killing mechanisms of the immune response (Rescigno, Rotta 
et al. 2001; Niedergang, Didierlaurent et al. 2004; Niess, Brand et al. 2005). 
There is again the possibility that these dendritic cells are hijacked by the 
bacterial cells so that they can infect the host. More recent work has shown that 
for Salmonella which fail to adhere to the epithelium, dendritic cells of the 
immune system can still sense their presence, either before or perhaps after 
other Salmonella have invaded, and pass through the epithelium to capture 
them before being ejected from the host via the lumenal route (Arques, 
Hautefort et al. 2009). 
 
1.2.2  Infection process 
 
The size of the infectious dose required to initiate and then to sustain a 
Salmonella infection depends on the bacterial strain, as well as the physiological 
state of the host and the types of foods consumed with the bacteria (Darwin and 
Miller 1999); between a thousand and one million S. Typhi bacteria have been 
identified as sufficient to successfully infect a human host (Hornick 1970; 
Hornick, Greisman et al. 1970). There are discrete stages of the infection 
process which occur during following ingestion of an infectious dose via the 
normal physiological route.  
1.2.2.1  Gastrointestinal Phase of Infection 
 
Pathogenic bacteria must be able to evade the defence mechanisms of their host 
at least for long enough for disease symptoms to appear in their host. If the 
bacterium is an opportunistic pathogen, it will exploit pre-existing weakness in 
the host’s immune response. However, where the immune system remains 
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intact, Salmonella, together with other enteric pathogens like Campylobacter, 
Escherichia and Listeria, must first overcome the action of the mammalian host’s 
first immune barrier, the acidic environment which is met in the stomach. 
Following ingestion, Salmonella switches on an acid-stress response enabling it 
to survive the acidic environment of the stomach (Foster 1991; Gahan and Hill 
1999). This response has been well-characterized, and is an adaptive response 
to lower pH levels, called the Acid Tolerance Response (ATR). Enteric bacteria 
principally rely on the global regulator RpoS to control the acid stress response 
(Foster 2004), although other regulatory proteins PhoPQ and Fur are also 
involved in the acid stress response in Salmonella (Rychlik and Barrow 2005). In 
S. Typhimurium, and C. jejuni, the ability to withstand low stomach pH is 
enhanced by the capacity of these microbes to ‘pre-adapt’ to an acid 
environment by employing their ATR (Foster 1991; Murphy, Carroll et al. 2005), 
and it is induced by exposure to a mildly acidic pH of between 5.5 and 6.0.This 
may also help to explain the observation that some individuals who habitually 
use antacid medication are more susceptible to Salmonella infections (Smith 
2003). After survival in the stomach Salmonella pass through to the small 
intestine, where they experience another change in their environment to one 
which is more alkaline.  
 
1.2.2.2  Invasion phase of Infection 
 
Penetration of the epithelial cells which line the gastrointestinal tract is vital to the 
progression of the infection of a host by Salmonella. During the initiation of an 
infection in the small intestine, Salmonella must adhere to the brush border 
membrane surface of the cells lining the gut epithelium (Haque, Bowe et al. 
2004; Haraga, Ohlson et al. 2008). In mice, entry of Salmonella to the 
gastrointestinal epithelium occurs only via M-cells within the Peyer’s Patches 
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(Jepson and Clark 2001). The Salmonella infection route in calves is via 
enterocytes or M-cells distributed along the epithelial lining other than the 
follicle-associated epithelium, with no apparent preference for either route (Wallis 
and Galyov 2000; Zhang, Kingsley et al. 2003). The precise route in humans is 
still to be elucidated, though it may be reasonable to conclude that M-cells could 
provide a major route for entry in the human gut (Jepson and Clark 2001). It has 
also been shown that on some occasions, Salmonella may effect entry via 
enterocytes (Haque, Bowe et al. 2004). The presence of the bacteria is sensed 
by the host cells via specific recognition by toll-like receptors (TLRs) of molecular 
motifs. This recognition by the TLRs of the presence of bacterial threats results in 
the switching on of signal transduction pathways in the host which lead to the 
expression of genes which control the innate immune response as well as the 
development of acquired immunity (Takeda and Akira 2005). TLR4 in particular 
is responsive to the bacterial lipopolysaccharide (LPS) of Gram negative bacteria 
(Takeuchi, Hoshino et al. 1999) while TLR5 recognises the molecular motifs 
present in bacterial flagellin (Fournier, Williams et al. 2009).The molecular motifs 
are  present on the surface of bacterial cells, and known as pathogen-associated 
molecular patterns (PAMPs) (Mumy and McCormick 2005). The PAMPs enable 
the host cells to identify the bacteria as ‘non-self’ cells, and target the foreign 
agents for attack by the host immune system (Coburn, Grassl et al. 2007). The 
PAMPs which stimulate the immune system response to Salmonella cells include 
several bacterial cell components such as the LPS component of the bacterial 
membrane, and flagellin, a protein which polymerises into a hollow cylinder, 
forming the filament of the bacterial flagellum (Philpott and Girardin 2004; 
Coburn, Grassl et al. 2007), involved in bacterial motility. It has however been 
shown that the main PAMP which mediates the response to Salmonella is LPS, 
and consequently, the cascade of responses from the immune system which 
follows recognition by TLR4 (Roy, Lariviere et al. 2006). 
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In preparation for invasion into non-phagocytic cells, such as epithelial cells, 
genes within the tightly regulated Salmonella Pathogenicity Island 1 (SPI-1) are 
induced in response to several inducing environmental cues. Changes in acidity 
and alkalinity during the transit through the gastrointestinal tract may induce 
SPI-1 expression, and this is explained in more detail later. SPI-1 induction can 
also be effected by increasing salt levels and this can be used to experimental 
advantage when induction is required, such as during invasion assays. 
Changes in the oxygen levels during gut transit, as well as exposure to 
metabolites produced by the usual gut flora and response to the presence of 
antimicrobial peptides produced by the host also alter the microbial environment 
(Rychlik and Barrow 2005).SPI-1 encodes a hypodermic syringe-like Type-III 
Secretion System (TTSS), through which Salmonella secretes pre-synthesised 
effector proteins (Geddes, Cruz et al. 2007). TTSS are complex structures 
which are employed by several pathogenic species to introduce bacterial 
proteins into host cells (Hueck 1998). The apparatus is assembled from 
components for which gene expression is conserved between species. The 
evidence suggests that TTSS have been acquired through horizontal transfer of 
genes in the course of bacterial evolution (Hueck 1998; Lawrence and Ochman 
1998; Wang 2001). 
Several effector proteins are required for this step in the infection process 
orchestrated by Salmonella (Galan and Zhou 2000; Geddes, Cruz et al. 2007). 
SopA (an E3 ligase) (Diao, Zhang et al. 2008) and SopB (an inositol 
polyphosphate phosphatase) (Galan and Zhou 2000)stimulate proteins within 
the host cell to effect cytoskeletal rearrangements of the host cell. They achieve 
this by stimulating Cdc42 and Rac, small GTP binding proteins present in the 
cell. SipA (Salmonella invasion protein) has been shown to lower G-actin 
concentrations and bind F-Actin, and in doing so, it causes conformational 
changes to the actin-based cytoskeleton of mammalian cells (Galan and Zhou 
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2000; Galkin, Orlova et al. 2002). Triggering the Cdc-42 and Rac-1 Rho-
GTPase-mediated manipulation of the actin cytoskeleton of the host cell is such 
that the host cell membrane forms ruffles which surround and engulf the 
bacterial cell (Chen, Hobbie et al. 1996; Hardt, Chen et al. 1998; McGhie, 
Brawn et al. 2009). This is reminiscent of the behaviour exhibited by phagocytic 
cells and results in the internalisation of the Salmonella cell to the mammalian 
host cell (Jepson, Kenny et al. 2001; Hapfelmeier, Ehrbar et al. 2004; Perrett 
and Jepson 2009). Additional effectors which regulate the actin cytoskeleton 
and contribute to invasion of cells by Salmonella are SopE, SopE2 and SopB 
(Perrett and Jepson 2009). The processes involved are illustrated in Figure 1. 
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cytoskeleton and seals the resultant invaginations of the membrane which ultimately 
forms the Salmonella containing vacuole.
 
 
 
Salmonella is mediated by the 
-1) type III secretion system (TTSS) and its effectors. 
(red) and actin cytoskeleton
. SipA and SipC alter 
es actin, initiating polymerization and SipA bind
SptP is a GTPase activating protein which 
, by inactivating Cdc42 and Rac. SigD subverts the ce
 
32 | P a g e  
Salmonella 
 
s 
can inhibit the 
llular 
 33 | P a g e  
 
SPI-1 mutants are still able to infect the host following intraperitoneal (IP), 
infection to the same extent as wild type Salmonella (Galan 1996; Ochman, 
Soncini et al. 1996).However, it is interesting that SPI-1 mutants fail to infect the 
host following oral infection, and also that SPI-1 mutants are not able to invade 
enterocytes in vitro (Lucas and Lee 2001). This suggests that while SPI-1 is 
required for invasion via the gut epithelium, it is not necessary for intracellular 
survival and the systemic phase of infection. 
The TTSS apparatus is assembled in response to gene expression induced by 
a range of conditions (Johnston, Pegues et al. 1996)which are present following 
oral ingestion. The conditions include basic pH (alkalinity, such as is found in 
the mammalian small intestine), low oxygen and high osmolarity (Ernst, 
Dombroski et al. 1990; Lee and Falkow 1990; Bajaj, Lucas et al. 
1996).Regulation of the TTSS is highly complex. The transcription factor HilA is 
one participant which activates the expression of genes required for TTSS-1, 
and this is encoded within SPI-1 (Bajaj, Hwang et al. 1995). Consequently, the 
ability of S. Typhimurium to successfully invade the mammalian epithelium via 
SPI-1 activation is completely dependent on functional HilA (Bajaj, Hwang et al. 
1995; Bajaj, Lucas et al. 1996). HilA itself is activated in part by SirA 
(Salmonella invasion regulator), and the invasion capability of Salmonella is 
reduced if sirA is not functional; unlike other transcriptional regulators of TTSS-
1, SirA is located outside the SPI-1 island (Johnston, Pegues et al. 1996). 
The interaction of the effector proteins of TTSS-1 results in completion of the 
first stage of invasion of the host’s epithelial barrier required for progression of 
the infection to the systemic phase. 
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1.2.2.3  Intracellular Survival and Replicative phase of infection 
 
Upon internalisation into host cells, Salmonella is surrounded by a membrane-
bound vacuole (Steele-Mortimer, Meresse et al. 1999). Recruitment of lysosome 
associated membrane proteins (LAMP1 and LAMP2) to replace the early 
endocytic markers follows, and Salmonella induced filaments (Sifs) also form 
(Garcia-del Portillo, Zwick et al. 1993; Garcia-del Portillo and Finlay 1994; Roark 
and Haldar 2008).Over the course of the next hour following entry of the 
bacteria, the vacuolar environment acidifies (Rathman, Sjaastad et al. 1996; 
Holden 2002).Salmonella controls the development of  this compartment, then 
called the Salmonella-containing vacuole (SCV) (Haraga, Ohlson et al. 2008). 
The SCV provides a relatively benign environment within which Salmonella is 
able to replicate. Salmonella Pathogenicity Island 2 (SPI-2),like SPI-1, was 
horizontally acquired during the evolution of the organism and encodes a 
second TTSS (Shea, Hensel et al. 1996), the effector proteins of which are 
critical for SCV formation and maintenance (Chakravortty, Hansen-Wester et al. 
2002). It is interesting, therefore, that a major Salmonella variant, Salmonella 
bongori, lacks the SPI-2 apparatus. This suggests that during evolution of the 
different strains, Salmonella enterica  and Salmonella bongori or their 
ancestors, split prior to the acquisition by Salmonella enterica of SPI-2 (Ochman 
and Groisman 1996). It has also been reported that another serovar, Salmonella 
Arizona, shows variability in the presence of SPI-2 which suggests that this 
strain also diverged separately from the other serovars (Chan, Baker et al. 
2003). Salmonella replicates inside the SCV, ultimately leading to host cell 
death; the ensuing host cell lysis, accompanied by the release from the lysed 
cell of viable bacteria, may facilitate infection of neighbouring cells (Fink and 
Cookson 2007).Recent work using macrophage cells has demonstrated that 
when the single Salmonella within the SCV replicates, the SCV also divides and 
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replicates so that there is only ever one bacterial cell within a SCV, and the 
number of vacuolar compartments within the host cell increases (Lahiri, 
Eswarappa et al. 2010). None of the SCVs will fuse with lysosomes within the 
host cell and so avoid destruction. Salmonella is not alone in its ability to induce 
host cell death, and Shigella and Yersinia spp. also exhibit this capacity 
(Navarre and Zychlinsky 2000). The death and destruction of host cells by 
Salmonella itself then generates the release of inflammatory cytokines 
(Zychlinsky and Sansonetti 1997). SipB has been shown to be necessary for the 
induction of apoptosis by Salmonella (Hersh, Monack et al. 1999), and 
apoptosis results through the interaction of SipB with caspase-1, which is then 
activated. Because caspase-1 activates pro-inflammatory cytokines Interleukins 
1-beta (IL1β) and  18 (IL18) (Sansonetti, Phalipon et al. 2000), the apoptotic 
cascade which follows results in the programmed cell death of infected 
macrophage cells. Salmonella Typhimurium, together with several other Gram-
negative pathogens like Shigella flexneri and Pseudomonas aeruginosa, 
induces a specific type of cell death known as ‘pyroptosis’, from the Greek 
meaning ‘pyro’ – fire or fever, and ‘ptosis’ – falling, elegantly describing the 
inherent inflammatory characteristics of caspase-1-dependent cell death 
(Cookson and Brennan 2001). Such pyroptosis is also dependent on the SPI-1 
TTSS, and the presence of bacterial flagellin (Fink and Cookson 2007). Strains 
which have mutations in either SPI-1 genes which encode TTSS (Monack, 
Raupach et al. 1996; Lundberg, Vinatzer et al. 1999; van der Velden, Lindgren 
et al. 2000)or which are non-flagellate (Franchi, Amer et al. 2006; Miao, 
Alpuche-Aranda et al. 2006), are not cytotoxic. Interestingly, Chen et al have 
also shown that translocated effector proteins sipA and sptP have no 
involvement in this pyroptotic pathway (Chen, Kaniga et al. 1996), since strains 
carrying mutations in these proteins are still able to cause pyroptosis. 
Pyroptosis is distinct from other types of apoptosis, which require the activation 
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of caspase-3, -6 or -8 (Brennan and Cookson 2000; Jesenberger, Procyk et al. 
2000). It has also been shown that pyroptosis of Salmonella infected 
macrophages is not accompanied by the mitochondrial release of cytochrome c 
normally associated with apoptotic caspase activation (Jesenberger, Procyk et 
al. 2000). 
The release of the caspase-1 dependent cleavage and activation of the IL1β 
and IL18 cytokines (Sansonetti, Phalipon et al. 2000; Monack, Detweiler et al. 
2001) leads to inflammation associated activation of the host immune response. 
Such a full-blown response causes an influx of immune cells to the affected 
area and enhances T-cell and natural killer (NK) cell involvement (part of the 
innate immune response) (Braddock, Quinn et al. 2004). While neither IL1β nor 
IL18 are required to kill macrophages (Monack, Detweiler et al. 2001), they are 
instrumental in the production of the fever which accompanies the infection 
observed in the host, as described earlier (Section 1.1.5). The rapid cell lysis 
which occurs as a result of pyroptosis also provokes further increase of the 
inflammatory response, which can ultimately lead to the tissue destruction 
observed in vivo, manifested by intestinal haemorrhage and/or perforation 
(Everest, Wain et al. 2001; Hosoglu, Aldemir et al. 2004; Hosoglu, Celen et al. 
2006) and abscesses (Gremillon, Geckler et al. 1977). 
Salmonella is also able to survive and replicate within professional phagocytes, 
such as macrophages. A local influx of neutrophils, dendritic cells and 
macrophages is generated by the cytokine signalling by the innate immune 
system, in response to the presence of the bacterial stimulus (Tukel, Raffatellu 
et al. 2006).Neutrophils, or leukocytes, are the most common white blood cell, 
and the first to arrive at the site of an infection in response to chemotactic 
signals provided by cytokines, such as IL1β and IL18 (Levy, Koeppen et al. 
2005).Their role is to ingest and destroy foreign particles and pathogens, and in 
doing so, they are themselves destroyed (Kindt 2007).Dendritic cells, (DCs) also 
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called antigen presenting cells (APCs) are, like neutrophils, phagocytic, but their 
main role is to isolate and process foreign antigens to present them to other 
cells of the immune system to generate a specific immune response (Levy, 
Koeppen et al. 2005). This is vital to the memory response engendered by 
immunisation. Macrophages are large phagocytic cells which ingest foreign 
particles and microbes, and form part of the reticuloendothelial system; they are 
stimulated by the presence of inflammation (Kindt 2007). 
Macrophages normally phagocytose  and kill invasive pathogens with strong 
oxidative and nitrosative bursts, which bombard the pathogen with lethal 
amounts of reactive oxygen intermediates (ROIs), nitric oxide and reactive 
nitrogen intermediates (RNIs), including nitrite and nitrous acid (Fang 1997). The 
production of NO which is mediated by the inducible Nitric Oxide Synthase 
(iNOS) in macrophages is an important protection against S. Typhimurium 
infection (Umezawa, Akaike et al. 1997). Mice lacking functional alleles of iNOS 
(iNOS-/-) are significantly more susceptible to Salmonella infection relative to 
control mice (Mastroeni, Vazquez-Torres et al. 2000). During the course of 
infection of iNOS-deficient mice bacterial population growth in murine tissues is 
controlled at levels similar to those observed in wild type mice during the first 
week post infection. However, this is subsequently followed by lethal overgrowth 
of S. Typhimurium in the organs. Such a relatively “late” role for NO in the 
infection process is distinct from the “early” role of superoxide produced 
phagocyte oxidase (phox). Increased proliferation of S. Typhimurium in phox-/- 
mice is observed as early as 24 hours post infection (Mastroeni, Vazquez-Torres 
et al. 2000). Salmonella has evolved several mechanisms to overcome killing by 
NO (Mastroeni, Vazquez-Torres et al. 2000; Vazquez-Torres, Jones-Carson et 
al. 2000), which are discussed later. Salmonella which resist phagocyte killing 
are disseminated around the body within macrophages via the lymphatic 
circulation system. In systemic infections, Salmonella is spread via the reticulo-
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endothelial system to the spleen, a secondary lymphoid organ, and to Kupffer 
cells dispersed throughout the liver (Nnalue, Shnyra et al. 1992). Kupffer cells 
are specialised liver macrophages (Kindt 2007). Salmonella bacteria ultimately 
induce pyroptosis of infected macrophages (Hernandez, Pypaert et al. 2003; Fink 
and Cookson 2007). The combination of both resistance to, and killing of, host 
cells, ensures the survival and dissemination of Salmonella during systemic 
infections (Detweiler, Cunanan et al. 2001). Figure 2 illustrates processes which 
occur during dissemination of Salmonella through the host immune system. 
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1.3 Treatment and prophylaxis of Salmonella infections 
 
Infection in humans by S. Typhimurium is generally self-limiting, with the 
gastroenteritic infection which it causes lasting between 4 and 7 days. In 
previously healthy patients, antibiotic treatment does not shorten this period. 
However, in the elderly or the very young, a systemic infection may ensue which 
does require intervention with antibiotics. This is further complicated where 
patients are immunocompromised, for example having undergone organ 
transplants or infected with the Human Immunodeficiency Virus (HIV). Some 
individuals may apparently recover from their symptoms, but then become 
chronic carriers of the infection, which they may periodically become infective for 
and pass on the infection to others, particularly if they are involved in food 
preparation. This was true of Mary Mallon, who during the early 1900s became 
known as ‘Typhoid Mary’. She worked as a cook, and was responsible for the 
infection of at least 53 people with Typhoid Fever, of which three died. She was 
herself completely asymptomatic. 
Current regimens for treatment of enteritis or food poisoning conditions, 
including salmonellosis are varied and can be controversial. Since the disease 
in an otherwise healthy individual is generally self-limiting, many doctors 
advocate letting the infection run its course, without any medical intervention 
using antibiotics. Other practitioners prefer to prescribe a course of antibiotics 
like ciprofloxacin for between 10 and 14 days. One problem with this approach 
is that it may prolong and/or exacerbate the carrier state. Antibiotic treatment, is 
however, generally agreed upon in those circumstances where the patient is 
immuno-suppressed for any reason. Pregnancy may also predispose an 
expectant mother to enteric infections. Certainly, if a fever or dehydration is 
suffered, they should expect extra support from their doctor, which may simply 
entail the administration of solutions to rebalance the electrolytic abnormalities 
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which may arise during prolonged bouts of diarrhoeal infections. In severe 
cases, administration of such medications may be favoured by the intravenous 
route. As described above in the case of Typhoid Mary, carriers can infect other 
people. Around 85% of carriers can be completely cured of their carrier status 
by surgical removal of their gall bladder, where the quiescent populations of 
bacteria reside, combined with antibiotic treatment.   
 
1.3.1 Antibiotic Resistance 
 
Of additional concern is the emergence and increase in numbers of multi-drug 
resistant variants of Salmonella, such as was identified as the infecting 
organism in the United States outbreak of December 2007. The phenomenon of 
antibiotic resistance has been a problem noticed early on following the 
introduction of antibiotics in the 1940s (JAMA 1960). Multi drug resistance is 
now becoming a worrying feature with many pathogenic bacteria, including 
Salmonella (WHO 2002). Other pathogens of major importance in terms of their 
resistance to antibiotic drug therapies are Mycobacterium tuberculosis(multi-
drug resistant TB, or MDR-tb) (Telenti, Imboden et al. 1993; Murray 1994; 
Andersson and Levin 1999), the increasingly common nosocomial infection 
Staphylococcus aureus(particularly methicillin resistant S. aureus, MRSA) 
(Locksley, Cohen et al. 1982; Herold, Immergluck et al. 1998; Enright, Robinson 
et al. 2002; Okuma, Iwakawa et al. 2002), and the sexually transmitted infection 
caused by Neisseria gonorrhoea (Hook, Brady et al. 1989; Handsfield and 
Whitlington 1996).It is a natural part of the evolutionary process that where an 
organism meets a challenge, if one organism possesses traits which enable it to 
meet and overcome that challenge, then it will survive and is likely to pass its 
genetic advantage on to the next generation (Baquero 1997; Levin, Perrot et al. 
2000; Blazquez, Oliver et al. 2002). In bacteria, which are able to reproduce 
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extremely rapidly, this ability can become noticeable fairly quickly after the 
challenge has been met, and is known as vertical evolution (Saunders 1984) 
which arises by the growth in the population of the bacteria. A major influence 
has been the free prescribing of antibiotics when their use is relatively 
unnecessary, such as might happen in a Salmonella infection of an otherwise 
healthy individual (Ridley, Lynn et al. 1970; Salyers and Amabile-Cuevas 1997). 
It is also common for patients to fail to complete the prescribed course of 
antibiotics, which increases the chances of survival of viable, resistant bacteria 
(Magee, Pritchard et al. 1999; Goossens, Ferech et al. 2005).This arises 
because less sensitive bacteria have the opportunity to multiply and eventually 
emerge as fully resistant strains. Antibiotic therapies are designed to 
compromise vital processes which normally occur to ensure survival of bacteria. 
The targets of the antibiotic may be the bacterial pathways involved in 
transcription, protein or cell wall synthesis or other metabolic processes. 
Penicillin, for example, affects the ability of microbes to synthesise cell wall 
components (Wise and Park 1965; Tomasz and Waks 1975). Antibiotic 
resistance is also acquired by the transfer of resistance (R) plasmids, which 
occurs during conjugation between bacteria, and is not dependent on growth of 
the bacterial population. This transfer of genetic material between bacteria is 
known as horizontal evolution (Beaber, Hochhut et al. 2004; Sorensen, Bailey et 
al. 2005), and can confer resistance to several antibiotics in one plasmid. A third 
way in which antibiotic resistance can be transferred is by the acquisition of a 
‘pathogenicity island’, a large genetic element flanked on either side by 
transposable elements and containing genes for the expression of a range of 
factors which contribute to virulence and successful infection (Ochman, Soncini 
et al. 1996). It is thought that horizontal evolution has played a major role in the 
acquisition by Salmonella spp., as well as other species, of pathogenicity islands 
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(Ochman and Groisman 1996; Hacker, Blum-Oehler et al. 1997; Hensel 2000), 
with spontaneous mutations potentially playing an additional minor role. 
 
1.3.2 Resistance to antibiotics in Salmonella 
 
Since the 1960s, when antibiotic resistance was identified in Salmonella 
(Schroeder, Terry et al. 1968; Bulling, Stephan et al. 1973; Sojka and Hudson 
1976), multidrug resistant strains have also emerged, and are becoming an 
increasing problem (Anderson 1968; Threlfall, Ward et al. 1997; Velge, 
Cloeckaert et al. 2005). It is thought that one of the major reasons for the 
increase in the resistance to antibiotic intervention in S. Typhimurium is the 
overuse of antibiotics in the livestock, poultry and fish farming industries (Davis, 
Hancock et al. 1999; Velge, Cloeckaert et al. 2005). Interestingly, in the case of 
S. Typhi and Paratyphi, it is more likely that the use and/or misuse of antibiotic 
therapies in human treatments has resulted in the increases in antimicrobial 
resistance seen in these pathogens (Goldstein, Chumpitaz et al. 1986; Parry, 
Wain et al. 1998; Threlfall 2002; Roumagnac, Weill et al. 2006). More recent 
work has also shown a correlation between different levels of metal 
contaminations, of various metals, and antibiotic resistance (Baker-Austin, 
Wright et al. 2006), which is also linked to the human pathogenic strain S. Typhi 
CT18. Indeed, metal contamination may serve as a selective agent in the 
spread of antibiotic resistance. Baker-Austin et al have postulated that this could 
be due to either the presence of different resistance functions on the same 
genetic element (co-resistance) or the same genetic determinant having a 
function which confers resistance to both antibiotics and metals (cross-
resistance). 
This shows another selection pressure which can contribute to the development 
of further antimicrobial resistance in Salmonella. Add to these features the 
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simple fact that Salmonella has a tough metabolism which has evolved over the 
millennia to survive a wide range of challenges (Becker, Selbach et al. 2006) 
and it is not surprising that the need for continual detection, identification and 
development of new molecular targets remains. 
Since 1990, there have been laboratory reports of the emergence of a multidrug 
resistant strain of Salmonella Typhimurium definitive type (DT) 104  (Wall, 
Morgan et al. 1994). These have been associated with many and varied 
zoonotic reservoirs from cats (Wall, Threllfall et al. 1996) to cattle (Low, Hopkins 
et al. 1996; Hollinger, Wray et al. 1998; Davis, Hancock et al. 1999), seals 
(Foster, Ross et al. 1998) to pigs (Baggesen and Aarestrup 1998; Rugbjerg, 
Wingstrand et al. 2004), and chickens (Rajashekara, Haverly et al. 2000) to, 
quite recently, rabbits (Borrelli, Fioretti et al. 2010). Isolates of phage type 
DT104 are often resistant to ampicillin, chloramphenicol, streptomycin, 
sulphonamides and also tetracycline, described as ACSSuT resistance. 
Concern also arises around the ability of this strain to resist eradication by 
antibiotics as a result of the ability of the Salmonellae to both gain and donate 
horizontally transferred regions of their genetic makeup (Briggs and Fratamico 
1999; Beaber, Hochhut et al. 2004; Sorensen, Bailey et al. 2005). This 
mechanism is believed to have operated during the acquisition by Salmonella of 
the pathogenicity islands associated with invasion (Ochman and Groisman 
1996; Hensel 2000). Although this strain may have developed wide antibiotic 
resistance through extensive use of antibiotic regimens in the livestock industry, 
if it subsequently causes infection among exposed human populations it carries 
the resistance with it and consequently such human infections are increasingly 
difficult to treat successfully. The antibiotic resistance observed in DT104 has 
also been shown to have extended to several other serovars of Salmonella 
enterica which carry a class 1 integron within genomic island SGI1, or variants 
of it containing different combinations of resistance genes (Levings, Lightfoot et 
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al. 2005), and all of which have been isolated from human infections. The 
DT104 variant is also more virulent than other strains, which adds to the 
problem, since the severity of any infection caused by DT104 is also increased. 
It is also possible that horizontal transfer will occur between species of bacteria, 
thus spreading the antibiotic resistance capability still further, and the likelihood 
that such a multi resistance gene fragment could be transferred to another 
bacterial pathogen should cause concern (Briggs and Fratamico 1999). 
In consequence of the various factors which are contributing to the development 
of resistance to antibiotic regimens, we are faced with increased difficulty in 
ensuring effective treatment of infections caused by Salmonella species, In 
some less economically developed countries, Salmonella infections are 
endemic. In addition, as global travel becomes more common and accessible, 
more opportunities for widespread dissemination of Salmonella-associated 
infection can be envisaged. As a result, there is an urgent need to identify new 
bacterial targets to enhance the development of novel antimicrobial therapies.  
 
1.3.3 Vaccines 
 
While it is possible to use Salmonella vaccines to immunise against Typhoid 
infections, they also have potential to be used as vaccine vectors or multivalent 
vaccines to deliver foreign antigens. The strains which are used for vaccines 
need to be stable, and provide long term protection, but there is a difficult 
balance between their ability to provoke an immune response (immunogenicity) 
and their capacity to produce an adverse reaction (reactogenicity) which must 
be achieved (Everest, Griffiths et al. 1995; Pasetti, Levine et al. 2003).The 
World Health Organization commissioned several trials during the 1960s of two 
potential vaccine candidates in areas where typhoid was endemic at that time, in 
Poland, the USSR, Yugoslavia and British Guyana (Cvjetanovic and Uemura 
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1965). This compared the performance of a heat-phenol inactivated vaccine to 
an acetone-dried inactivated vaccine. Both gave good protection in the short 
term, but results were not so notable in a long term study carried out later in 
Tonga (Tapa and Cvjetanovic 1975), and both vaccines caused side effects 
which ranged from injection site reactions to headache and fever over 1 to 2 
days. Such reactions tended not to prevent return of the participants for the 
follow-up injection. Other work also considered the differences in efficacy 
between heat-killed, chemical and alcoholised vaccines (Hejfec 1965), and 
found that while the heat-killed vaccine was more protective than either of the 
other two, that difference was probably mostly dose dependent, as were the 
reactogenicity levels. Ultimately, this reactogenicity has been linked to the 
bacterial LPS which remains in these ‘whole cell’ preparations (Hoops, Prather 
et al. 1976). 
The World Health Organisation advocates the use of two typhoid vaccines which 
are currently licensed worldwide; one, based on the Vi polysaccharide of S. 
Typhi is given parenterally, and the other, Ty21a is a live vaccine using an 
attenuated strain of S. Typhi which is administered orally (WHO 2009). Only the 
parenteral vaccine is approved by NICE for use in the United Kingdom. 
An interesting adjunct is that as a result of intensive annual vaccination of 
children in Asia, which use the Vi vaccine, a dramatic reduction in the number of 
cases of typhoid has been observed, across age groups which have not been 
specifically targeted by the vaccination programmes. This suggests that herd 
immunity is arising as a result of effective immunisation programmes (WHO 
2009). 
With the ongoing development of resistance to antibiotic treatment which is 
evident, there is no room for complacency, and the importance of making 
continued advances in the area of prevention of Salmonella infections should 
not be underestimated (DeRoeck, Jodar et al. 2007; Chakravortty 2010). 
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1.3.3.1  Purified Vi Polysaccharide 
The potential of the Vi capsule of S. Typhi as a protective antigen was 
investigated, and it was shown that earlier failed attempts to produce a vaccine 
using the Vi capsule had processed the Vi antigen in such a way that the protein 
was denatured (Robbins and Robbins 1984), and consequently incapable of 
initiating the desired immunogenic response. They developed a non-denaturing 
method for large scale purification of the capsule, which resulted in the 
development of a vaccine which has been in use since 1990. The vaccine has 
been shown to be highly effective, and suitable for use in young children, since it 
is much less reactogenic than it’s whole-killed-cell predecessor (Acharya, Lowe 
et al. 1987; Klugman, Gilbertson et al. 1987; Klugman, Koornhof et al. 
1996).Because of the requirement for a booster dose to be given every three 
years with this vaccine, it is not ideal in many regions of the World where 
Typhoid Fever is endemic. Consequently, work has continued and ongoing 
investigations continue to explore and maximise the efficacy of this type of 
vaccine (House, Ho et al. 2008; Kothari 2010; Staats, Kirwan et al. 2010) 
1.3.3.2  Live Ty21a 
A live, but attenuated, strain of S.Typhi provided the first oral vaccine used to 
combat Typhoid  Fever (Germanier and Furer 1975).This work initially attributed 
the avirulence of the strain, called S. TyphiTy21a, to the loss of functional galE, 
which resulted in the erroneous uptake of galactose which ultimately resulted in 
the lysis of the cells. However, it has subsequently been suggested that there 
are probably multiple mutations in the strain, due to the chemical method used 
to induce the attenuated phenotype (Silva, Gonzalez et al. 1987). Indeed, in 
addition to Vi capsular mutations and nutritional auxotrophies (Cryz and Furer 
1988), Ty21a is also deficient in rpoS (Robbe-Saule, Coynault et al. 1995). A 
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strain mutant only in galE also retains its virulence in humans (Hone, Attridge et 
al. 1988). 
The Ty21a vaccine requires several doses to generate immunity (Levine, 
Ferreccio et al. 1987), confirmed in work which also showed that the material 
used to make the capsule to contain this oral vaccine also affects its efficacy. 
However, it concluded that the Ty21a oral vaccine was a preferable tool to the 
whole killed cell alternative due to the lower reactivity which it caused in 
subjects. 
Because of its modest immunogenicity, and the fact that even after multiple 
doses, not all patients are protected from Typhoid Fever (Simanjuntak, 
Paleologo et al. 1991), it is necessary for the search for alternative and 
improved prophylactic solutions to be continued. 
 
1.3.3.3  Other Live Oral Vaccine Candidates 
In those regions of the World where Typhoid Fever presents the greatest risk to 
health, it is often also the most difficult to transport, store and administer 
vaccines safely. Often, other infections, such as HIV may also be prevalent in 
these areas, so the least invasive routes through which to provide immunisation 
are preferable. Consequently, oral administration is to be favoured, where 
efficacious candidates can be identified. Ideally, Salmonella strains can be 
modified so that while they are incapable of causing an infection, they are 
immunogenic enough to induce a protective immune response after only a 
single dose is administered. Staats et al. showed that oral dosing engendered 
both serum IgG and a secretory IgA response (Staats, Jackson et al. 1994). The 
gut mucosal system is critical to the body’s defence against, in particular, 
pathogens which cause enteric infections and diarrhoeal disease. In 1981, 
Hoiseth and Stocker proposed that a S. Typhimurium strain defective in aroA 
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and avirulent in mice, would be a good candidate for use as a live oral vaccine 
(Hoiseth and Stocker 1981). Later, the same aromatic pathway was mutated in 
S. Typhi by the deletion of aroA and aroC, to produce strain WBL2000 (Dougan, 
Chatfield et al. 1988), with later work refining the mutations further to produce 
vaccine strains CVD906 and CVD908, lacking aroC and aroD (Hone, Harris et 
al. 1991). Further work characterized strains BRD691 (mutated in aroA and 
aroC) and BRD1116 (with mutations in aroA, aroC and htrA), and showed the 
potential for use of these strains both as typhoid vaccines and vaccine vectors 
for other or multiple pathogens (Tacket, Sztein et al. 1997; Lowe, Savidge et al. 
1999). Later work has further engineered the strains to limit the virulence of 
potential vaccine strains by mutating the SPI-2 pathways, for example by 
deletion of aroC and ssaV (strain S. Typhi Ty2 ZH9), to provide highly 
attenuated yet immunogenic candidates for both human typhoid vaccines and 
potentially for delivery of heterologous antigens as vaccine vectors (Khan, 
Stratford et al. 2003).  
 
1.3.3.4  Vaccines for Other Diseases 
Along with other attenuated bacterial variants, Salmonella spp. have been 
investigated extensively as likely vectors (Curtiss, Galan et al. 1990; Galen, Nair 
et al. 1999; Stephens, Darsley et al. 2006).  The application of recombinant DNA 
techniques makes it possible for engineered strains of S. Typhi to express a 
range of antigens from other species which cause human disease, and hence to 
be exploited as oral vaccine vectors for afflictions other than Typhoid Fever. The 
fact that S. Typhi provides an efficient vehicle for oral immunisation makes them 
safer and easier to administer, and any risks or complications which arise due to 
the use of parenteral methods in connection with other blood-borne pathogens, 
such as HIV in many parts of the World, are minimised. Also, as mentioned 
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previously (Section 1.3.3.3), Salmonella vectors also induce powerful humoral 
and cellular responses from the immune system, helping to ensure effective 
immunogenicity (Levine, Galen et al. 1996). The possibility that such vaccines 
can also be used to immunize populations against several diseases in one dose, 
is also highly attractive both from an economic and practical standpoint (Tacket, 
Sztein et al. 1997; Roberts, Li et al. 1998). Recent work, in mice using an 
attenuated strain of S. Typhimurium, also suggests that an alternative mucosal 
route to oral administration may be by intranasal dosing which could be 
accomplished in a fairly simple spray (DiGiandomenico, Rao et al. 2007). 
Progress is also being made with vaccines to offer protection against Human 
Immunodeficiency Virus (HIV) infections using Salmonella or Shigella vectors 
(Devico, Fouts et al. 2002; Chin'ombe, Bourn et al. 2009).  
Another exciting possibility is that of using Salmonella vectors to deliver anti-
tumour therapeutics directly to the site, or sites in metastatic disease, of 
cancerous, and possibly malignant, tumours (Pawelek, Low et al. 1997); 
potentially, Salmonella as a RNA interference vector (Basu and Herlyn 2008) 
could also be employed to deliver cancer gene therapies.  
Recent observations suggest that some disappointing results in human trials of 
some of these vector vaccines may, at least in part, be due to the over-
attenuation of vaccine vector strains which has caused a loss of immunogenicity 
(Galen, Pasetti et al. 2009). However, with continued improvements in 
techniques, and the identification of more novel variants in which stability of the 
expression of antigens can be balanced with effective immunogenicity, further 
advances in this field will be possible.   
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1.4 Salmonella metabolism 
 
Salmonella is able to grow under both aerobic and anaerobic conditions 
(Yamamoto and Droffner 1985; Aliabadi, Warren et al. 1986; Gunsalus and Park 
1994). It is facultatively anaerobic, which means that it can carry out all 
necessary metabolism without oxygen, although when oxygen is available, it 
prefers to use that as the terminal respiratory chain electron acceptor until it has 
been exhausted, when it will switch to anaerobic respiration. Unlike strict 
anaerobes, such as Clostridium perfringens (Stickland 1934; Marrie, Haldane et 
al. 1981), or microaerophiles like Campylobacter jejuni (Lander and Gill 1980) or 
the closely related pathogen Helicobacter pylori (Pesci, Cottle et al. 1994), the 
presence of oxygen at increasing concentrations is not lethal to Salmonella. Its 
ability to switch to anaerobic metabolic activity means that Salmonella can then 
use other electron acceptors, such as nitrate. Naturally, this ability confers an 
advantage to Salmonella since as an enteric pathogen, it encounters a wide 
range of oxygen concentrations during its passage through the gastrointestinal 
tract. Until recently, this internal environment was thought to be largely 
anaerobic, but current thinking is that there are also many microaerobic niches 
within the gut (Jones, Chowdhury et al. 2007). 
Interesting work has recently reported that while a complete TCA cycle is 
advantageous to Salmonella during its occupation of epithelial cells, it survives 
better in macrophages if the TCA cycle has been interrupted (Bowden, 
Ramachandran et al. 2010). Bowden et al postulate that this may be linked to 
the inability of epithelial cells to mount a response through reactive oxygen or 
nitrogen intermediates, while that is a feature of the macrophage response to 
infection. They conclude however, as a result of the attenuation of such mutants 
in mouse infection, that a complete TCA cycle is necessary to ensure survival in 
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a range of different environments which may be encountered in the course of an 
infection. 
1.4.1 Metabolism of Glucose by Salmonella 
The favoured carbon source for most microorganisms is glucose, which contains 
six carbon molecules. The presence of glucose, even with another useable 
carbon source, often results in repression of the pathways capable of using the 
second source, until the glucose supply has been exhausted (Magasanik 1961). 
In Salmonella, (though also in E. coli), glucose is transported via the 
phosphoenolpyruvate : phosphotransferase system (Kaback 1968; Postma, 
Neyssel et al. 1982).Aerobic glucose metabolism produces 38 Adenosine 
Trisphosphate molecules (ATPs), the energy currency of the cell, from each 
glucose molecule; in contrast, only two ATPs are released under anaerobic 
conditions. This is because in the absence of oxygen as an electron acceptor, 
not all the carbon molecules can be oxidised to carbon dioxide. Salmonella 
makes use of the glycolysis fermentation pathway to release energy from 
glucose, which is less efficient than the aerobic pathway.  
Critically, Salmonella must also be able to metabolise successfully within the 
macrophage environment, and Bowden et al have shown that S. Typhimurium 
requires glycolytic processes and the transport of a supply of glucose within the 
SCV of macrophages (Bowden, Rowley et al. 2009). This was demonstrated by 
the inability of mutants in which vital genes involved in sugar transport and 
catabolism had been deleted to successfully replicate in macrophages or infect 
mice.  
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1.4.2 Metabolism of Glycerol by Salmonella 
In contrast to glucose, glycerol consists of a three-carbon chain, and unusually 
for carbohydrate transport, requires facilitated diffusion via a pore channel to 
enter E. coli (Heller, Lin et al. 1980). Anaerobic glycerol metabolism also frees 
two ATP per molecule of glycerol. 
1.4.3 Nitrate Metabolism by Salmonella 
Salmonella is able, along with E. coli, to use nitrate as a terminal electron 
acceptor during anaerobic respiration (Stewart 1988; Stewart 1993; Glaser, 
Danchin et al. 1995). Other bacteria, for example Pseudomonas aeruginosa, 
and including the enteric bacterium Klebsiella pneumonia also assimilate nitrate 
(Campbell and Kinghorn 1990). During assimilation of nitrate, reduction through 
nitrite to ammonium can provide the sole nitrogen source. Nitrate assimilation 
and anaerobic nitrate respiration are the two forms of nitrate reduction which 
occur in microbial metabolism. 
1.4.3.1  Nitrate Assimilation 
Nitrate is an important source of nitrogen for many microorganisms, including 
Salmonella (Lin and Stewart 1998). To enable microorganisms to handle 
nitrates safely, they possess a range of enzymes which are expressed under 
conditions where nitrate is present. Nitrate reductases comprise iron-sulphur 
clusters and a molybdenum cofactor, while nitrite reductases, which facilitate the 
next stage of nitrate reduction and detoxification incorporate sirohaem with iron-
sulphur clusters (Lin and Stewart 1998). However, during aerobic growth, 
neither Salmonellanor E. coli are able to assimilate nitrate (Ingledew and Poole 
1984; Stewart 1994; Glaser, Danchin et al. 1995; Stenuit, Eyers et al. 2006). 
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1.4.3.2  Anaerobic Nitrate Respiration 
A combination of two systems, anaerobic respiratory nitrate reduction and nitrite 
reduction, covered later, allow Salmonella and E. coli to use nitrate as a sole 
nitrogen source under anaerobic conditions (Neidhardt 1996). 
 
1.5 Salmonella and Reactive Nitrogen Species (RNS) 
 
The environment within the mammalian gastrointestinal tract has been shown to 
be largely anaerobic, and to contain high levels of nitrate. Since nitrate may act 
as a terminal electron acceptor for respiration in the absence of oxygen 
(Lundberg, Weitzberg et al. 2004), it could be anticipated that a link exists 
between nitrate reductase activity and Salmonella survival in the gut (Contreras, 
Toro et al. 1997). However, recent work using respiratory mutants of E. coli 
revealed that the intestinal environment varies between microaerobiosis and 
anaerobiosis (Jones, Chowdhury et al. 2007), since the cytochrome bd oxidase, 
which has a high affinity for oxygen, is vital for successful colonization. 
Consequently, it seems possible to deduce that the mammalian gut comprises 
both anaerobic and microaerobic niches. Interestingly, it has been shown that the 
terminal respiratory oxidase cytochrome bd in E. coli is potently inhibited by nitric 
oxide (NO) (Borisov, Forte et al. 2004). 
1.5.1 Reactive Nitrogen Species (RNS): an important 
component of the innate immune system 
 
1.5.1.1  Innate Mammalian Defence 
Innate host defence systems respond non-specifically to the presence of 
pathogens. The responses do not confer long-lasting or protective immunity or 
the establishment of immunological memory, such as occurs in the adaptive 
immune response (Levy, Koeppen et al. 2005). However, activity of the innate 
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defences may later result in activation of the adaptive immune system, through 
presentation of antigens (Kindt 2007).   
Innate immunity includes barrier defences, such as the integrity of the skin, which 
prevents entry of pathogens. The skin surface is also maintained at a slightly 
acidic pH by secretions, produced by hair follicles which contain lactic acid and 
fatty acids (Maggini, Wintergerst et al. 2007). Ciliary activity in the lungs expels 
foreign particles, including pathogenic microbes, by beating of the hair-like cilia in 
an upward direction (Levy, Koeppen et al. 2005). Coughing and sneezing 
responses also expel irritants. Mucus is produced in both the respiratory and 
gastrointestinal tracts, and this can trap microbes, preventing their further activity 
(Levy, Koeppen et al. 2005). The normal flushing by tears, saliva and urine also 
removes pathogens. Indeed, tears and saliva contain lysozyme which can 
destroy the cell membrane of Gram-positive bacteria, leading to bacterial lysis 
(Abergel, Monchois et al. 2007). The immune processes function together to help 
mammals to prevent infection by bacterial pathogens. 
 
  
1.5.1.2  Stomach Acidity and RNS 
One of the first innate mammalian defences to be encountered by ingested 
enteric pathogens is the acidic environment of the stomach. Here, acidity may 
dip as low as pH1 in the immediate post-prandial period (Levy, Koeppen et al. 
2005; Rychlik and Barrow 2005). Bacterial survival of the transit through the 
stomach is achieved through activation of the acid tolerance response (ATR), the 
mechanisms of which have been discussed in more detail previously. 
As well as directly stressing the bacteria, the acidity of the stomach converts 
dietary and salivary nitrite to NO, to produce nitrosative stress which the bacteria 
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must also survive. Nitrosative stress can cause changes to bacterial proteins 
which inhibits their normal functions, or inhibit DNA replication (Bang, Liu et al. 
2006), rendering the bacteria non-viable. Exogenous nitrogen species are 
introduced to the gut in the diet. Most dietary nitrate present in the 
gastrointestinal tract is produced from vegetables (Lundberg, Weitzberg et al. 
2004); beets, celery and leafy vegetables are especially rich in nitrates (Bryan 
2006).  In the oral cavity, salivary nitrate is reduced to nitrite by commensal 
bacteria on the tongue. In the stomach, the nitrite is acidified in a reaction with 
stomach acid, to nitrous acid, and subsequently by disproportionation to other 
nitrogen species, including NO (Equation 1) (Benjamin, O'Driscoll et al. 1994; 
van Wonderen, Burlat et al. 2008). Nitrite is also ingested in the diet, most often 
with cured and processed meats, to which nitrite is added as a preservative 
(Bryan 2006). Nitrite has also been shown to enhance mucus production at the 
epithelial surface of the gut (Bjorne, Petersson et al. 2004), which has 
ramifications for bacteria present in the gut which have already been described. 
Residual nitrate and nitrite are ultimately excreted in the urine, at levels similar to 
those ingested in the diet (Lundberg, Weitzberg et al. 2004), ensuring that in the 
normal, uninfected system, a steady state of nitrate and nitrite levels is 
maintained. Faeces and sweat have been shown to constitute only minor routes 
for excretion of nitrate and nitrite ions (Weller, Pattullo et al. 1996; Ten 
Bruggencate, Bovee-Oudenhoven et al. 2004). Nitrogen species are 
consequently found distributed throughout the length of the gastrointestinal tract, 
representing a serious problem for enteric pathogens, and potentially also for 
commensal bacteria. However, the presence of the commensal bacterial 
community may itself also generate production of reactive nitrogen species by 
enterocytes of the mammalian mucosa, (Macpherson, Martinic et al. 2002). This 
means that as well as competing with pathogens for space i
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commensal bacteria ensure a background response from the host immune 
system is switched on.  
 
Equation 1 – The disproportionation of Nitrite to Nitric Oxide 
 
 
 
 
 
 
1.5.1.3  Macrophages and RNS 
NO is produced by the normal constitutive activity of the L-arginine-NO pathway, 
which maintains various physiological functions like vascular tone, 
neurotransmission and platelet function (Levy, Koeppen et al. 2005). 
Endogenous NO is vital as a signalling molecule for many processes in the 
mammalian system, and is produced from the amino acid L-arginine and 
molecular oxygen by NO synthases (NOS) (Nelson and Cox 2004). There are 
three NOS isoforms; endothelial NOS (eNOS), neuronal NOS (nNOS) and 
inducible NOS (iNOS) (Moncada, Higgs et al. 1997). Basal plasma NO levels are 
generated by the endogenous L-arginine-NO pathway. The NO can be detoxified 
by reacting with oxy-ferrous haemoglobin (Hb(FeII)) (Gow and Stamler 1998), 
the form of haemoglobin in which oxygen can bind to it, and in mammals, the NO 
reacts with oxidized haemoglobin in red blood cells, to produce nitrate  
(Lundberg, Weitzberg et al. 2004). 
Macrophages use iNOS to produce NO, without the need for elevated 
intracellular Ca2+ which is required by eNOS and nNOS (Marletta 1994; Nathan 
(a)       NO2- +  H+ HNO2
(b)       2HNO2 H2O  +  N2O3
(c)        N2O3 NO• +  NO2•
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and Xie 1994; Griffith and Stuehr 1995; Michel and Feron 1997). Macrophages 
are mononuclear phagocytic leukocytes, which develop by differentiation from 
monocytes circulating in blood plasma. They operate in both innate and adaptive 
immunity. Some macrophages are migratory, flooding in to the site of an infection 
or to a breach in the immune barriers, while others are located in specific tissues, 
such as the Kupffer cells in the liver (Kindt 2007).  Macrophages form a crucial 
part of the early response of the immune system to attack by pathogens, and 
production of NO is a vital part of the macrophage armoury. Macrophages 
produce copious amounts of NO from iNOS activation, in response to the 
presence of interleukin-1 (IL-1) and tumour necrosis factor alpha (TNF-α), which 
are cytokines generated at the initiation of an immune response (Busse and 
Mulsch 1990). Another cytokine, gamma-interferon (IFN-γ) stimulates NO 
production via IFN-γ receptor signalling.  IFN-γ signalling causes the dimerization 
of Janus kinase (JAK) proteins, present in the macrophage cell membrane, and 
the subsequent recruitment of STAT proteins. Phosphorylation of the STAT 
proteins causes activation, dimerization and translocation to the cell nucleus, 
resulting in increased expression of the IRF-1 transcription factor. IRF-1 binds to 
the iNOS gene promoter region of the DNA and upregulates iNOS gene 
expression (Figure 3).  
The main modulator of NO production is Transforming Growth Factor beta 
(TGF-β); since NO is also toxic to host cells, NO production must be tightly 
regulated (Berg, Gupta et al. 2007). The consequence of a systemic 
inflammatory reaction is the elevation of the basal level of endogenous 
production of NO as part of the defence mechanism, by the induction of iNOS in 
macrophages that have been challenged. Oxidation of NO by oxidized 
haemoglobin can increase the levels of nitrate in plasma; the nitrate is secreted 
in saliva, to be reduced in the oral cavity to nitrite as explained earlier. As shown 
in Equation 1, the nitrite will be disproportionated to produce NO. Consequently, 
 59 | P a g e  
 
the levels of NO in the lumen of the gastrointestinal tract are also increased by 
the mammalian immune-mediated systemic inflammatory response. In patients 
with severe inflammation due to acute pancreatitis, total nitrite excretion is 
elevated (Rahman, Ammori et al. 2003), probably in response to the up-
regulation of iNOS activity. Inflammation caused by Salmonella infection 
(Stecher and Hardt 2008) could also increase the amounts of NO to which 
remaining bacteria in the gut are exposed. Increased levels of NO may also be 
toxic to non-pathogenic bacteria in the gut, and alter the balance of the normal 
gut flora. Host-mediated inflammation, such as that which occurs during the 
course of an infection by Salmonella, also disrupts the normal intestinal 
microbiota, and consequently upsets the normal equilibrium which ensures 
homeostasis within the gut. This can result in the provision of a competitive 
advantage to pathogenic enterobacteria (Lupp, Robertson et al. 2007; Stecher, 
Robbiani et al. 2007; Henard 2011). 
 
 
 
 
 Figure 3 - The signalling cascade for iNOS activation in 
interferon (IFN-γ) stimulates NO production by 
Janus kinase (Jak) proteins, present at the macrophage cell membrane. STAT proteins 
are recruited and phosphorylated to activate them; they also dimerise and translocate
the cell nucleus, increasing expression of the IRF
the iNOS gene promoter region of the DNA, upregulating iNOS gene expression, 
resulting in NO production. NO is able to diffuse through the macrophage plasma 
membrane 
 
 
macrophages.
dimerising IFN-γ receptor (IFN
-1 transcription factor. IRF
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Macrophages also produce reactive oxygen species (ROS) to attack invading 
microbes, in addition to generating nitrosative stress. The NADPH oxidase 
enzyme bound in both the plasma and phagosome membranes of macrophages 
uses one electron of molecular oxygen to form superoxide, a highly reactive free 
radical. In phagosomes, superoxide can spontaneously convert to hydrogen 
peroxide, to produce other ROS. One possible product is hypochlorous acid, the 
effective agent in bleach which is used to kill bacteria (Roos and Winterbourn 
2002; Winterbourn, Hampton et al. 2006). Hypochlorous acid production is 
catalysed by myeloperoxidase ((MPO)2) acting upon chloride and hydrogen 
peroxide in the phagosome (Winterbourn, Hampton et al. 2006), as shown in 
Equation 2.  
 
Equation 2 – The catalysis of hydrogen peroxide and chloride to hypochlorous 
acid 
 
 
To summarize, the intraphagosomal environment of the macrophage is 
potentially lethal to most invading bacteria. However, Salmonella employs a 
range of defence mechanisms to avoid, and ultimately, exploit, the 
characteristics of macrophages. Primarily, Salmonella uses the SPI-2 TTSS, 
which allows the secretion of effector proteins to inhibit normal macrophage 
function (Chakravortty, Hansen-Wester et al. 2002). 
 
 
MPO2
H2O2 +  2Cl                                                       2HOCl
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1.6 Nitric Oxide (NO) Detoxification 
The free radical NO• is highly reactive, and can form other toxic reaction 
intermediates and reaction products, or reactive nitrogen intermediates (RNIs) 
that enhance NO activity as an antimicrobial compound (Chakravortty and 
Hensel 2003). Mutations resulting from NO-induced damage to DNA have been 
observed in S. enterica (Wink, Kasprzak et al. 1991). In eukaryotic pathogens 
like Leishmania major, NO inhibits enzymes of the citric acid cycle (aconitase) 
(Green, Nacy et al. 1991). To overcome this stress, Salmonella employs at least 
three mechanisms, including the metalloenzymes cytochrome c nitrite reductase 
(nrfA), flavorubredoxin (norV) and flavohaemoglobin (hmpA). The activities of 
each of the three enzymes differ in their oxygen requirement. The anaerobic 
respiratory enzyme, NrfA, is only expressed and active in anoxic (an 
environment depleted of oxygen) or micro-oxic (an environment with low levels 
of oxygen present) conditions, and reduces either nitrite or NO to ammonium. 
NorV reduces NO to nitrous oxide (N2O) in either anaerobic or low oxygen 
conditions. HmpA acts in oxic (replete in oxygen) environments to oxidize NO to 
nitrate (Gardner and Gardner 2002), or in anaerobic conditions it reduces NO to 
N2O. In order to successfully manipulate mammals as hosts, pathogenic 
bacteria have evolved strategies for the detoxification of NO and the evasion of 
the ravages of the mammalian immune response. The resistance mechanisms 
used by Salmonella involve cytochrome c nitrite reductase, flavorubredoxin, and 
flavohaemoglobin and are described below. Figure 4 further illustrates the 
interplay between the various enzymes involved in NO detoxification. 
  
 
 
 
Figure 4 - Ammonification respiratory pathways in 
NO produced exogenously is able to diffuse across both the outer and inner membrane 
of Salmonella.  NO is detoxified anaerobically by enzymes such as cytochrome 
reductase (nrfA), flavorubredoxin (
work aerobically. The pathways of each enzyme differs in their oxygen requirement; 
NrfA is expressed in anoxic or micro
ammonium; NorV reduces NO to nitrous oxide (N
conditions; HmpA acts in oxic environments to oxidize NO to nitrate. In anaerobic 
conditions HmpA reduces NO to N
reductase NAD(P)H, which associates with the small subunit, NirD. NirB is a
anaerobic conditions and reduces NO
nitrate reductase system expressed under high nitrate concentrations, converting NO
to NO2-, while NAP is the periplasmic nitrate reductase system expressed under
limiting conditions. The periplasmic location of this enzyme suggests that NapA could 
carry out the first step in nitrate reduction and detoxification
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1.6.1 Cytochrome c nitrite reductase 
Cytochrome c nitrite reductase (NrfA) is a structurally and 
spectropotentiometrically characterized enzyme (Bamford, Angove et al. 2002; 
Burlat, Gwyer et al. 2005; Clarke, Kemp et al. 2008), which catalyses the 
reduction of nitrite to ammonia. In E. coli, NrfA has also been shown to reduce, 
and consequently detoxify, NO (Poock, Leach et al. 2002; van Wonderen, Burlat 
et al. 2008). In the related enteric pathogen Campylobacter jejuni, HmpA and 
NorV are absent, (Pittman, Elvers et al. 2007), although C. jejuni possesses a 
single domain globin, Cgb, which is inducible by, and protects against, nitrosative 
stress (Elvers, Turner et al. 2005).  
NrfA, positioned in the periplasm of the bacterial cell, is well placed to carry out 
the detoxification of NO before NO enters the cell. NrfA may provide the first line 
of defence in protection against RNIs (Pittman, Elvers et al. 2007). However, it 
has been shown that the presence of oxygen inhibits NrfA activity (Wang and 
Gunsalus 2000; Poock, Leach et al. 2002), suggesting that any potential role for 
NrfA exists under anoxic or micro-oxic environmental conditions.  
A study with E. coli NrfA using protein film voltammetry has unambiguously 
demonstrated that purified NrfA has a genuine NO reductase activity (van 
Wonderen, Burlat et al. 2008). At pH 7, the Km of Nrf for NO is around 300 µM, 
which compares to around 10 µM for nitrite.  It should be noted though that the 
NrfA kcat is very high. It can turnover NO at around 5000 e s-1, giving a catalytic 
efficiency (kcat/Km) of ~2x106 M-1s-1, which is an order of magnitude higher than 
that of flavorubredoxin (40x106 M-1 s-1) (Gardner, Helmick et al. 2002; Gomes, 
Giuffre et al. 2002; van Wonderen, Burlat et al. 2008). Thus even at NO 
concentrations well below the Km, turnover of NO by NrfA could be fast. For 
example, at the 10 µM NO levels produced extracellularly by activated 
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macrophages (Raines, Kang et al. 2006), it has been estimated that NrfA will 
reduce 27 NO s-1 (van Wonderen, Burlat et al. 2008). 
Given the higher Km for NO than nitrite it is plausible that important roles for NrfA 
as an NO reductase might occur in environments in which the NO concentration 
is higher than the nitrite concentration. Such environments might be found in the 
gastrointestinal tract where the acidic conditions of the stomach lead to nitrite 
disproportionating to a range of species, including NO(Equation 1). Since NrfA is 
a periplasmic protein its activity will be influenced strongly by the extracellular 
pH. However, NrfA is most active as an NO reductase at acid pH with activity 
demonstrated at pH3 (van Wonderen, Burlat et al. 2008), which would suggest 
that it would be active in a micro-oxic, acidic, NO-containing stomach 
environment.  
As well as being exposed to exogenous NO, Salmonella also produces NO, 
when exposed to increased levels of nitrite. It is interesting that in Salmonella, 
though not in E. coli, both NrfA and NirB have been excluded as candidates for 
this NO production; however, the membrane-bound nitrate reductase NarGHJI 
seems to be responsible for nitrite-induced NO production (Gilberthorpe and 
Poole 2008). Vasodilation and disruption of the tight junctions between epithelial 
cells are two effects of NO in the gut (Resta-Lenert, Smitham et al. 2005). It 
could be to the advantage of Salmonella to produce NO to cause these effects, 
to facilitate easier invasion of the epithelium, and access to sub-epithelial tissues. 
In addition, NO produced by Salmonella may kill other competing microbial 
populations in the gut, while Salmonella itself is capable of detoxifying the NO 
through various pathways involving  Nrf as already described, Nor and Hmp.    
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1.6.2 Flavorubredoxin 
Flavorubredoxin (NorV) is a nitric oxide reductase which reduces NO to N2O in 
anaerobic conditions (Gardner, Helmick et al. 2002; Hutchings, Mandhana et al. 
2002). NorV has been extensively studied in E. coli, and work on other 
proteobacteria, including S. Typhimurium, has demonstrated that both NorV and 
NorR are largely conserved (Tucker, D'Autreaux et al. 2004). NorR senses NO 
levels, and activates transcription of norV. In E. coli, activity of NorV contributes 
to bacterial resistance to nitrosative killing (Gardner, Helmick et al. 2002; 
Hutchings, Mandhana et al. 2002). However, NorV on its own is not required for 
E. coli survival in mouse macrophages (Pullan, Gidley et al. 2007) and is not 
required for Salmonella survival in mice (Bang, Liu et al. 2006). In a norR mutant 
of E. coli, NO is not reduced to N2O rapidly enough to prevent formation of nitrite. 
In cultures of E. coli norR mutants, nrfA expression is induced in response to the 
increase in nitrite, which combined with the continuing activity of HmpA (see 
below), would mask the loss of NorV, and could explain the lack of attenuation of 
the norV mutant in murine macrophages (Pullan, Gidley et al. 2007). 
 
1.6.3 Flavohaemoglobin 
Flavohaemoglobin (HmpA) is an enzyme containing an N-terminal haem group 
and a C-terminal reductase; it has been suggested that HmpA  may play a role 
in NO detoxification in both aerobic and anaerobic environments (Mills, Rowley 
et al. 2008). It is clear that in both Salmonella and E. coli, transcription of the 
hmpA gene is activated by the addition of NO (Poole, Anjum et al. 1996; 
Crawford and Goldberg 1998). In E. coli, the free radical nitric oxide is 
dioxygenated by HmpA to produce nitrate (Gardner, Gardner et al. 1998; 
Hausladen, Gow et al. 1998; Gardner 2005).Expression of hmpA in Salmonella 
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has been shown to be induced by NO, and repressed by intracellular iron, an 
important mechanism by which detoxification of NO is accomplished without 
causing oxidative stress (Bang, Liu et al. 2006). Such NO detoxification is vital 
for the survival of both oxidative and nitrosative stresses. A key regulator of 
HmpA expression is NsrR, which encodes a NO sensitive regulator (Bodenmiller 
and Spiro 2006). Purified NsrR from E. coli has been experimentally confirmed 
to contain an NO sensitive iron-sulphur cluster which is vital for effective DNA 
binding activity (Tucker, Hicks et al. 2008). Other recent work has demonstrated 
that hmp expression is repressed in the absence of NO by NsrR, resulting in 
protection of S. Typhimurium in vitro and in macrophages, from the effects of 
both oxidative and nitrosative stress (Gilberthorpe, Lee et al. 2007). Troxell et al 
have also recently demonstrated that HmpA is repressed by the Fur regulon in 
Salmonella, which is responsible for iron homeostasis in bacteria as a Ferric 
Uptake Regulator (Troxell, Fink et al. 2011). The work of Troxell et al also 
reinforces the link between Fur regulation and H-NS repressed genes. 
Other work reveals that hmpA is highly induced in S. Typhimurium inside 
macrophages (Eriksson, Lucchini et al. 2003), suggesting that HmpA is involved 
in the bacterial defence against nitrosative burst.  However, this is not the case 
in epithelial cells, where Salmonella is not exposed to the oxidative or nitrosative 
killing mechanisms (Hautefort, Thompson et al. 2007). S. Typhi also up-
regulates HmpA production inside human macrophages (Faucher, Porwollik et 
al. 2006), and a S. Typhimurium hmpA mutant is attenuated in human 
macrophages (Stevanin, Poole et al. 2002). Other work reports that hmpA 
mutants of the S. Typhimurium strain 14028 are attenuated in a C3H/HeN 
mouse virulence model (ityR – genetically resistant to Salmonella infection), but 
not in C57/BL6 mice (ityS– genetically susceptible to Salmonella infection) 
(Bang, Liu et al. 2006). C57/BL6 mice succumb to S. Typhimurium infection 
before they produce a nitrosative burst.  Candida albicans also uses two domain 
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flavohaemoglobins which are similar to Hmp which may explain at least in part 
how C. albicans overcomes the presence of otherwise toxic salivary nitrogen 
species when initiating oropharyngeal infections (Poole, Anjum et al. 1996). 
 
It is clear that NrfA, NorV, and HmpA play crucial roles in the detoxification of NO 
in anaerobiosis by Salmonella (Kim, Orii et al. 1999). Mills et al. (2008) 
constructed all possible combinations of norV, nrfA and hmpA single, double and 
triple mutants. Addition of NO to cultures of all single mutants and wild type 
strains caused a temporary growth arrest. In wild type, hmpA and nrfA single 
mutants, the growth rate recovered after a similar interval, but in the norV 
mutant, this recovery only occurred after a significant delay (Mills, Rowley et al. 
2008). This suggests an important role for NorV in anaerobic NO detoxification. 
However, as the norV mutant strain eventually recovered from the addition of 
NO, another enzyme, possibly NrfA or HmpA, must be responsible for 
detoxification of the NO in the absence of NorV. Double mutants revealed that 
the most severe growth arrest occurred in the ∆nrfA∆norV double mutant (Mills, 
Rowley et al. 2008). The continued presence of HmpA in this mutant was unable 
to compensate for the loss of NrfA and NorV, under anoxic conditions, which was 
consistent with some earlier work using E. coli (Gardner and Gardner 2002), but 
contrary to previous findings in Salmonella (Crawford and Goldberg 1998). 
Therefore the most important enzymes for continued growth of Salmonella in 
anoxic minimal glucose media after exposure to NO are NrfA and NorV. HmpA 
was shown to have a minor role in NO detoxification under anoxia, but a more 
important role in aerobic conditions (Mills, Rowley et al. 2008).  
Although a Salmonella strain that lacks NrfA, NorV and HmpA is hypersensitive 
to killing by NO in vitro, and is significantly more sensitive to NO than any of the 
single mutants, this same triple mutant is only partially attenuated during 
infection of cultivated murine macrophages or following intraperitoneal infection 
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of C3H/HeN mice (G. Rowley, unpublished data). These findings suggest that 
other mechanisms for NO detoxification exist which are induced during animal 
infection. 
As discussed previously, various nitrogen species are present in the 
gastrointestinal tract, which is also a largely anaerobic environment in mammals 
(Backhed, Ley et al. 2005). However, a microaerobic niche is potentially vital for 
successful occupation by E. coli in competitive environments (Jones, 
Chowdhury et al. 2007), challenging the established view of the gut as an 
exclusively anaerobic environment. Still, it is likely that Salmonella is exposed to 
NO, nitrate or nitrite, or all three, which must be detoxified to allow Salmonella to 
survive in the lumen of the gastrointestinal tract (Xu, Xu et al. 2001; Lundberg, 
Weitzberg et al. 2004). Figure 5 outlines the activities and functionalities of 
various NO detoxification enzymes in enteric bacteria. The NO detoxification 
mechanisms which Salmonella uses in the luminal environment of the 
gastrointestinal tract remain to be fully explored and understood. In contributing 
to this understanding, Bourret et al have elegantly demonstrated that nitric oxide 
prevents production of a de novo ATR by S. Typhimurium (Bourret, Porwollik et 
al. 2008). The authors propose that this suppression of the ATR contributes to 
the antimicrobial activity of nitrogen oxides, and have shown that this impacts 
both on oral virulence and faecal shedding of S. Typhimurium. It is interesting to 
note that induction of the ATR increases the vulnerability of Salmonella to 
succumb to oxidative stress (Greenacre, Lucchini et al. 2006). 
 Figure 5 – Involvement of enzymes in nitric oxide detoxification in enteric 
bacteria. Detoxification
NrfA, a cytochrome c nitrite 
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1.7 NR-A, Nap and NR
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systems, mainly nitrate reductases, in their respiratory pathways to deal with 
other compounds such as nitrate. 
nitrate reductase systems, which are the NarGHJI membrane
periplasmic Nap nitrate reductase and the NarZYWV isozyme of NarGHJI, as 
described earlier. The extent of any involvement 
systems in Salmonella 
 
 of NO is achieved through involvement of several enzymes. 
reductase (nrfA), reduces either nitrite or NO to ammonium;  
) reduces NO to nitrous oxide (N2O) in either anaerobic or low 
hmpA), works in oxic environments to 
n anoxic conditions HmpA reduces NO to N
-bound. 
-Z nitrate reductase systems
S. Typhimurium possesses three distinct 
-bound system, the 
of these three nitr
infection remains to be fully understood. 
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1.7.1 NR-A 
NR-A is the structurally defined NarGHJI membrane-bound nitrate reductase 
system expressed under high nitrate concentrations in anaerobiosis in E. coli 
(Stewart and Berg 1988; Jormakka, Richardson et al. 2004; Bertero, Rothery et 
al. 2005). Structurally, the enzyme comprises three subunits. The catalytic site 
(NarG) is a large molybdoprotein, with smaller iron-sulphur (NarH) and 
cytochrome b (NarI)subunits (Neidhardt 1996). NarJ is a chaperone protein vital 
to the assembly of this enzyme (Sodergren, Hsu et al. 1988; Blasco, Dos Santos 
et al. 1998). The active site for nitrate reduction, the NarG and NarH subunits, 
faces into the cytoplasm of the bacterial cell; the quinol oxidation occurs at the 
NarI subunit with accompanying release of protons to the periplasm (Sodergren, 
Hsu et al. 1988), while nitrate reduction is carried out at the NarG site with 
consumption of protons from the cytoplasm (Bertero, Rothery et al. 2003). When 
the NR-A operon is fully activated, it carries out 98% of the nitrate reductase 
activity in E. coli, under the regulation of FNR in anaerobiosis, and NarL-
Phosphate in nitrate-rich conditions (Bonnefoy and Demoss 1994).  In 
Pseudomonas aeruginosa, the narK1K2GHJI operon encodes two nitrate/nitrite 
transporters and a nitrate reductase (Schreiber, Krieger et al. 2007). Other 
pathogenic microbes also use similar transport and reductase systems, although 
regulation may differ between species (Fedtke, Kamps et al. 2002). Expression 
of the Mycobacterium tuberculosis narGHJI genes in a nitrate reductase E. coli 
mutant allowed anaerobic growth in the presence of nitrate (Sohaskey and 
Wayne 2003). This has been further refined to show that a M. tuberculosis narG 
mutant is unable to grow on nitrate, with the conclusion that NarGHJI is vital to 
M. tuberculosis in the assimilatory reduction of nitrate (Malm, Tiffert et al. 
2009).Expression of narG has been shown to be under strict positive control by 
FNR in E. coli (Ansaldi, Theraulaz et al. 2007). Recent work has concluded that 
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NarGHJI is responsible for NO production in Salmonella, in response to high 
levels of nitrite (Gilberthorpe and Poole 2008).This has been explored further by 
Rowley et al who have reported that it is a combination of sufficiency of nitrate, 
accumulation of nitrite and activity of the NarGHJI membrane-bound nitrate 
reductase in Salmonella which results in production of both nitrous oxide (N2O) 
and NO (Rowley, Hensen et al. 2012). It is interesting that the NarL 
transcriptional regulator component which lies upstream of the NarGHJI operon 
has been shown to be controlled by Fur in Salmonella enterica (Teixido, Cortes 
et al. 2010). Fur is a metalloregulator of Fe2+ cations within the cell, and a global 
regulator due to its involvement in both iron uptake and control of nitrate 
respiration due to the ability to sense the redox status within the cell. Other 
recent work has also confirmed that Fur exerts a negative regulatory effect on 
HmpA (Troxell, Fink et al. 2011).  
1.7.2 Nap 
Nap is the recently identified periplasmic nitrate reductase system where NapA is 
the catalytic enzyme, which in E. coli is expressed under nitrate limiting 
conditions. While this enzyme has been well explored in other bacterial species, 
such as Paracoccus denitrificans (P. denitrificans), previously known as 
Thiosphaera pantotropha (Berks, Richardson et al. 1995; Sears, Bennett et al. 
1995), in Salmonella, much work remains to be done. The Nap system has been 
characterized structurally and potentiometrically in E. coli (Jepson, Mohan et al. 
2007), using methods including crystallography, X-ray electrochemistry, and 
electron spin resonance spectroscopy. The large subunit (NapA) comprises a 
molybdoprotein with an iron-sulphur cluster (Breton, Berks et al. 1994), while the 
NapB subunit is the cytochrome b component of this enzyme (Berks, Richardson 
et al. 1994; Berks, Richardson et al. 1995). There is an additional cytochrome c 
encoded by the NapC subunit in E. coli and Salmonella (Bamford, Angove et al. 
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2002), although in several species (Wolinella succinogenes, Campylobacter 
jejuni, Shewanella oneidensis), this component is not an integral part of the  Nap 
operon (Simon, Sanger et al. 2003). Additional polypeptides are encoded by 
NapD and NapE subunits; it has been suggested that NapD plays a role in the 
maturation of NapA (Potter and Cole 1999; Brige, Leys et al. 2002). The precise 
function of NapE is, as yet, unknown, but has been predicted simply as an 
integral membrane protein (Simon, Sanger et al. 2003). Recent work suggests 
that it is possible for different arrangements of the subunits for the Nap operon to 
reflect the requirement for physiologically different processes depending on the 
environmental conditions which prevail (Simpson, Richardson et al. 2010), at 
least in the highly adaptive organism Shewanella.The periplasmic location of this 
enzyme suggests that NapA carries out the first step in nitrate reduction and 
detoxification. Nap is repressed in the presence of oxygen in denitrification and 
dissimilation to ammonia (nitrate ammonification) (Cruz-Garcia, Murray et al. 
2007). The genome sequence of E. coli revealed the Nap structural genes 
napFDAGHBC (Stewart, Lu et al. 2002). It may be that the Nap reductase, which 
has a higher affinity for nitrate than NR-A, is anaerobically induced when nitrate 
is limited, while NR-A is induced by a high concentration of nitrate (Potter, 
Millington et al. 1999; Constantinidou, Hobman et al. 2006). This has been borne 
out by recent work with Salmonella by Rowley et al (Rowley, Hensen et al. 
2012). In Shewanella, at least, regulation of Nap expression has been attributed 
to the oxygen responsive fumarate nitrate regulator Fnr, and the cAMP receptor 
protein (Crp) (Simpson, Richardson et al. 2010). Previously, it has also been 
shown (Stewart, Bledsoe et al. 2009) that in anaerobic and nitrate limited 
conditions, transcription of napF is also regulated by Fnr. In addition, the same 
work concluded that in E. coli, napF expression could be stimulated under 
energy limitation by Crp (Stewart, Bledsoe et al. 2009).  
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1.7.3 NR-Z 
It had been noted that narG mutants still displayed some residual nitrate 
reductase activity (Barrett and Riggs 1982; Iobbi, Santini et al. 1987), supporting 
the suggestion that a second nitrate reductase in addition to the NR-A system 
existed. NR-Z, encoded by narZYWV, is an isozyme of the membrane-bound 
nitrate reductase enzyme encoded by the narGHJI operon (Blasco, Iobbi et al. 
1990), and also comprises three subunits (Blasco, Pommier et al. 1992). The 
transcription unit for NR-Z is 73% homologous to that for NR-A, leading to the 
hypothesis that the presence of NR-Z in the E. coli genome has arisen due to 
duplication of a DNA fragment larger than the narGHJI operon, but including the 
components of the narGHJI operon. Nevertheless, the narZYWV (NR-Z)and 
narGHJI (NR-A) operons are regulated differently, and it has been suggested 
that expression of NR-Z is stress-related in Salmonella (Spector, Garcia del 
Portillo et al. 1999). The narZYWV operon is constitutively expressed in E. coli 
(Bonnefoy and Demoss 1994). Under aerobic conditions, the only anaerobic 
respiratory system shown to be induced is the nitrate reductase NR-Z, controlled 
by the alternative sigma factor RpoS, and expressed during the stationary 
growth phase (Chang, Wei et al. 1999; Rychlik and Barrow 2005; Clegg, Jia et 
al. 2006; Jones, Chowdhury et al. 2007). 
 
1.8 Summary and context 
Salmonella and other pathogens have clearly developed several overlapping or 
complementary systems to avoid the innate immune response and killing by NO. 
Helicobacter pylori have the capacity to inhibit the production of NO by 
eukaryotic host macrophage cells (Gobert, McGee et al. 2001). H. pylori inhibits 
macrophage NO production by competing with host cell iNOS for the available L-
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arginine used by NOS to produce NO. However, little is known about how entero-
pathogens such as Salmonella adapt to the biochemical environment of the 
mammalian gastrointestinal tract during the early stage of infection. Given the 
largely anoxic nature of the gastrointestinal tract, the ability of nitrate to serve as 
a terminal electron acceptor during anaerobic bacterial growth, and the relatively 
high levels of nitrate, it is possible that there is a connection between the process 
of bacterial infection, occupation of the gastrointestinal tract and nitrate 
dissimilation by Salmonella. The role of the three nitrate reductase systems of 
Salmonella, NR-A, Nap and NR-Z, has not yet been elucidated, and needs to be 
established in the successive environmental adaptations of Salmonella which 
must take place in order for successful infection, colonization and invasion to 
occur.   
Undoubtedly, further work to elucidate the role of NO detoxification by NorV, NrfA 
and HmpA in the growth and/or survival of Salmonella in the gastrointestinal tract 
is indicated. It is possible that other factors are involved in the survival of 
Salmonella in the gastrointestinal tract, not only in the detoxification of RNIs, but 
also by the dissimilation of nitrate. The functions and roles of various 
components of nitrate reductase systems are under investigation in our 
laboratory. An understanding of the precise role of different aspects of nitrogen 
metabolism and detoxification during infection could lead to the elucidation of 
novel opportunities and potential targets for the development of therapeutic 
approaches or vaccines.  
As described above, many virulence determinants for Salmonella have been 
identified and studied, but little attention has been paid to some aspects of 
Salmonella metabolism in relation to virulence (Darwin and Miller 1999; Wallis 
and Galyov 2000; Zhang, Kingsley et al. 2003).Salmonella is exposed to a range 
of reactive nitrogen species, during both the enteric and systemic phases of 
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infection. Salmonella Typhimurium has three distinct nitrate reductase systems, 
NR-A, Nap and  NR-Z, as outlined above.  
Since (i) the gastrointestinal tract is largely anaerobic, albeit with microaerobic 
niches (Jones, Chowdhury et al. 2007), (ii) nitrate can serve as a terminal 
electron acceptor during anaerobic bacterial growth (Lundberg, Weitzberg et al. 
2004), and (iii) there are relatively high levels of nitrate in the mammalian gut, 
perhaps bacterial infection, colonisation of the mammalian gastrointestinal tract 
and nitrate dissimilation are connected.  
The possibility that a link exists between nitrate, NO dissimilation and 
detoxification and gut occupation by Salmonella is an interesting one, and this 
project provides the first integrated view of the importance of nitrate reduction on 
gut colonization by an enteric pathogen. In the long-term, this will lead to the 
development of new strategies to defend the host against Salmonella infection. 
With changes between aerobic and anaerobic growth, there are also differences 
in the carbon substrates which are used for growth. Each of these substrates has 
a specific route which enables it to be catabolised and converted to energy, 
which in turn requires a specific set of enzymes. In the in vitro work in this study, 
Salmonella was grown and challenged aerobically and anaerobically using 
glucose and glycerol as different carbon sources, to investigate and identify any 
differences between some of the enzymes involved in nitrogen species as 
electron acceptors. 
The role of the three nitrate reductase systems in Salmonella infection will be 
assessed. For example, the nap operon encodes periplasmic nitrate reductase, 
and related proteins, that make up one of the three nitrate reductase systems of 
Salmonella, outlined previously. A nap operon deletion mutant has previously 
been tested for its ability to invade epithelial cells, and shows a 20-30% 
attenuation of invasive capability compared with SL1344 wild type (Alston et al., 
unpublished data), suggesting that the nap operon could play a role in the early 
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process of Salmonella infection. Other work on S. Typhi has found that mutants 
which were unable to use either nitrate or fumarate as their terminal electron 
acceptor were less invasive in epithelial cells than wild type (Contreras, Toro et 
al. 1997), leading this team to conclude that anaerobic respiration is a 
requirement to ensure successful invasion for S. Typhi. 
Targets for novel therapeutics or vaccines may be identified through 
development of an integrated view of any link between nitrate reduction and gut 
colonisation by enteric pathogens. 
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Chapter 2 - Materials and Methods 
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2.1 Bacterial strains and culture conditions 
 
The bacterial strains used in this study are derived from Salmonella 
Typhimurium wild type strain SL1344 (Hoiseth and Stocker 1981; Wray and 
Sojka 1984), and shown in Table 1. 
Table 1 - Strains and Plasmids used in this study 
Strain Genotype Reference 
SL1344 S.Typhimurium WT, His- Hoiseth and Stocker, 
1981 
JH3523 S. TyphimuriumSL1344 ∆narZYWV::kan 
 
This study 
JH3524 S. TyphimuriumSL1344 ∆narZ::kan 
 
This study 
JH3525 S. TyphimuriumSL1344 ∆narWV::kan 
 
This study 
JH3526 S. TyphimuriumSL1344 ∆narGHJI::kan 
 
This study 
JH3527 S. TyphimuriumSL1344 ∆narG::kan 
 
This study 
JH3528 S. TyphimuriumSL1344 ∆napDA::kan 
 
This study 
JH3529 S. Typhimurium SL1344 ∆narZYWV::cat 
 
This study 
JH3530 S. TyphimuriumSL1344 ∆narZ::cat 
 
This study 
JH3531 S. Typhimurium SL1344 ∆narWV::cat 
 
This study 
JH3532 S. TyphimuriumSL1344 ∆narGHJI::cat 
 
This study 
JH3533 S. TyphimuriumSL1344 ∆narG::cat 
 
This study 
JH3534 S. TyphimuriumSL1344 ∆napDA::cat 
 
This study 
JH3553 S. TyphimuriumSL1344 ∆narG::cat ∆napDA::kan 
 
This study 
JH3554 S. TyphimuriumSL1344 ∆narWV::cat ∆napDA::kan 
 
This study 
JH3555 S. Typhimurium SL1344 ∆narWV::cat ∆narGHJI::kan 
 
This study 
JH3556 S. TyphimuriumSL1344 ∆narZ::cat ∆narGHJI::kan 
 
This study 
JH3557 S. Typhimurium SL1344 ∆narZ::cat ∆narG::kan 
 
This study 
JH3558 S. TyphimuriumSL1344 ∆narZYWV::cat ∆napDA::kan 
 
This study 
JH3559 S. TyphimuriumSL1344 ∆narZYWV::cat ∆narG::kan 
 
This study 
JH3560 S. TyphimuriumSL1344 ∆narZ::cat ∆napDA::kan 
 
This study 
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Strain Genotype Reference 
 
JH3561 
 
S. TyphimuriumSL1344 ∆narWV::cat ∆narG::kan 
 
 
This study 
JH3562 S. TyphimuriumSL1344 ∆narGHJI::cat ∆napDA::kan 
 
This study 
JH3563 S. TyphimuriumSL1344 ∆narZYWV::cat ∆narGHJI::kan 
 
This study 
JH3564 S. Typhimurium SL1344 ∆narZ::cat ∆narWV::kan 
 
This study 
GR0281 S. TyphimuriumSL1344 ∆narZYWV::kan ∆narGHJI::cat 
∆napDA 
 
This study 
MG1655 E. coliK12  
 
 
 E. coliBW25141/pKD3 CGSC# 7631::cat 
 
Datsenko & Wanner, 
2000 
 E. coliBW25141/pKD4 CGSC# 7632::kan 
 
Datsenko & Wanner, 
2000 
 E. coliBW25113/pKD46 CGSC# 7630::amp 
 
Datsenko & Wanner, 
2000 
 S. Typhimurium LT2A(pCP20)::amp 
 
Datsenko & Wanner, 
2000 
 S. TyphimuriumSL1344 Wild Type:pMP220 
 
This study 
 S. TyphimuriumSL1344∆hilA:pMP220 
 
This study 
 S. TyphimuriumSL1344∆crp:pMP220 
 
This study 
 S. TyphimuriumSL1344∆fnr:pMP220 
 
This study 
 S. TyphimuriumSL1344∆rpoS:pMP220 
 
This study 
 S. TyphimuriumSL1344∆SO1(SPI-1):pMP220 
 
This study 
 S. TyphimuriumSL1344∆fisA:pMP220 
 
This study 
 S. TyphimuriumSL1344 Wild Type:pMP220:napF 
 
This study 
 S. TyphimuriumSL1344∆hilA:pMP220:napF 
 
This study 
 S. TyphimuriumSL1344∆crp:pMP220:napF 
 
This study 
 S. TyphimuriumSL1344∆fnr:pMP220:napF 
 
This study 
 S. TyphimuriumSL1344∆rpoS:pMP220:napF 
 
This study 
 S. TyphimuriumSL1344∆SO1(SPI-1):pMP220:napF 
 
This study 
 S. TyphimuriumSL1344∆fisA:pMP220:napF 
 
This study 
 S. TyphimuriumSL1344 Wild Type:pMP220:narG 
 
This study 
 S. TyphimuriumSL1344∆hilA:pMP220:narG 
 
This study 
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Strain Genotype Reference 
 S. TyphimuriumSL1344∆crp:pMP220:narG 
 
This study 
 S. TyphimuriumSL1344∆fnr:pMP220:narG 
 
This study 
 S. TyphimuriumSL1344∆rpoS:pMP220:narG 
 
This study 
 S. TyphimuriumSL1344∆SO1(SPI-1):pMP220:narG 
 
This study 
 S. TyphimuriumSL1344∆fisA:pMP220:narG 
 
This study 
 
 
The following media was used for culturing bacterial strains: 
• Luria-Bertani (LB) broth, (Sambrook and Russell 2001); 
 10g Bacto-tryptone, 5g bacto-yeast extract, 10g NaCl in 
1L water, pH adjusted to 7.2, and autoclaved at 121°C  
• LBS (modified LB with 0.3M NaCl final concentration); 
 10g Bacto-tryptone, 5g bacto-yeast extract, 20g NaCl in 
1L water, pH adjusted to 7.2, and autoclaved at 121°C  
• M9 broth (Sambrook and Russell 2001); 
 100mL 5xM9 salts, 1mL 1M MgSO4, 10mL 20% Glucose 
and 500µL 1M CaCl2, all sterilised solutions, in 375mL 
pre-autoclaved water  
• Lennox broth (Sambrook and Russell 2001); 
 10g Bacto-tryptone, 5g bacto-yeast extract, 5g NaCl in 1L 
water, pH adjusted to 7.2, and autoclaved at 121°C  
Plasmid Genotype Reference 
 
pKD3 
 
Template plasmid: pANT-S γderivative AmpR, FRT-
flanked catR gene 
(Datsenko and 
Wanner 2000) 
pKD4 Template plasmid: pANT-S γ derivative AmpR, FRT-
flanked kanR gene 
(Datsenko and 
Wanner 2000) 
pKD46 pINT-ts derivative (Ts-), araC+ PBAD (λβexo DNA 
fragments), AmpR 
(Datsenko and 
Wanner 2000) 
pCP20 bla cat pSC101 oriTS FLP-, λ cI857+,λpR  Repts, 
AmpR, CatR 
(Cherepanov and 
Wackernagel 1995) 
pMP220 IncP vector with promoterless lacZ, reporter plasmid, 
TetR 
(Spaink 1987) 
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• Xylose-Lysine-Desoxycholate (XLD) (Oxoid, product code CM0469); 
• non-lysogenic P22 transductants were screened on green plates 
(Bochner 1984); 
• Minimal Glucose Medium (MGM) (Mills, Rowley et al. 2008); 
 
o Per litre 
• KH2PO4     2.25g 
• K2HPO4     5.25g 
• Ammonium Sulphate   1g 
• Sodium Citrate    0.5g 
• Magnesium Sulphate   0.05g 
 ((NH4)6Mo7)24   1mL of 1mM solution 
(0.024g in 20mL water)  
 Na2SeO4    1mL of 1mM solution 
(0.003g in 20mL water 
 Magnesium Chloride  0.25mL of 30% solution 
 Manganese Chloride  0.25mL of 4% solution 
 Calcium Chloride  0.25mL of 0.51% solution 
 Iron Chloride   0,25mL of 1.85% solution 
Autoclaved at 121°C, and just prior to use, the addit ion of: 
 Glucose    50mL of 20% solution 
 Casamino Acids   1mL of 10% solution  
 
• Minimal Glycerol Nitrate (Fumarate) Medium (GN/GNF) (Mills, Rowley et 
al. 2008); 
o Per litre 
• KH2PO4     2.25g 
• K2HPO4     5.25g 
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• Ammonium Sulphate   1g 
• Sodium Citrate    0.5g 
• Magnesium Sulphate   0.05g 
 ((NH4)6Mo7)24   1mL of 1mM solution 
(0.024g in 20mL water)  
 Na2SeO4    1mL of 1mM solution 
(0.003g in 20mL water 
 Magnesium Chloride  0.25mL of 30% solution 
 Manganese Chloride  0.25mL of 4% solution 
 Calcium Chloride  0.25mL of 0.51% solution 
 Iron Chloride   0,25mL of 1.85% solution 
 Sodium Nitrate     1.9g 
Autoclaved at 121°C, and just prior to use, the addit ion of: 
 Glycerol   20mL of 2M solution 
 (Sodium Fumarate 40mL of 1M solution 
 Casamino Acids   1mL of 10% solution  
Ampicillin and Streptomycin antibiotics were used at 100µg/ml, Chloramphenicol 
at 10µg/ml, Kanamycin and Tetracyclin at 50µg/ml final concentration. 
 
2.2 Storage of Strains 
 
Long term storage of the mutants constructed was carried out by picking a 
single colony to set up an overnight culture in 5ml LB supplemented with the 
appropriate antibiotic, incubated at the appropriate temperature (30°C or 37°C). 
The culture was frozen down (930µl culture + 70µl Dimethyl Sulfoxide (DMSO) 
as a cryoprotectant) in 1ml cryotubes, at -80°C. 
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2.3 DNA Isolation 
 
2.3.1 Isolation of Bacterial Chromosomal and Plasmid DNA 
 
Rapid isolation of chromosomal and plasmid DNA for use as templates in 
polymerase chain reactions (PCR) was achieved by using a boilate method. A 
single colony was picked from a fresh plate and mixed in 200µl sterile water. 
This was boiled for five minutes at 100°C, centrifuged at 5000rpm in a 
microcentrifuge. A 2µl aliquot of the supernatant was used in a 50µl PCR 
reaction.  
 
2.3.2 Plasmid DNA purification 
Briefly, strains were grown overnight at 30°C, for pK D46 and pCP20, or 37°C for 
pKD3, pKD4 and pMP220, in LB broth containing the appropriate antibiotic. 
DNA purification was carried out using kits from QIAgen, according to their 
protocol, and based on the alkaline lysis method (Sambrook and Russell 2001). 
Purified plasmids were checked by agarose gel electrophoresis (0.8% agarose 
in 1xTAE with 0.5µg/ml ethidium bromide). 
 
2.4 Transfer of DNA 
 
2.4.1 Electroporation of Bacterial Cells 
 
Electrocompetent cells were prepared for the routine transformation of plasmid 
DNA and ligation reactions and also for mutant construction. Based on the 
technique described by Datsenko and Wanner, an overnight culture of the 
recipient strain of interest was diluted 100-fold in 25ml LB broth and cultivated 
until it reached a ∆OD600nm of between 0.6 and 1.0 (Datsenko and Wanner 
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2000). For gene deletion mutant construction, the cultures were carried out in 
Lennox broth containing 10mM L-Arabinose at 30°C. The  culture was 
immediately stopped on ice. Bacterial cells were harvested by centrifugation for 
5 minutes at 8000rpm at 4°C. The supernatant was remov ed and cells were 
washed three times in 20ml of sterile ice-cold 10% glycerol to remove excess 
salts from the growth medium. The electrocompetent cells were subsequently 
concentrated 100-fold in 10% glycerol and kept on ice until further processing. 
For long term storage, the cells were aliquoted by 50µl and snap frozen in a 
mixture of dry ice and ethanol, and stored at -80°C.   
To 50µl of electrocompetent cells was added 500ng to 1µg of the plasmid or 
PCR product. This cell/DNA mix was transferred to ice cold electroporation 
cuvettes, and electroporated using a Life Technology electroporator (capacitance 
330µF, low Ω, charge rate fast and 4KΩ), set to 2.5kV. Immediately following the 
electroporation, 1ml of pre-warmed broth was added to the electroporated cells 
and gently mixed by pipetting. Recovery of the cells was permitted at 30°C 
(pKD46 or pCP20) or 37°C (PCR products) for one hour.  Aliquots (10µl, 100µl 
and 200µl) were spread plated on selective medium and incubated overnight at 
30°C (pKD46 or pCP20) or 37°C (PCR product). A ‘no DNA’ negative control was 
set up for each experiment. 
 
 
 
 
2.4.2 Transformation using chemically prepared competent 
E. coli cells 
 
Chemically competent E. coli TOP10’ cells (Invitrogen) were also used for some 
ligation reactions. A 5µl aliquot of DNA at a concentration of 1µg/µl from a 
ligation reaction was added to 200µl of the competent cells and left on ice for 30 
minutes, then heat shocked at 42°C for two minutes. T hey were immediately re-
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incubated on ice for two minutes, and the 800µl of LB medium was added, and 
the cells were allowed to recover at 37°C in aerobic con ditions. After a one hour 
recovery period, the aliquot was centrifuged at 13000rpm in a microcentrifuge, 
the supernatant was discarded and the cells were resuspended in 400µl fresh 
LB medium. The transformed cells were spread plated on selective medium and 
incubated at the appropriate temperature. 
 
2.5 Mutagenesis 
Mutations were constructed by one step inactivation of chromosomal genes in S. 
Typhimurium strain SL1344 by PCR products, using the Lambda-Red (λ-red) 
inactivation technique (Datsenko and Wanner 2000). The λ-red method uses 
three genes, γ (Gam), β (Bet), and exo (Exo), to inhibit host RecBCD 
exonuclease V (by Gam) allowing Bet and Exo to promote recombination by 
accessing DNA fragment ends. A representation of the method is visualised in 
Figure 6. 
Chloramphenicol or kanamycin resistance cassettes were amplified by PCR 
from plasmids pKD3 and pKD4, respectively. Amplification was achieved by 
using primers listed in Table 2. The 5’ end of each primer carried a 40 base pair 
flanking region homologous to the upstream or downstream regions of the 
operon or gene to be deleted, linked to a 3’ region homologous to the antibiotic 
resistance cassette to be amplified. Each operon was to be replaced by both a 
kanamycin and a chloramphenicol resistance cassette to allow future 
combination of mutations. These PCR products were transformed by 
electroporation into the strain SL1344 harbouring the thermosensitive plasmid 
pKD46, which encodes the λ-red recombinase.  This plasmid allows inducible 
expression (after addition of L-arabinose) of the recombination functions 
necessary for the gene replacement approach. Chloramphenicol and kanamycin 
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resistant colonies were purified on selective plates. Gene and operon deletions 
were subsequently transduced with P22 HT105/1 int-201phage (Schmieger 
1972; Mann and Slauch 1997), back into a clean S. Typhimurium SL1344 
background to avoid possible non-intentional recombination events (Gemski and 
Stocker 1967). PCR amplification of the mutated genome region was used to 
check for loss of the targeted gene. Mutagenesis was confirmed by using 
primers designed externally to the chromosomal loci where the desired mutation 
should lie, as well as primers designed specifically to the antibiotic cassette. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 6 - Lambda red one
H1 and H2 indicate the homology regions, whilst P1 and P2 identify the 
A. Chloramphenicol or kanamycin resistance cassettes were amplified by PCR from 
plasmids pKD3 and pKD4, respectively;
B. These PCR products were transformed by electroporation into the strain SL1344 
harbouring the thermosensitive plasmid pKD46, which encodes the 
C.  Chloramphenicol and kanamycin resistant colonies were purified on selective plates
D.  Incubation above 30°C eradicated the temperature se nsitive pKD46
were subsequently transduced back into a clean 
avoid unintended recombination events.
PCR. 
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 Loss of the targeted gene was confirmed by 
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Table 2 – List of primers selected for specific deletion mutants 
 
 
2.5.1 P22 lysate preparation and transduction    
Overnight cultures of the mutants of interest were diluted 100 fold in 5ml LB 
broth, and incubated at 37°C in aerated conditions (250 rpm) for an hour. 10µl of 
P22 HT105/1 int-201 SL1344 lysate was added to these cultures and incubated 
for a further five hours. Cells were subsequently lysed by addition of 500 µl 
CHCl3. After at least one hour at 4°C, the lysates were centrifuged in order to 
separate phage particles and bacterial cell debris. The supernatant containing 
the lysate was transferred into clean tube and stored at 4°C after addition of few 
drops of CHCl3 for long term storage. Transductions of the mutations were 
Oligonucleotide Sequence (5’ to 3’) 
nargredf TTTATCAGAGAGCCGTAAGGTTCCACACAGGAGAAACCCGGTGTAGGCTGGAGCTGCTTC 
nargredr TTATCGAGATTCAGCACCATGCCGACTTGTGAACGAATTTCATATGAATATCCTCCTTAG 
nariredr AAAACTCCGCCGAAGCGGAGTTTAGGGCATCGAGAGAAAACATATGAATATCCTCCTTAG 
narzredf GACAGGATGGCGGAAAATTTATCGAAGCAGGAGAAATGTCGTGTAGGCTGGAGCTGCTTC 
narzredr TTATCGAGATTCAGTACCATCCCAACCTGTGAGCGTATTTCATATGAATATCCTCCTTAG 
narvredr TTTTTCTTTGCCCGGTAAGCGTATCCCCGGGCAAAGAGAACATATGAATATCCTCCTTAG 
narwredf TCAATATCACCGAAGTACGTGATAAAGCGGAGGGGGAATAGTGTAGGCTGGAGCTGCTTC 
napdredf GCTATCTGCCCCGTGTCAGCCATCAAAGCGGAGAACCACCGTGTAGGCTGGAGCTGCTTC 
naparedr GGCGGCCATTTTGGGGTTTCGCTGTACGGGACATAACGCGCATATGAATATCCTCCTTAG 
nargextf 
nariextr 
CGTTATCAATTCTCACGC 
AACGAAACAAGGCGGCGG 
narzextf 
narvextr 
CAACAATAACAACATACG 
TTCTCCTTTGACTGAAGA 
narwextf 
narvextr 
ACGGTTGCCACGGGTCGG 
TTCTCCTTTGACTGAAGA 
nargextf 
nargextr 
CGTTATCAATTCTCACGC 
CCTTCGCGACTGGTCCAG 
narzextf 
narzextr 
CAACAATAACAACATACG 
CCTTCACGTCCGGTCCAG 
napdextf 
napaextr 
TCCGGTATTTACCAGCCG 
GCGCCACGCCAACCGCCG 
NarGpromF GAATTCGCATTAACCGGTTC 
NarGpromR CTGCAGCGGGTTTCTCCTGT 
NapFpromF GAATTCTCTTCATTTGATTGT 
NapFpromR CTGCAGGATATCGCCCTTCC 
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carried out by addition of 10µl of the freshly prepared lysates to 90µl of an 
overnight culture of the recipient strain.  After 45 minutes incubation at 37°C the 
mix was plated on selective agar plates. Non-lysogenic colonies were selected 
twice on Green Plates where they appear pale green. Finally, the mutations 
were confirmed by PCR to ensure that disruption of genes had been achieved 
using the external primers listed in Table 2. 
 
2.5.2 Construction of double deletion mutants 
Transductions of the double mutants were carried out by addition of 10µl of 
lysates to 200µl of an overnight culture of the recipient strain. After 60 minutes 
incubation at 37°C the mix was plated on selective agar  plates. Non-lysogenic 
colonies were selected twice on green plates, and finally, the mutations were 
confirmed by PCR, using the primers listed in Table 2. 
 
2.5.3 Construction of triple deletion mutant 
The pCP20 plasmid was used to flip out the resistance cassettes from single 
operon deletion mutants SL1344∆narGHJI, SL1344∆narZYWV and 
SL1344∆napDA (Ellermeier, Janakiraman et al. 2002). The pCP20 plasmid is 
temperature sensitive and encodes for the FLP recombinase (Cherepanov and 
Wackernagel 1995) which was required to ‘flip’ out the region of DNA between 
the FRT sites as illustrated and described in Figure 6 above. Strains containing 
either the chloramphenicol or kanamycin resistance cassettes were transformed 
with pCP20, recovered and plated on LB with appropriate antibiotic at 30°C. 
Resultant colonies were restreaked on LB with appropriate antibiotic at 30°C, 
and tested for loss of the resistance cassette by patching onto selective plates. 
Subsequently, culture at 37°C prevented replication of  the pCP20 plasmid. The 
single deletion mutants, containing no antibiotic resistance cassettes could then 
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be used as recipient cells for further P22 transduction to produce double 
mutants, with resistance to one antibiotic, for example ∆narGHJI∆narZYWV 
KmR. This double mutant was then transduced with the P22 lysate for ∆napDA 
CtR to produce the ∆narGHJI∆narZYWV∆napDA triple deletion mutant, resistant 
to both kanamycin and chloramphenicol. Two successive purifications on green 
plates, and PCR amplification confirmed successful transduction of the 
mutations.  
 
2.6 Growth Curves 
2.6.1 Aerobic 
Single colonies of wild-type SL1344, and SL1344 mutant strains were picked 
from freshly streaked LB agar plates and cultured in 5ml LB, M9, or MGM broth 
at pH7, overnight at 37°C in aerated conditions (250r pm). The SL1344 strain of 
Salmonella is a histidine auxotroph, due to a hisG point mutation, so immediately 
prior to use, 0.02% of filter-sterilized histidine was added to the M9 minimal 
medium. Subsequently, 1000-fold dilutions of these overnight cultures were 
cultivated in triplicates in 25ml final volume of the appropriate pre-warmed media 
in 250ml flasks, in aerated conditions at 250rpm. In order to establish colony 
forming units from these assays, samples were taken of each culture, 10-fold 
serially diluted in Phosphate Buffered Saline (PBS), and plated on LB agar in 
order to determine the number of viable bacterial cells. This was repeated three 
times, and provided the data required to calculate viability from the optical 
density measurements in later assays. Additionally, 1ml of each culture was 
taken immediately following inoculation, for measurement of the optical density 
(OD) using a spectrophotometer set to take measurements at 600nm. 
Subsequent repeats of this procedure were carried out one hour after 
inoculation, then at 30 minute intervals for five hours. Colony forming units 
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(CFUs) were counted for each time point. A growth curve showing the CFUs/ml 
of culture was created, and association with the OD reading was established. 
 
 
 
2.6.2 Acid shock assays 
Single colonies of wild-type SL1344 and SL1344 mutant strains were picked from 
LB agar plates and cultured in 5ml LB pH7 overnight at 37°C in aerated 
conditions (250rpm). 1000-fold dilutions of these overnight cultures were 
subsequently cultivated in triplicate in 25ml final volume of pre-warmed LB media 
in 250ml flasks, in aerated conditions. After 2 hours (early log phase), 4 hours 
(mid log phase) and 7 hours (late log phase), the subculture was 25-fold diluted 
in pre-warmed LB pH7 and pH3. Samples were taken at 5, 15, 30 and 45 minute 
intervals from each 1:25 subculture, serially diluted in Phosphate Buffered Saline 
(PBS), and plated on LB agar in order to determine the number of viable 
bacterial cells. Colony forming units (CFUs) were counted for each time point.  
 
2.6.3 Artificial gastric juice assay 
Artificial gastric juice was prepared in accordance with the methods described by 
Mandalari et al (Mandalari, Faulks et al. 2008). 
Single colonies of wild-type SL1344, and SL1344 mutant strains were picked 
from LB agar plates and cultured in 5ml LB pH7 overnight at 37°C in aerated 
conditions (250rpm). 1000-fold dilutions of these overnight cultures were 
subsequently cultivated in triplicate in 25ml final volume of pre-warmed LB media 
in 250ml flasks, in aerated conditions. After 4 hours (mid log phase), 5.5 hours 
(mid/late log phase) and 8 hours (late/stationary log phase), subcultures were 
diluted 25-fold in pre-warmed gastric juice, with and without additional enzymes 
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(pepsin and gastric lipase analogue). Samples were taken at 15, 30 and 45 
minute intervals from each 1:25 subculture, serially 10-fold diluted in Phosphate 
Buffered Saline (PBS), and plated on LB agar in order to determine the number 
of viable bacterial cells. Colony forming units (CFUs) were counted for each time 
point.  
 
2.6.4 Acid / Nitrite Assay 
Single colonies of wild-type SL1344, and SL1344 mutant strains were picked 
from LB agar plates and cultured in 5ml LB pH7 overnight at 37°C in aerated 
conditions (250rpm). 1000-fold dilutions of these overnight cultures were 
subsequently cultivated in triplicate in 25ml final volume of pre-warmed LB media 
in 250ml flasks, in aerated conditions. After 2 hours (early log phase), 4 hours 
(mid log phase) and 7 hours (late log phase), 25-fold diluted subculture in pre-
warmed LB pH7 and pH3. Sodium Nitrate (NaNO2) was added to 761.5µM final 
concentration (McKnight, Smith et al. 1997). Samples were taken at 5, 15, 30 
and 45 minute intervals from each 1:25 subculture, 10-fold serially diluted in 
Phosphate Buffered Saline (PBS), and plated on LB agar in order to determine 
the number of viable bacterial cells. Colony forming units (CFUs) were counted 
for each time point.  
 
2.6.5 Anaerobic 
Single colonies of wild-type SL1344, and SL1344 mutant strains were picked 
from LB agar plates and cultured in LB or MGM or GN broth, overnight at 37°C in 
static conditions. The bottles were filled to the top and sealed with a screw cap 
and parafilm was applied so that the bottles became anaerobic quickly. 10-fold 
dilutions (250µl in 2.5ml medium) of these overnight cultures were subsequently 
inoculated into glass cuvettes, sealed with rubber septa and sparged with 
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nitrogen gas for 5 minutes. The cuvettes were cultured anaerobically at 37°C 
without shaking. Growth was monitored by measuring the absorbance OD at 
600nm (∆OD600nm) every hour. Before every reading was taken, the cultures were 
mixed by inversion to prevent settling of the bacterial cultures. 
 
2.6.6 Preparation of NO solution 
To ensure that nitrite would not form, water adjusted to pH3 was prepared by 
addition of HCl. In a 5ml glass bottle, sealed with a rubber septum and parafilm, 
3ml of pH3 water was sparged with nitrogen gas to remove all oxygen present. A 
gas-tight Hamilton syringe was used to add 7ml of nitric oxide gas in 1ml stages, 
by bubbling the gas through the liquid. The NO gas had been scrubbed with 
0.1M NaOH to remove impurities. This method produced a saturated NO solution 
of approximately 2mM concentration, and was used immediately following 
preparation to prevent degradation of the solution. 
 
2.6.7 Sensitivity of Salmonella strains to NO 
Cultures for anaerobic growth curves were prepared as outlined above. As the 
∆OD600nm absorbance reached 0.1, NO solution was added to a final 
concentration of 40µM in the cuvettes, using a gas-tight Hamilton syringe. The 
concentration of 40µM NO is physiologically relevant and equates to the NO 
concentration which is expected to be encountered in the macrophages of the 
mammalian innate immune response to infection. Following NO addition, 
monitoring of growth during incubation at 37°C was con tinued by measurement 
of ∆OD600nm. 
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2.7 Motility assays 
Minimal medium agar plates, with 10g bacto-tryptone, 5g NaCl and 4g agar 
(0.4%) per litre were made. These were inoculated with 1µl of overnight cultures 
of the strains to be tested, and 1:10 dilutions of the overnight cultures were used 
to assess the ∆OD600nm. The ∆OD600nm measurement was then used to calculate 
the number of bacterial cells in the overnight culture using an Excel spreadsheet 
for inoculum calculations based on an ∆OD600nm≈1.0 = 1.7x109 viable cells 
(G.Rowley). This allowed adjustments to be made when comparing motility 
between strains, depending on bacterial numbers in the original inoculum. The 
diameters of the motility zones on the plates were measured in millimetres. 
 
2.8 Epithelial cells – invasion assays 
Epithelial cells of the immortalised epithelial HeLa cell line were cultured in 
DMEM medium (Sigma) with 10% foetal bovine serum, 1% L-Glutamine and 1% 
non-essential amino acids, at 37°C and 5% CO 2.  
S. Typhimurium strains were grown on LB plates, and colonies were picked and 
suspended in 3ml PBS to form a cloudy suspension. The OD600nm of a 1:10 
dilution of the suspension was taken so that bacterial numbers present could be 
calculated.  Dilution ratio to ensure a multiplicity of infection (MOI) of 1:1 was 
calculated. 
If induction of the SPI-1 apparatus was required, S. Typhimurium strains were 
grown overnight in LB, and a 1:10 subculture in LBS cultured for one hour and 45 
minutes, to activate the SPI-1 T3SS in the bacteria. The bacteria were again 
incubated with epithelial cells at a multiplicity of infection ratio of 1:1. Bacteria 
which remained extracellular were killed after 30 minutes by the addition of 
30µg/ml gentamycin. After 30 minutes, the killing medium was replaced with a 
maintenance medium containing only 5µg/ml gentamycin. After 1 hour or 5 
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hours, the medium was removed, and the monolayer of epithelial cells was 
washed twice with sterile PBS. The epithelial cells were lysed using a solution of 
0.1% SDS, and serial dilutions of the intracellular bacteria were plated on 
selective plates and counted after overnight incubation at 37°C.     
Epithelial cells of the immortalised epithelial HeLa cell line were cultured in 
DMEM medium (Sigma) with 10% foetal bovine serum, 1% L-Glutamine and 1% 
non-essential amino acids, at 37°C and 5% CO 2.  
 
 
2.9 Macrophage cells – gentamycin protection assays 
Macrophage cells of the murine cell line RAW264.7 were cultured in MEM 
medium (Sigma) supplemented with 10% foetal bovine serum, 1% L-Glutamine 
and 1% non-essential amino acids, at 37°C and 5% CO 2.  
S. Typhimurium strains were grown on LB plates, and colonies were picked and 
suspended in 3ml PBS to form a cloudy suspension. The OD600nm of a 1:10 
dilution of the suspension was taken so that bacterial numbers present could be 
calculated.  Dilution ratio to ensure a multiplicity of infection (MOI) of 1:1 was 
calculated, and the bacteria were incubated with macrophage cells at a MOI of 
1:1. Bacteria which remained extracellular were killed after 60 minutes by the 
addition of 50µg/ml gentamycin. After 30 minutes, the medium was replaced with 
one containing only 10µg/ml. After 30 minutes for the 2 hour timepoint, or 22.5 
hours for the 24 hour timepoint, this maintenance medium was removed, and the 
monolayer of macrophage cells was washed three times with sterile PBS. The 
epithelial cells were lysed using a solution of 0.1% SDS and 1% Triton-X, and 
serial dilutions of the intracellular bacteria were plated on selective plates and 
counted after overnight incubation at 37°C.     
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2.10 Murine infection virulence assays 
Infections were carried out in accordance with the requirements of the Home 
Office, under the Scientific Procedures (Animals) Act 1986. 
 
2.10.1 Oral infection 
As the infection progresses in mice, bacteraemia and development of fever 
causes progressive changes in the behaviour and appearance of the animals, 
giving identifiable symptoms.  Four sets of symptoms (reduced activity, anorexia, 
hunched posture, ruffled fur) were scored, depending on the severity of each 
symptom observed, in each mouse at least twice daily, to ensure that 
unnecessary suffering was avoided. Mice were sacrificed at the latest on day five 
following infection, and gut contents were isolated from stomach, 
proximal/mid/distal small intestine, caecum and colon, weighed and 
homogenised in 200µl PBS. Tissue samples were also collected from small 
intestine Peyer’s Patches, spleen and liver. Peyer’s Patches were homogenised 
in 200µl PBS, and liver and spleen in 5ml PBS. All content and Peyer’s Patch 
tissue samples were serially diluted and plated on XLD agar containing 
streptomycin to exclude commensal enterobacteria. Spleen and liver tissue 
samples were plated on LB agar. Plates were incubated overnight at 37°C. 
Viable colonies were then counted, and CFU/g content/tissue calculated. 
 
2.10.1.1 SPI-1 induction method 
Salmonella strains were cultivated overnight in LB broth at 37°C in aerated 
conditions (250rpm). A 10-fold dilution of each strain was made in pre-warmed 
LBS, and incubated at 37°C for 1 hour and 45 minutes.  Cells were harvested by 
centrifugation at room temperature at 8000rpm for 10 minutes. The supernatant 
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was removed and cells were washed twice in PBS. The cells were subsequently 
concentrated so that 5x108 bacterial cells were contained in a 20µl dose volume. 
BALB/c mice were starved for 16 hours prior to infection. Water was removed 
from cages up to four hours prior to infection. Animals were infected orally with 
5x108 bacterial cells of each strain tested. Inoculae were serially diluted in PBS 
and plated on XLD containing streptomycin. 
2.10.1.2  Without SPI-1 induction 
Salmonella strains were cultivated overnight in 45ml LB broth at 37°C in static 
conditions.  Cells were harvested by centrifugation at 4°C room temperature at 
4000rpm for 15 minutes. The supernatant was removed and cells were 
resuspended in 3ml PBS. The ∆OD600nm measurement was then used to 
calculate the number of bacterial cells in the inoculum using an Excel 
spreadsheet for inoculum calculations based on an ∆OD600nm≈1.0 = 1.7x109 
viable cells (G.Rowley).The inoculum was subsequently diluted in PBS so that 
5x107 bacterial cells were contained in a 20µl dose volume. 
BALB/c mice were starved for 16 hours prior to infection. Water was removed 
from cages up to four hours prior to infection. Animals were infected orally with 
5x107 bacterial cells of each strain tested. Inoculae were serially diluted in PBS 
and plated on XLD containing streptomycin. 
 
2.10.2 Intra-peritoneal competitive index infection 
Salmonella strains were cultivated overnight in 45ml LB broth at 37°C in static 
conditions. Cells were harvested by centrifugation at 4°C, 4000rpm for 15 
minutes. The cells were resuspended in 3ml PBS, and the ∆OD600nm of a 1:10 
dilution used to calculate the dilution required to ensure that 2x103 cells, a 50/50 
mix of wild type and the mutant strain, would be administered in a 200µl dose. 
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Animals were infected by injection into the intra-peritoneal cavity with a mixed 
inoculum of 2x103 bacterial cells. The inoculae were serially diluted in PBS and 
plated on LB with streptomycin, and LB with streptomycin and kanamycin to 
select for the mutant strain only. Once the numbers of bacteria recovered had 
been calculated, the competitive index (CI) value was established by dividing the 
output ratio of both the strains by the input ratio of the two strains. 
The four sets of symptoms (reduced activity, anorexia, hunched posture, ruffled 
fur) were again scored, depending on the severity of each symptom observed, in 
each mouse at least twice daily, to avoid unnecessary suffering of the animals. 
Mice were sacrificed at the latest on day five following infection and the liver and 
spleen removed, weighed and homogenized in 5ml PBS. Spleen and liver tissue 
samples were plated on LB agar. Plates were incubated overnight at 37°C. 
Viable colonies were then counted, and CFU/g content/tissue calculated. The 
competitive index calculation (CI value) was calculated for each strain. This is 
done by dividing the CFU for each strain by the total CFU of all the strains to 
obtain a ratio of each strain in each organ, and related back to the original 
inoculum ratios for the strains. A value of around one showed that a mutant 
strain was capable of competing (and infecting) just as well as the wild type 
strain. Conversely, very low CI values of significantly less than one would 
demonstrate that a mutant strain was attenuated for infection in comparison to 
the wild type strain.   
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2.11 β-Galactosidase Activity Assays 
2.11.1 Aerobic Assays 
Aerobic β-Galactosidase Assays were carried out on strains of S. Typhimurium 
which had been transformed with the low-copy number lacZ promoter fusion 
reporter plasmid pMP220.  
10ml cultures in LB with tetracycline to select for the plasmid were grown 
overnight, and diluted 1:10 in fresh medium and grown to mid-log, demonstrated 
by OD600nm of close to 0.6. 1ml aliquots in micro-centrifuge tubes were incubated 
on ice for twenty minutes to stop further growth, then the cells were pelleted by 
centrifugation at 6000rpm for 10 minutes. The supernatant was removed and the 
cell pellet was resuspended to a volume of 1ml in chilled Z-buffer (see Section 
2.11.2 below). The OD600nm was recorded. 
Diluted 0.5ml cells in Z-buffer in further 0.5ml Z-buffer. Added 100µl chloroform 
and 50µl 0.1% sodium dodecyl sulphate (SDS), vortexed to mix and equilibrated 
at 28°C for 5 minutes. 
Start the β-galactosidase activity reaction by adding 0.2ml ONPG solution (see 
Section 2.11.3 below), which acts as a colour substrate to the enzyme, and a 
pale yellow colour similar to LB broth developed when incubated at 28°C. The 
reaction was stopped by adding 0.5ml 1M Na2CO3, which stops the reaction by 
raising the pH to 11. The time taken for the colour to develop was accurately 
recorded. 
A 1ml aliquot of the reaction mixture was centrifuged for 5 minutes at 13000rpm 
to remove debris and chloroform, and the OD550nm and OD420nm recorded. 
The units of enzyme activity were calculated in Miller Units as follows: 
1000 x (OD420 – (1.75 x OD550)) 
time (minutes) x volume (mls) x OD600 
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2.11.2 Z-Buffer 
Dissolve in H2O, 0.80g Na2HPO4.7H2O (0.06M); 0.28g NaH2PO4.H2O (0.04M); 
0.5ml 1M KCl (0.01M); 0.05ml 1M MgSO4 (0.001M); 0.135ml β-mercaptoethanol 
(BME) (0.05M); pH adjusted to 7.0. Make up to 50ml with H2O. 
2.11.3 O-nitrophenol-β-D-galactopyranoside (ONPG) 
ONPG to a final dilution of 4mg/ml dissolved in phosphate buffer (0.80g 
Na2HPO4.7H2O (0.06M); 0.28g NaH2PO4.H2O (0.04M); dissolved in H2O, 
adjusted to pH 7.0).Make up to 50ml with H2O. 
2.11.4 Anaerobic Assays 
Anaerobic β-Galactosidase Assays were also carried out on strains of S. 
Typhimurium transformed with the low-copy number lacZ promoter fusion 
reporter plasmid pMP220.  
Strains were cultured in universals filled with LB with tetracycline to select for the 
plasmid, overnight at 37°C in static conditions. The bot tles were filled to the top 
and sealed with a screw cap and parafilm was applied so that the bottles became 
anaerobic quickly. The overnight cultures were diluted 1:10 in Glycerol Nitrate 
(GN) medium in 3ml optical glass cuvettes, which were sealed with rubber septa 
and sparged with nitrogen gas for 5 minutes. The cuvettes were incubated at 
37°C for six hours. 1ml aliquots in micro-centrifuge tub es were incubated on ice 
for twenty minutes to stop further growth, then the cells were pelleted by 
centrifugation at 6000rpm for 10 minutes. The supernatant was removed and the 
cell pellet was resuspended to a volume of 1ml in chilled Z-buffer. The OD600nm 
was recorded. 
Added 100µl chloroform and 50µl 0.1% SDS, vortexed to mix and equilibrated at 
28°C for 5 minutes. 
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The β-galactosidase activity reaction was started by adding 0.2ml ONPG 
solution, and incubated at 28°C. The reaction was stopp ed by adding 0.5ml 1M 
Na2CO3. The time taken for the colour to develop was accurately recorded. 
A 1ml aliquot of the reaction mixture was centrifuged for 5 minutes at 13000rpm 
to remove debris and chloroform, and the OD550nm and OD420nm recorded. 
The units of enzyme activity were calculated in Miller Units as shown above.
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Chapter 3 –NorV, NrfA and HmpA, analysis of the 
activity of 
theSL1344∆norV∆nrfA∆hmpA triple 
mutant in the lumen of the murine 
gastrointestinal tract 
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3.1 Introduction 
 
Work carried out previously has investigated the sensitivity of the 
SalmonellaSL1344∆norV∆nrfA∆hmpAtriple deletion mutant to exposure to nitric 
oxide using in vitro methods (Mills, Rowley et al. 2008). This suggested an 
additive effect of NorV and NrfA in the defence against NO, and also a minor role 
for HmpA in the anaerobic detoxification of NO, with a larger role for aerobic NO 
detoxification by HmpA. Although the genes required for detoxification of nitric 
oxide in vitro may be established by using in vitro methods, in order to ascertain 
the effect on virulence of deletion of genes likely to be required for nitric oxide 
detoxification in vivo, the best model to use is the murine model. Only in this way 
can any physiological role be determined for any particular gene, or combination 
of genes. 
In this regard, other previous work has shown that the SL1344 
∆norV∆nrfA∆hmpA triple deletion mutant was not attenuated after intraperitoneal 
infection of mice, or in cultured murine macrophages (G. Rowley, unpublished 
data). However, intraperitoneal infection of mice does not expose Salmonella to 
the harsh environment of the murine gastrointestinal tract, containing various 
antimicrobial compounds together with the anaerobiosis generally observed in 
the gastrointestinal tract. The work carried out under the auspices of this project, 
using oral infection of mice, ensured that the mutant would be challenged within 
the gut environment via a more ‘natural’ route of infection in a truly in vivo 
fashion. Hence, work on this project aimed to complete the characterisation of 
the SL1344 ∆norV∆nrfA∆hmpA triple deletion mutant (strain called JH3518). 
The flavorubredoxin NorV of E. coli is a NO reductase which, sensitive to 
oxygen, assists NO detoxification in E. coli in anaerobiosis (Gardner, Helmick et 
al. 2002; Gomes, Giuffre et al. 2002). NorV is required by E. coli in the presence 
of the NO+ donor sodium nitroprusside (SNP) (Hutchings, Mandhana et al. 2002), 
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but since this chemical source of NO also produces other toxic substances, such 
as cyanide, there may in this case be other forces at work apart from NO 
sensitivity (Mills, Rowley et al. 2008). Upregulation of norV expression has been 
reported under conditions where NO has been increased from various sources 
(Flatley, Barrett et al. 2005; Justino, Vicente et al. 2005; Pullan, Gidley et al. 
2007). NorR is the NorV regulator which responds to the presence of NO to 
cause this phenomenon (Hutchings, Mandhana et al. 2002; Mukhopadhyay, 
Zheng et al. 2004). Within macrophages, in response to the NO burst, norV 
expression is upregulated (Eriksson, Lucchini et al. 2003), though E. coli survives 
here even without the NorV enzyme (Pullan, Gidley et al. 2007). 
The cytochrome c nitrite reductase NrfA has been structurally and 
spectropotentiometrically characterised (Bamford, Angove et al. 2002; Burlat, 
Gwyer et al. 2005; Clarke, Kemp et al. 2008). It catalyses reduction of nitrite to 
ammonia, and also reduces NO (Poock, Leach et al. 2002; van Wonderen, Burlat 
et al. 2008). Poock et al also showed that in E. coli, a nrfA mutant was more 
sensitive to NO in anaerobic conditions (Poock, Leach et al. 2002). The NO 
sensitive repressor NsrR is responsible for regulation of NrfA expression in E. 
coli (Filenko, Spiro et al. 2007). Recent work has also shown that in E. coli, NsrR 
downregulates activation of the nrf promoter which is in turn FNR-dependent 
(Browning, Lee et al. 2010) 
It has previously been established that HmpA, the cytoplasmic flavohaemoglobin 
enzyme in Salmonella and E. coli, works as a  NO dioxygenase (Crawford and 
Goldberg 1998; Gardner, Gardner et al. 1998; Hausladen, Gow et al. 1998). The 
activity of this enzyme as an anaerobic NO reductase required further 
elucidation. It is known to reduce NO to nitrous oxide in the absence of oxygen in 
E. coli (Kim, Orii et al. 1999), and in Salmonella, anaerobic sensitivity to S-
nitrosoglutathione (GSNO) has been demonstrated (Crawford and Goldberg 
1998). Some work had suggested that HmpA has a role in survival and 
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replication of Salmonella in macrophages (Stevanin, Poole et al. 2002; Bang, Liu 
et al. 2006; Gilberthorpe, Lee et al. 2007)  This may also offer some explanation 
of observations that virulence of Salmonella in mice is also supported by HmpA 
(Bang, Liu et al. 2006).It has been shown that Salmonella has the ability to 
produce NO endogenously, and it is likely that HmpA consumes this NO, 
consequently preventing inactivation of the FNR by the reaction of NsrR to the 
NO, thus maintaining NO homeostasis by preventing transcription of the FNR 
regulon which incorporates NrfA (Gilberthorpe and Poole 2008). NsrR is a key 
regulator in the circumvention of nitrosative stress for S. Typhimurium 
(Gilberthorpe, Lee et al. 2007), acting as it does as a transcriptional repressor 
(Tucker, Hicks et al. 2008).  
The infection in mice which is caused by S. Typhimurium is symptomatically very 
similar to that which is caused by S. Typhi in humans.  As early as 1974, Carter 
and Collins were able to demonstrate that following infection from three points of 
inoculation, the site of bacterial penetration was the distal ileum (Carter and 
Collins 1974). The bacterial inoculum can be administered either orally or 
intraperitoneally. Earlier work had already shown that following intra-peritoneal 
infection of BALB/c mice and murine macrophages, the triple SL1344 
∆norV∆nrfA∆hmpA mutant was not attenuated in vivo (Rowley et al., 
unpublished work). Since intra-peritoneal inoculation, in which the inoculum is 
dispensed directly into the peritoneal cavity which houses the intestines, stomach 
and liver, effectively bypasses the normal route of ingestion for enteric 
pathogens, it was decided for this work to use oral infection, which would more 
closely mimic the natural route of infection. Indeed, some work has shown that 
bacterial cells may be killed by low pH, such as would be encountered in the 
acidic stomach, combined with the presence of nitrate (Dykhuizen, Frazer et al. 
1996). Although the use of cultured cells, such as macrophages, may provide 
useful complementary data, since macrophages do provide an important niche 
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for replication of Salmonella during the infection process, it cannot be considered 
definitive, since it is not possible to replicate exact in vivo conditions during their 
use, so such models effectively provide ex vivo information (Mills, Rowley et al. 
2008).    
 
3.1.1 Attenuation of the SL1344∆norV∆nrfA∆hmpA triple 
mutant in the lumen of the murine gastrointestinal tract 
 
To determine whether the triple mutant was attenuated following oral infection, 
bacterial loads in a range of organs was calculated post infection. The first 
experiment which was conducted to provide a comparison between population 
levels reached in vivo by both the wild type and ∆norV∆nrfA∆hmpA triple mutant 
appeared to show that some attenuation occurred (Figure 7). The inoculum was 
prepared using the SPI-1 inducing method described earlier. Bacterial loads from 
both the contents of various parts of the gastrointestinal tract and tissue samples 
are based on the numbers of viable CFUs which were extracted. Both strains 
were present in all intestinal compartments. Strikingly, the wild type strain 
reached higher population levels in all samples tested, particularly in the upper 
small intestine, than the mutant, suggesting that the norV, nrfA and hmpA genes 
might play an important role in the early stages of Salmonella infection when 
Salmonella resides in the gastrointestinal tract lumen. The mutant also reached 
lower levels than its parental strain in the spleen and liver. This last result was 
different to previous results obtained by Rowley et al. that showed that 
intraperitoneal infection of mice resulted in similar colonisation of the spleen and 
liver by both the triple mutant and the wild type strain. However, we speculated 
that the difference observed between the two strains here could result from the 
attenuation observed in the intestine of the animals. Less mutant cells might be 
able to survive and/or replicate inside the gastrointestinal tract lumen, so less 
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bacterial cells might maintain contact with and invade the epithelium, and hence 
reach the spleen and liver. We noted a high variability in the SL1344 wild type 
viable counts in the upper intestinal compartments, such as stomach and 
duodenum. This can result from the coprophagic habits characteristic of rodents; 
one animal might ingest some faecal pellets containing high levels of Salmonella 
when other animals from the same group might not, or not at the same time. This 
could bias the average population levels calculated in the upper intestinal 
compartments. Nonetheless, this initial set of experiments suggested a potential 
role of NorV, NrfA and HmpA in the upper part of the gastrointestinal tract, such 
as the stomach. 
However, subsequent repeat experiments failed to reproduce the results which 
were initially observed (Figure 8). It can be seen that any difference between the 
wild type and mutant survival in the gastrointestinal tract had been eroded, and 
systemically also, there is nothing to choose between the strains in terms of 
viable counts of bacteria which were harvested from the tissue samples. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 7 - Comparison of population levels of SL1344 Wild Type and SL1344 
∆norV∆nrfA∆hmpA triple deletion mutant in murine gut contents and tissue. 
of BALB/c mice (13 mice in total) 
following infection, the mice were sacrificed and gut contents and tissue were harvested. The
SL1344 Wild Type (blue bars) was present in higher numbers than the SL1344 
∆norV∆nrfA∆hmpA triple mutant (
 
 
 
 
were infected with separate strains of interest. Five days 
mauve bars). Error bars show the Standard Error of the Mean.
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Figure 8 - Later comparison of population levels of SL1344 Wild Type and SL1344 
∆norV∆nrfA∆hmpA triple deletion mutant in murine gut contents and tissue. 
BALB/c mice (10 mice in total) were infected with separate strains of interest. Five days following 
infection, the mice were sacrificed and gut contents and tissue were harvested. There was no 
difference in bacterial numbers present between S
∆norV∆nrfA∆hmpA triple mutant (mauve bars). Error bars show the Standard Error of the Mean.
 
 
L1344 Wild Type (blue bars) and the SL1344 
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3.1.2 In vitro assays to test the SL1344∆norV∆nrfA∆hmpA 
triple mutant 
 
3.1.2.1  Acid shock assays 
Growth curves carried out previously had shown that there was no difference in 
growth rate between SL1344 wild type and the SL1344 ∆norV∆nrfA∆hmpA triple 
mutant in either LB or M9 minimal media in aerobic conditions. However, initially at 
least, the oral infection of BALB/c mice described in Section 3.1.1 suggested that 
there was attenuation of the SL1344 ∆norV∆nrfA∆hmpA triple mutant when 
administered via the oral route. Since Salmonella is challenged by exposure to 
conditions of very low pH during gastric transit, it was decided that acid shock 
assays would also be performed. Conditions in the mammalian stomach are also 
at least partially aerobic (Rath, Wilson et al. 1999; Xu, Xu et al. 2001). 
The acid shock assays were carried out aerobically at neutral (pH7) and acidic 
(pH3) in LB medium, and showed that, regardless of the log phase to which the 
cultures had been grown, there is little difference between SL1344 wild type and 
the triple mutant (Figures 9, 10, 11) in their response to a highly acidic 
environment. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 - Early log phase acid shock assay for 
∆norV∆nrfA∆hmpA triple deletion 
assayed in Luria-Bertani broth at both pH7 and pH3 (by the addition of HCl). The data are the 
averages from three independent experiments, and the error bars show standard error of the 
mean. There was no differenc
(black bars) and Mutant, pH7 (dark 
within 15 minutes of their first exposure, Wild Type pH3 (open bars) and Mutant 
bars). By 45 minutes following exposure, no viable bacteria survived, and this was the same for 
both the SL1344 wild type and the SL1344 
 
Salmonella SL1344 Wild Type and SL1344 
mutant. Survival of early log phase Salmonella 
e in the growth at pH7 between the two strains, Wild Type, pH7 
grey bars). Both strains in pH3 broth were seriously debilitated 
∆norV∆nrfA∆hmpA triple deletion mutant.
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Figure 10 - Mid log phase acid shock assay for 
SL1344 ∆norV∆nrfA∆hmpA 
strains was assayed in Luria
data are the averages from three independent experiments, 
error of the mean. There was no difference in the growth at pH7 between the two strains, Wild 
Type, pH7 (black bars) and Mutant, pH7 (dark 
affected within 15 minutes of their first
(pale grey bars). The number of viable bacteria which survive reduced continuously over time 
up to 45 minutes following exposure and there was no difference in the response to pH3 
between the SL1344 wild 
 
 
Salmonella SL1344 Wild Type and 
triple deletion mutant. Survival of mid log phase 
-Bertani broth at both pH7 and pH3 (by the addition of HCl). The 
and the error bars show standard 
grey bars). Both strains in pH3 broth were 
 exposure, Wild Type pH3 (open bars) and Mutant pH3 
type and the SL1344 ∆norV∆nrfA∆hmpA triple deletion mutant.
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Figure 11 - Late log phase acid shock assay for 
SL1344 ∆norV∆nrfA∆hmpA 
strains was assayed in Luria
data are the averages from three independent experiments, and the error bars show standard 
error of the mean. There was no difference in the growth at pH7 between the two stra
Type, pH7 (black bars) and Mutant, pH7 (dark 
within 15 minutes of their first exposure, Wild Type pH3 (open bars) and Mutant 
bars). The number of viable bacteria which survive 
minutes following exposure and there was no difference in the response to pH3 between the 
SL1344 wild type and the 
 
 
 
Salmonella SL1344 Wild Type and 
triple deletion mutant. Survival of late log phase 
-Bertani broth at both pH7 and pH3 (by the addition of HCl). The 
grey bars). Both strains in pH3 broth were
reduced continuously over time up to 45 
SL1344 ∆norV∆nrfA∆hmpA triple deletion mutant. 
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In early-log phase, both the SL1344 wild type and mutant were susceptible to acid 
shock by the time they had been exposed to pH3 conditions for 15 minutes, and 
no viable bacteria remained in the pH3 cultures (Figure 9). This result is 
analogous to those achieved in other work, particularly where no pre-conditioning 
to induce the acid tolerance response by exposing to a lower pH has been carried 
out first (Foster 1991). 
In mid-log phase, once again there was a reduction in viable bacterial numbers 
noticeable by 15 minutes following exposure to pH3, with the numbers reducing 
progressively over time (Figure 10). This effect was also apparent for late-log 
phase cultures, although to a lesser degree, showing that late-log bacteria had a 
higher resistance to the effects of acid shock than those in earlier growth phases 
(Figure 11). Overall, however, there was no discernible difference between 
SL1344 wild type and the SL1344 ∆norV∆nrfA∆hmpA triple mutant under these 
acid shock conditions. 
 
3.1.2.2  Artificial gastric juice assay 
Work by Mandalari et al at the Institute of Food Research, Norwich (IFR) has 
resulted in the development of an artificial gastric juice, which can be used in a 
model gastric system to simulate digestion of food items (Mandalari, Faulks et al. 
2008). The artificial gastric juice contains egg   L-α-phosphatidylcholine, used to 
construct phospholipid vesicles within the juice, together with gastric mucosal 
enzymes pepsin and trypsin. The gastric juice was adjusted to pH3, to match the 
test carried out previously in the acid shock assay. However, the pH at which 
these enzymes operate in vivo is pH2.5. To test whether there was any difference 
between a purely chemical acid shock assay, and that which might be 
experienced in a more natural model, both SL1344 wild type and the SL1344 
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∆norV∆nrfA∆hmpA triple mutant were exposed to this artificial gastric juice using 
similar methods to those of the acid shock assays. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 12 - Early log phase gastric fluid assay for 
SL1344 ∆norV∆nrfA∆hmpA 
strains exposed to artificial gastric 
difference in survival the two strains, although the SL1344 Wild Type bacterial numbers (with 
enzymes = black bars, without enzymes = 
minutes exposure, In contrast, numbers of the SL1344 
= dark grey bars, without enzymes = pale 
period of exposure. Neither strain increased in viable bacterial numbers during the period of the 
assay, so growth and/or replication was inhibited in gastric fluid.
 
Salmonella SL1344 Wild Type and 
triple deletion mutant. Survival of early log phase 
juice. The data are from one experiment. There was no 
open bars) appeared to reduce between 15 and 30 
∆norV∆nrfA∆hmpA mutant (with enzymes 
grey bars) remained fairly static throughout the who
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Figure 13 - Late log phase gastric fluid assay for 
SL1344 ∆norV∆nrfA∆hmpA 
strains exposed to artificial gastric juice. 
strains, SL1344 Wild Type bacterial numbers (with enzymes = black bars, without enzymes = 
open bars) and SL1344 
enzymes = pale grey bars) was unaffected in either strain. It was interesting that, at least in the 
absence of pepsin and lipase enzymes, the SL1344 
may have shown some advantage over the SL1344 wild type in terms of its ability to grow
 
 
 
 
Salmonella SL1344 Wild Type and 
triple deletion mutant Survival of late log phase 
The data are from one experiment. Survival of both 
∆norV∆nrfA∆hmpA mutant (with enzymes = dark grey bars, without 
∆norV∆nrfA∆hmpA triple deletion mutant 
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There is little discernible difference in the observed effects of the artificial gastric 
juice between the SL1344 wild type and the SL1344 ∆norV∆nrfA∆hmpA triple 
deletion mutant regardless of the growth phase of the bacteria, as shown in 
Figures 12 and 13. However, survival of viable colony forming bacterial units is 
better in the artificial gastric juice than in acidified LB for all growth phases. There 
did appear to be a small growth advantage to the SL1344 ∆norV∆nrfA∆hmpA 
triple deletion mutant over SL1344 Wild Type in the late log phase experiment, as 
the mutant bacterial numbers increased slightly over the period of the assay. The 
presence of liposomes in the gastric juice may also offer protection to the 
bacteria, shown by improved survival when compared to acidified LB. Since only 
one experiment was completed using this method, further testing would be 
necessary to explore both possibilities. 
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3.2 Discussion 
Despite early results of in vivo experiments in which Balb/C mice were inoculated 
orally with both SL1344 wild type and the SL1344 ∆norV∆nrfA∆hmpA triple 
deletion mutant, which appeared to suggest that the mutant may have had 
increased virulence over the wild type, this effect could not be repeated and 
substantiated over subsequent experiments. The experiments were repeated 
several times, and this finding suggests that there are many other factors which 
contribute to successful Salmonella infections via the oral route. 
Work was extended into carrying out in vitro investigations looking at the effects of 
exposure to acid, such as would occur during the passage through the 
mammalian stomach during a natural infection. This also demonstrated little 
difference in the performance between the SL1344 wild type strain compared to 
the SL1344 ∆norV∆nrfA∆hmpA triple deletion mutant. 
Similar results were achieved following exposures of the wild type and mutant 
strains to synthetic gastric juice, and also an acid assay which included the 
addition of nitrite. 
Consequently, it was concluded that under the conditions which were tested, the 
SL1344 ∆norV∆nrfA∆hmpA triple deletion mutant was no more or less affected 
than the isogenic parent. 
This aligns with the findings of Rowley et al (unpublished data) when testing was 
carried out using intraperitoneal infection of Balb/C mice; their conclusions were 
that there was no difference in virulence between this mutant and the wild type. 
Such findings support the hypothesis that other mechanisms for NO detoxification 
exist which are induced during animal infection, and which remain to be 
elucidated. 
It is known that S. Typhimurium proliferation increases during an infection if NO 
production by the innate immune system of mice is constrained (Umezawa, 
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Akaike et al. 1997; MacFarlane, Schwacha et al. 1999). The ability of mutant 
strains of Salmonella to downregulate host NO production has also been 
demonstrated (Eriksson, Bjorkman et al. 2000). Since there are several 
pathogens which, as part of their normal infection strategy, survive intracellularly 
within their host, it follows that there must exist ways in which they circumvent 
attempts by the host immune system to eradicate them whilst there. Both S. 
Typhimurium and Mycobacterium tuberculosis, while inducing iNOS production in 
macrophages, are also able to detoxify both ROS and RNI. It has been shown 
that S. Typhimurium interferes with the recruitment of components required by 
phagocytic host cells to mount their defensive burst (Vazquez-Torres, Xu et al. 
2000). 
Recent work further suggests that transporters of nitrogen species may also be 
crucial for governing the interplay between NO and host defences in combating 
the effects of Salmonella infection (Das, Lahiri et al. 2009). Production of NO in 
response to IFN-γ activation of RAW264.7 macrophages is inhibited in 
macrophages infected with wild-type Salmonella, and the nitrite transporter nirC 
was found to be fundamental to this effect (Das, Lahiri et al. 2009). Apparently, 
then, some bacterial species, including Salmonella, are able to exert this effect on 
mammalian cells and in doing so, defend themselves from attack by NO, one of 
the main resources available to the mammalian immune response. 
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Chapter 4 –Construction of nitrate reductase 
mutants and their characterisation in 
vitro 
 
 
 
 
 
 
 
 
 
 
 123 | P a g e  
 
4.1 Introduction 
A wealth of work on E. coli, has demonstrated its ability to use nitrate as a 
terminal electron acceptor during anaerobic respiration (Stewart 1982; Stewart 
1988; Stewart 1993; Glaser, Danchin et al. 1995). Although E. coli can use 
oxygen, nitrate (or fumarate) as terminal electron acceptors, it will use the one 
with the highest redox potential which is available (Iuchi and Lin 1987). This 
would mean that the presence of oxygen prevents use of nitrate, the presence of 
which would in turn deny the use of fumarate.  
Although NorV, NrfA and HmpA are implicated in the detoxification of nitric oxide, 
and therefore potentially in the ability of Salmonella to survive the presence of 
this reactive nitrogen intermediate during its transit through the mammalian 
gastrointestinal tract, it is likely that there are other participants in this process. 
Many virulence determinants for Salmonella have been identified and studied, but 
some aspects of Salmonella metabolism in relation to virulence have attracted 
little attention to date (Darwin and Miller 1999; Wallis and Galyov 2000; Zhang, 
Kingsley et al. 2003). During the course of an infection, Salmonella is exposed to 
various reactive nitrogen species. Salmonella Typhimurium has three distinct 
nitrate reductase systems, NR-A, Nap and NR-Z, as outlined above.   
Also, because the gastrointestinal tract is largely anaerobic with microaerobic 
niches (Jones, Chowdhury et al. 2007), nitrate can be used as a terminal electron 
acceptor during anaerobic bacterial growth (Lundberg, Weitzberg et al. 2004). 
There are relatively high levels of nitrate in the mammalian gut and it is possible 
that bacterial infection, colonisation of the mammalian gastrointestinal tract and 
nitrate dissimilation are connected.  
Nitrate is a source of nitrogen for many microorganisms, including Salmonella 
(Lin and Stewart 1998). In nitrate replete conditions, microorganisms employ a 
range of enzymes with which to assimilate the nitrogen which they require, and 
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for detoxification of reactive nitrogen intermediates. Nitrate reductases comprise 
iron-sulphur clusters and a molybdenum cofactor, while nitrite reductases, which 
facilitate the next stage of nitrate reduction and detoxification incorporate 
sirohaem with iron-sulphur clusters (Lin and Stewart 1998). However, during 
aerobic growth, Salmonella is unable to assimilate nitrate and this is also true of 
E. coli (Ingledew and Poole 1984; Glaser, Danchin et al. 1995). 
Under anaerobic conditions, two systems, anaerobic respiratory nitrate reduction 
and nitrite reduction, facilitate the use by Salmonella and E. coli of nitrate as a 
sole nitrogen source under anaerobic conditions (Neidhardt 1996). 
In E. coli, the role of the periplasmic nitrate reductase, Nap, has been shown to 
be the scavenging of nitrate in conditions where the availability of nitrate is limited 
(Potter, Millington et al. 1999). By growing a series of double mutants which 
expressed only one nitrate reductase, anaerobically with glycerol as the carbon 
source and nitrate as the terminal electron acceptor, Potter et al found that only 
one strain, that retaining narGHJI grew well in these conditions. They also 
showed that loss of the nar gene resulted in enhanced growth of the Nap strain. 
However, in a limited nitrate environment, they found that the strain with intact 
Nap expression had a selective advantage. 
Other pathogens, as well as E. coli (Stewart 1982), may also use nitrate as a 
terminal electron acceptor for respiration in the absence of oxygen (Lundberg, 
Weitzberg et al. 2004), and there may be a link between nitrate reductase activity 
and Salmonella survival in the gut (Contreras, Toro et al. 1997), which has been 
considered to be an anaerobic environment. Work using respiratory mutants of 
E.coli revealed that the intestinal environment also harbours microaerobic niches 
(Jones, Chowdhury et al. 2007). Through the construction of mutants which 
lacked ATP synthase, necessary for respiratory energy-conserving metabolism, 
Jones et al showed that these mutants were unable to compete with wild-type 
strains. Further, they found that cytochrome bo(3) oxidase, used when oxygen 
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tension is high, was not required for successful colonisation, whilst cytochrome 
bd oxidase, used when oxygen tension is low, was necessary. Colonization by 
nitrate and fumarate reductase deletion mutants was also adversely affected, and 
Jones et al concluded that the ability to respire both anaerobically and 
microaerobically was a prerequisite.  
In E. coli, the membrane-bound nitrate reductase NarGHJI has been shown to be 
responsible for nitrite-induced NO production (Gilberthorpe and Poole 2008). 
Recently, it has been shown that a combination of sufficiency of nitrate, 
accumulation of nitrite and activity of the NarGHJI membrane-bound nitrate 
reductase in Salmonella results in production of both nitrous oxide (N2O) and NO  
(Rowley, Hensen et al. 2012). The NarGHJI system is also expressed under high 
nitrate concentrations in anaerobiosis in E. coli(Stewart and Berg 1988; 
Jormakka, Richardson et al. 2004; Bertero, Rothery et al. 2005). When nitrate 
was limited, Rowley et al also showed that the periplasmic nap genes were 
preferentially expressed, resulting in little production of N2O (Rowley, Hensen et 
al. 2012).  
Under aerobic conditions, the narZYWV operon (NR-Z) was thought to be 
constitutively expressed in E. coli (Bonnefoy and Demoss 1994). Later 
expression studies suggest that the NR-Z operon is controlled at transcription 
level, and in replete media is induced 10-fold in stationary phase (Chang, Wei et 
al. 1999). The NR-Z system, which is an isozyme of the membrane-bound nitrate 
reductase enzyme encoded by the narGHJI operon (Blasco, Iobbi et al. 1990), is 
also controlled by the alternative sigma factor RpoS, upon which NR-Z is highly 
dependent in minimal media (Chang, Wei et al. 1999; Rychlik and Barrow 2005; 
Clegg, Jia et al. 2006; Jones, Chowdhury et al. 2007). Other work has concluded 
that narZYWV has an important role in the survival of E. coli under conditions of 
stress and starvation, in which its expression is highly regulated (Spector, Garcia 
del Portillo et al. 1999). 
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This project investigated the possibility that a link exists between nitrate, NO 
dissimilation and detoxification and gut occupation by Salmonella. The 
importance of nitrate reduction on gut colonization by an enteric pathogen was 
targeted.  
The carbon substrates used preferentially by Salmonella also vary with changes 
between aerobic and anaerobic growth. Each substrate has a specific metabolic 
route, requiring specific enzymes, through which it is catabolised and converted 
to energy. The in vitro work in this study challenged Salmonella in both aerobic 
and anaerobic conditions, with carbon sources glucose and glycerol.  
In this way, the role of the three nitrate reductase systems in Salmonella infection 
would be assessed. Previous work has already indicated that a nap operon 
deletion mutant, tested for its ability to invade epithelial cells, showed a 20-30% 
attenuation of invasive capability compared with SL1344 wild type (Alston et al., 
unpublished data). This suggested that the nap operon may have a role crucial to 
the early stages of Salmonella infection. In the case of S. Typhi, it has been 
shown that anaerobic respiration is a necessary requirement for successful 
invasion, and this was demonstrated in mutants unable to use either nitrate or 
fumarate as their terminal electron acceptor (Contreras, Toro et al. 1997).  
In this chapter we investigated further not only the detoxification of a range of 
reactive nitrogen intermediates (RNIs), as well as the ability of Salmonella to 
dissimilate nitrate, strains of Salmonella lacking each and any of the three known 
nitrate reductase systems were constructed. 
This enabled investigation of any role played by nitrate reductase enzymes in the 
gastrointestinal tract. The mutants were constructed using the well-established λ-
Red one step gene inactivation technique (Datsenko and Wanner 2000). Some 
earlier work to investigate the relationships between expression levels of various 
genes in S. Typhimurium strains had already been carried out in this laboratory 
(Rowley, Alston, unpublished data). One interesting observation suggested that 
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genes of the Nap operon were co-expressed with those involved in SPI-1 
synthesis, which is known to be required for Salmonella to successfully invade 
epithelial cells. It was therefore reasoned that the mutants to be tested for this 
project should include those components of the Nap operon involved in the 
construction of the periplasmic nitrate reductase. In addition, both of the other 
known nitrate reductase systems were deleted, comprising narGHJI and 
narZYWV. 
 
4.1.2 Plasmid Purification from E. coli 
The λ-Red system for gene knockout is an efficient way to disrupt chromosomal 
genes, and is highly effective in Salmonella. PCR primers provide the homology to 
the target genes, and recombination requires the phage λ recombinase, which is 
synthesized under the control of an inducible promoter on an easily curable, low 
copy number plasmid. The use of plasmids which also confer antibiotic resistance 
ensures that the mutants obtained can be easily isolated as antibiotic resistant 
colonies, by using selective plating techniques. 
The template plasmids used were pKD3 and pKD4, containing chloramphenicol 
and kanamycin cassettes respectively. Another plasmid, pKD46, was used to 
provide the recombinase functions. Figure 14 illustrates the successful isolation of 
each of the plasmids from E.coli. 
The plasmid pKD46 was transformed into the SalmonellaSL1344 wild type strain 
by electroporation, to produce the SL1344 recipient strain which was used to 
construct the mutants. 
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Figure 14 - Plasmids pKD3, pKD4 and pKD46 were 
successfully isolated from E. coli to be used to confer 
chloramphenicol and kanamycin resistance and the 
recombinase functions respectively during construction of the 
Salmonella mutant strains  
 
 
 
4.1.3 Construction of gene deletions 
Chloramphenicol or kanamycin resistance cassettes were amplified by PCR from 
plasmids pKD3 and pKD4, using primers selected for the deletion of the narGHJI 
and narZYWV operons, narG, narZ, narWV and napDA genes, shown in Table 2. 
The chromosomal context for each of the nar and nap operons is illustrated in 
Figure 15. The resulting PCR products were transformed by electroporation into 
the strain SL1344 which was harbouring the pKD46 temperature sensitive 
plasmid. Chloramphenicol and kanamycin resistant strains for each of the gene 
deletions were constructed in this way. 
pKD3 
pKD46 
pKD4 
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Figure 15 - Chromosomal Context for each of the three nitrate reductase systems in Salmonella enterica 
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 4.1.4 Confirmation of gene knockouts
The deletion of the target genes
the external primers listed in Table 
Figure 16 illustrates the successful construction of each of the seven deletion 
mutants.  
 
 
 
 
 
 
 
 
 
 
 
(a)                                           
 
Figure 16 - PCR Confirmation of successful deletion of target genes and operon components.
napDA mutants, and 16b) shows 
mutants of each of the target genes were achieved. ‘WT’ indicates wild type. Three colonies per mutation were 
tested, along with wild type as a control.
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4.1.5 Creating the double and triple deletion mutants 
The double and triple deletion mutants were created by following the protocol in 
Section 2.5 above. Successful transductants were confirmed by double 
purification using two successive purifications on green indicator plates, to ensure 
that unstable P22 lysogens had been eradicated. PCR products were sequenced 
to check accuracy, although the PCR itself also confirmed the correct mutants. 
 
4.2 Growth Curves 
4.2.1  In LB and Minimal Glucose Medium (MGM) 
Growth curves were carried out using nutrient sufficient media and a minimal 
medium containing glucose as a carbon source, both aerobically and 
anaerobically, to ensure that the results of future assays would reflect only any 
other changes or alterations made to the assay. Also, it has been shown that cells 
grown in Minimal Glucose Medium (MGM) have low levels of endogenous nitrite 
reductase activity (Mills, Rowley et al. 2008). 
Figure 17 shows that in aerobic conditions and a nutrient replete medium (LB), 
there is no difference in growth between SL1344 wild type and the SL1344 nitrate 
reductase single and double mutants which had been constructed. 
Similarly,in MGM in which glucose is available as the carbon source, and aerobic 
conditions, there was no difference in growth between SL1344 wild type and 
SL1344 nitrate reductase double mutants (Figure 18). 
 
  
 
 
Figure 17 - Aerobic growth curve in Luria
Wild Type to nitrate reductase single and double gene deletion mutants. 
were grown in aerated conditions at 250rpm and 37°C  in LB medium, in which nutrients 
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Figure 18 - Aerobic growth curve in Minimal Glucose Medium (MGM) comparing 
SL1344 Wild Type to nitrate reductase double gene deletion mutants. 
grown in aerated conditions at 250rpm and 37°C in m inimal glucose medium (MGM) in 
which glucose is available as the carbon source. 
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4.2.2.  In Glycerol Nitrate (GN) Medium, +/- Fumarate (GNF) 
In aerobic growth in LB and also anaerobically in MGM, nitrate reductase deletion 
mutants were not growth inhibited compared to SL1344 wild type. Using glycerol 
as the carbon source, supplemented by nitrate and fumarate as respiratory 
electron acceptors, induces NrfA in E. coli (Darwin, Hussain et al. 1993). To 
further test whether the nitrate reductase mutants could grow in the presence of 
nitrate, the GNF medium developed in that work was adapted by removing the 
fumarate from it, and using anaerobic conditions.  
In anaerobic growth in Glycerol  Nitrate (GN) medium, there was no difference in 
growth between SL1344 Wild Type and SL1344 ∆narZYWV and ∆napDA (NR-Z 
and Nap respectively) nitrate reductase system single deletion mutants. In 
contrast however, growth of the SL1344 ∆narGHJI (NR-A nitrate reductase 
system) single deletion mutant showed a clear reduction compared to the wild 
type and other two single mutants. 
In a further comparison between SL1344 Wild Type and the ∆narGHJI single and 
∆narGHJI∆narZYWV∆napDA triple nitrate reductase deletion mutants, it was not 
only confirmed that the single mutant was growth inhibited, compared to the wild 
type, it also showed that growth of the triple deletion mutant was even more 
reduced (Figures 19 and 20). 
In conclusion, of the single nitrate reductase deletion mutants only the growth of 
the NR-A ∆narGHJI mutant was inhibited in this minimal medium. Since 
theSL1344 ∆narGHJI∆narZYWV∆napDA triple deletion mutant triple nitrate 
reductase deletion mutant also exhibited reduced growth in this medium, and in 
fact grew less well than the ∆narGHJI single mutant, I suggest that there are 
other contributory factors involved in nitrate reduction in this medium, and nitrate 
reductase activity is not restricted solely to the NR-A nitrate reductase system. 
 
  
 
 
 
 
 
Figure 19 - Anaerobic growth curve in Glycerol Nitrate (GN) minimal medium. SL1344 Wild 
Type compared to SL1344 single nitrate reductase mutants 
anaerobic conditions.  Absorbance was measured at OD600
rate of ∆narGHJI in anaerobic GN is significantly different (student t test, p<0.05) than the other 
strains. SL1344 Wild Type (
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
D
 
@
 
60
0n
m
 
 
Grown in GN at 37°C and 
nm over a period of 26 hours. 
) and SL1344 ∆narZYWV ()and ∆napDA 
Time (hours) 
135 | P a g e  
 
 Growth 
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Figure 20 - Anaerobic growth curve in Glycerol Nitrate (GN) minimal medium. 
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In conclusion, of the single nitrate reductase deletion mutants only the NR-A 
∆narGHJI mutant was growth inhibited in this minimal medium. The SL1344 
∆narGHJI∆narZYWV∆napDA triple deletion mutant triple nitrate reductase 
deletion mutant also exhibited reduced growth in this medium, and grew less than 
the ∆narGHJI single mutant, suggesting that not only the NR-A nitrate reductase 
system is involved in nitrate reduction in this medium. 
To explore the possibility of any contribution by the other nitrate reductase 
mutants to the inhibition apparent in the triple mutant, a further assay using the 
same conditions, with the addition of the double nitrate reductase mutants was 
carried out. 
As is shown in Figure 21, there was no difference in growth between SL1344 
Wild Type and SL1344 ∆narZYWV∆napDA (NR-Z and Nap systems) double 
nitrate reductase system deletion mutants. In contrast however, growth of the 
SL1344 ∆narGHJI∆narZYWV (NR-A and NR-Z systems) was initially reduced, 
but gradually recovered, though not to completely unaffected levels. Growth of 
the ∆narGHJI single mutant was still severely curtailed compared to wild type, but 
the most severely affected mutants were the ∆narGHJI∆napDA (NR-A and Nap 
systems) double and the triple ∆narGHJI∆narZYWVA∆napDA deletion mutants. 
This result suggested that the loss of both the NR-A and Nap nitrate reductase 
systems together accounts for the adverse effect on growth observed in the triple 
nitrate reductase system deletion mutant.  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 21 - Anaerobic growth in GN minimal medium, SL1344 Wild Type compared to 
∆narGHJI single, all double and the triple nitrate reductase system mutants. 
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While growth of the SL1344 ∆narZYWV∆napDA  (NR-Z, Nap nitrate reductase 
system) double mutant matches that of wild type, anaerobically in GN medium, 
growth of the SL1344 ∆narGHJI∆narZYWV double mutant is initially inhibited but 
later recovers, although without reaching similar levels as the wild type strain. 
Deletion of the ∆narGHJI NR-A system alone did not inhibit growth to the same 
extent as the loss of both the NR-A and Nap systems in the ∆narGHJI∆napDA 
double mutant, in which growth was as severely curtailed as that of the triple 
∆narGHJI∆narZYWVA∆napDA deletion mutant. Since growth of the NR-Z, Nap 
nitrate reductase mutant was unaltered from that achieved by the wild type, I 
suggest that the complete loss of growth in the triple mutant is in fact due to the 
loss of the NR-A and Nap systems, and not loss of the NR-Z system. 
To test whether substitution with a different electron acceptor would rescue 
growth in the mutants which showed growth inhibition in the GN media, Fumarate 
was added to the medium. 
Figure 22 shows that when grown anaerobically in GN minimal medium, with the 
addition of Fumarate as a replacement electron acceptor, there was no difference 
in growth between SL1344 Wild Type and SL1344 ∆narZYWV∆napDA  (NR-Z 
and Nap systems) double nitrate reductase system deletion mutant. In contrast 
however, growth of the SL1344 ∆narGHJI∆narZYWV (NR-A and NR-Z systems) 
double deletion mutant was initially reduced, but gradually recovered, though not 
to completely unaffected levels. Growth of the ∆narGHJI single deletion mutant 
(NR-A system only) was still severely curtailed compared to wild type, but the 
most severely affected mutants were the ∆narGHJI∆napDA (NR-A and Nap 
systems) double and the triple ∆narGHJI∆narZYWVA∆napDA deletion mutants. 
Clearly, the addition of fumarate did not rescue growth in those mutants. 
  
 
 
 
 
 
 
 
 
Figure 22 – Anaerobic growth in GN minimal medium, SL1344 Wild Type compared 
to ∆narGHJI single, all double and the triple nitrate reductase system mutants with 
the addition of Fumarate as a replacement electron acceptor to the GN minimal 
medium. Grown in GN + Fumar
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In order to characterize and summarize the growth profiles of all of the nitrate 
reductase system mutants, single and double system deletions as well as the 
triple nitrate reductase deletion mutant, in the presence of nitrate, a series of 
anaerobic growth curves using GN minimal medium and without the addition of 
fumarate was performed. 
For Figure 23, the growth was observed over a 24 hour period. No difference was 
apparent between the wild type and ∆narZYWV single deletion mutant. The 
∆napDA single deletion mutant and the ∆narZYWV∆napDA double deletion 
mutant grew at a similar rate as wild type for 10 hours, but thereafter, the decline 
in bacterial density occurred more quickly than for the wild type. In the case of the 
∆narGHJI single deletion mutant and the ∆narGHJI∆narZYWV double deletion 
mutant, growth was considerably curtailed over the initial 10 hour period. 
However, growth also continued for the next 14 hours, albeit at a very slow rate. 
Growth was most severely inhibited in the ∆narGHJI∆napDA double deletion 
mutant, and the triple ∆narGHJI∆narZYWV∆napDA deletion mutant. This 
suggests that the loss of the narGHJI operon and the napDA operon accounts for 
most if not all of the effect observed in the triple mutant. In contrast, loss of the 
narZYWV operon makes little if any contribution to inhibiting the growth of 
Salmonella in a minimal medium containing nitrate. 
To ascertain whether there was any further difference in the growth pattern, it 
was decided to carry out a similar assay over twice this time period, and the 
result of those assays is shown in Figure 24.  Over two days, the growth pattern 
for the wild type and the ∆narZYWV∆napDA double deletion mutant were very 
similar. Over the first twelve hours, the growth for the ∆narZYWV and ∆napDA 
single deletion mutants were very similar to each other, although markedly slower 
than for the wild type and the ∆narZYWV∆napDA double deletion mutant. 
However, between 12 and 36 hours, the differences between these four strains 
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were lost so that after 48 hours there is no significant difference between the 
bacterial densities in any of them.  
Noticeably, the other four mutants (∆narGHJI single deletion mutant, the 
∆narGHJI∆narZYWV and the ∆narGHJI∆napDA double deletion mutants and the 
∆narGHJI∆narZYWV∆napDA triple deletion mutant)all failed to thrive or grow. 
This confirms that of the three nitrate reductase systems, narGHJI has the major 
effect on growth in minimal medium containing nitrate.  
  
 
Figure 23 - Anaerobic growth over 24 hours in GN medium of 
wild type compared to single, double and triple nitrate reductase mutants.
type(), SL1344∆narZYWV
SL1344∆narZYWV∆napDA 
SL1344∆narGHJI∆napDA 
was measured at OD600
∆narGHJI,  ∆narGHJI∆
p<0.05) to WT in GN 
Mean for three separate experiments.
O
D
 
@
 
60
0n
m
 
 
Salmonella 
(),SL1344∆napDA (), SL1344
(), SL1344∆narGHJI∆narZYWV 
(), SL1344∆narGHJI∆narZYWVnapDA (
nm.  Final OD of ∆narZYWV∆napDA,  ∆
narZYWV∆napDA mutants significantly different (student t test, 
medium after 24 hrs. Error bars show the Standard Error of the 
 
Time (hours) 
143 | P a g e  
 
SL1344 
Wild 
∆narGHJI(), 
(), 
). Absorbance 
narGHJI∆napDA,  
  
 
 
Figure 24 - Anaerobic growth in GN medium over 48 hours of 
compared to single, double and triple nitrate reductase deletion mutants. 
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4.2.3  In MM5.8 Minimal Medium 
Since Salmonella is able to survive and replicate within macrophages, we wanted 
to test the ability of nitrate reductase mutants to grow in this environment. It was 
necessary to assess the fitness of the nitrate reductase mutants which had been 
constructed to grow and replicate in a medium which closely mimics the 
intracellular environment of the Salmonella Containing Vacuole (SCV) within 
macrophages.It has been shown that the internal environment of SCVs is acidic, 
and concluded that this acidity is in fact a requirement for Salmonella to 
successfully replicate within macrophages (Rathman, Sjaastad et al. 1996). This 
finding has been further refined to show that the assembly of the SPI-2 TTSS 
apparatus is dependent on an acidic environment (Beuzon, Banks et al. 1999; 
Rappl, Deiwick et al. 2003; Xu and Hensel 2010). The medium used was MM5.8, 
a minimal medium adjusted to pH5.8. The macrophage environment is likely to 
be also at least microaerobic, since it is bathed in the serum of oxygenated 
blood.Therefore, the assay was carried out in physiologically relevant conditions 
at 37°C and 5% CO 2, and the results of the growth assay carried out in this 
aerated medium are shown in Figure 25. 
In fact, there was no difference between the growth patterns observed for the 
SL1344 single, double or triple nitrate reductase mutant when compared to the 
SL1344 wild type strain in MM5.8 medium. 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 25 - Aerobic growth in MM5.8 medium, of 
compared to SL1344 single, double and triple nitrate reductase deletion mutants.
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4.3 Motility Assays 
As mentioned previously, (Section 1.6.1), Pseudomonas aeruginosa contains a 
narK1K2GHJI operon which encodes two nitrate/nitrite transporters and a nitrate 
reductase (Schreiber, Krieger et al. 2007). Other work has revealed that nar 
mutants in P. aeruginosa also suffer motility and swarming defects (Van Alst, 
Picardo et al. 2007). In E.coli, a∆hmp deletion mutant fails to show swarming 
motility (Stevanin et al, 2007). Other work has also shown that virulence of a 
nitrate reductase mutant of P. aeruginosa is attenuated in Caenorhabditis 
elegans (Van Alst, Picardo et al. 2007), which further strengthens the link 
between nitrate metabolism and motility and pathogenesis in this opportunistic 
human pathogen. In order to explore this aspect of the characteristics of the 
nitrate reductase mutants which have been constructed in Salmonella, motility 
assays using minimal medium 0.4% agar plates were carried out to test whether 
nar mutants in Salmonella would be similarly affected by the loss of one, all, or 
any combination of the nitrate reductase systems.  
The results of these assays are illustrated in Figure 26. In contrast to the findings 
reported for P. aeruginosa nitrate reduction mutants (Van Alst, Picardo et al. 
2007) and E. coli ∆hmp deletion mutant (Stevanin, Read et al. 2007), mutation of 
the nitrate reductase systems does not affect motility of S. Typhimurium. 
In P. aeruginosa, the production of the biosurfactant rhamnolipid or its precursor 
hydroxyalkanoyloxy alkanoic acid, is essential to the ability of the bacterium to 
adopt swarming motility, and this is in turn dependant on the presence of a good 
nitrogen source in the form of nitrate (Van Alst, Picardo et al. 2007). It is this 
mechanism which has been proposed as the relevant one in the observation of 
this effect on motility in P. aeruginosa which arises when the nitrate reductase 
enzymes have been compromised by mutation. 
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Figure 26 - Motility Assay to compare the ability of SL1344 Wild Type and each of 
the nitrate reductase single, double and triple mutants to remain motile in 0.4% 
agar. Differences in the number of bacteria inoculated to the plates was allowed for, and 
no difference in the motility of the bacteria was demonstrable. ‘WT’ denotes SL1344 wild 
type samples. 
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4.4 Discussion 
To facilitate characterisation of nitrate reductases in Salmonella, single, double 
and triple nitrate reduction deletion mutants were constructed. A combination of 
colony PCR and PCR analysis confirmed that the intended mutations had been 
induced in the Salmonella strains to be tested further, by both in vitro and in vivo 
methods. Some of the mutants produced have also been used successfully in 
another project (Rowley, Hensen et al. 2012).  
In either nutrient replete medium (LB) or minimal medium containing glucose 
(MGM), the growth of SL1344 nitrate reductase mutants is similar to that of 
SL1344 wild type, regardless of whether growth proceeds aerobically or 
anaerobically. In aerobic conditions, it was demonstrated that in LB, there was no 
growth difference between SL1344 wild type and the SL1344 nitrate reductase 
single and double mutants which had been constructed. Furthermore, there was 
no growth difference between SL1344 wild type and the SL1344 nitrate reductase 
single and double mutants given aerobic conditions and MGM. Even in anaerobic 
conditions which we might have expected to present a greater challenge to 
growth in the mutants, we observed no significant growth differences between 
SL1344 Wild Type and the ∆narGHJI nitrate reductase single deletion mutant. 
The addition of 40µM NO also exerted no effect on the NR-A operon deletion 
mutant. This is what would have been expected, since a nitrate reductase would 
be involved in the production of nitrite and subsequently nitric oxide, rather than 
their detoxification. It has recently been confirmed that both the membrane bound 
nitrate reductase (Nar) and the periplasmic nitrate reductase (Nap) are 
instrumental in the production of both NO and nitrous oxide (N2O) (Rowley, 
Hensen et al. 2012). Other work has shown that use of glycerol rather than 
glucose as the carbon source and supplemented with nitrate and fumarate 
induced expression of nrfA in E.coli (Darwin, Hussain et al. 1993). In E.coli, NrfA 
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requires fumarate, since it is the terminal reductase of the formate-dependent 
pathway of nitrite reduction to ammonia (Darwin, Hussain et al. 1993). However, 
supplementation of this respiratory electron acceptor is not required for nitrate 
reductases, pathways for which are not formate dependent. Consequently, to 
assess the ability of the  nitrate reductase mutants to grow in the presence of 
replete nitrate, the Glycerol Nitrate Fumarate (GNF) medium developed by 
Darwin et al was adapted, to remove the fumarate, and then tested against the 
nitrate reductase mutants in anaerobic conditions. Although no difference in 
growth betweenSL1344 Wild Type and SL1344 ∆narZYWV and ∆napDA (NR-Z 
and Nap respectively) nitrate reductase system single deletion mutants was 
established, it was interesting that the SL1344 ∆narGHJI (NR-A nitrate reductase 
system) single deletion mutant consistently and repeatedly showed a significant 
growth  reduction compared to the wild type and other two single mutants. Work 
elsewhere has found that a narG mutant of M. tuberculosis also fails to grow in 
nitrate replete broth media (Malm, Tiffert et al. 2009). Before speculating on what 
the reasons for this difference might be, comparison was also made between 
SL1344 Wild Type and the ∆narGHJI single and ∆narGHJI∆narZYWV∆napDA 
triple nitrate reductase deletion mutants. This confirmed the growth inhibition of 
the single mutant, and also demonstrated that growth of the triple deletion mutant 
was even more reduced.  The fact that the triple deletion mutant was even more 
growth inhibited than the single ∆narGHJI mutant suggested that not only the 
NR-A nitrate reductase system is involved in nitrate reduction in this medium. 
This idea was tested by carrying out further assays using double nitrate 
reductase mutants. There was no difference in growth between SL1344 Wild 
Type and SL1344 ∆narZYWV∆napDA (NR-Z and Nap systems) double nitrate 
reductase system deletion mutant. In contrast however, growth of the SL1344 
∆narGHJI∆narZYWV (NR-A and NR-Z systems) was initially reduced, and 
gradually recovered, though not to completely unaffected levels. Growth of the 
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∆narGHJI single mutant was still severely curtailed compared to wild type, but the 
most severely affected mutants were the ∆narGHJI∆napDA (NR-A and Nap 
systems) double and the triple ∆narGHJI∆narZYWVA∆napDA deletion mutants. 
From these results, it was possible to conclude that loss of both the NR-A and 
Nap nitrate reductase systems together inhibits growth almost completely, and 
accounts for the entire adverse effect on growth observed in the triple nitrate 
reductase system deletion mutant. These findings agree with those of earlier 
work on M. tuberculosis and E.coli in which it was shown that NarGHJI mutants 
were disadvantaged in replete nitrate under anaerobic conditions (Sohaskey 
2008; Malm, Tiffert et al. 2009). Growth of the SL1344 ∆narZYWV∆napDA  (NR-
Z, Nap nitrate reductase system) double mutant matches that of wild type, 
anaerobically in GN medium. However, growth of the SL1344 
∆narGHJI∆narZYWV double mutant is initially inhibited but later recovers, 
although without reaching similar levels as the wild type strain. This suggests that 
when Nap is present in the absence of NR-Z, expression of Nap is upregulated. 
Still, while the NR-A system could compensate for the loss of both the NR-Z and 
Nap systems, this was not reciprocal as the Nap system did not compensate 
completely for the loss of the NR-A system. This suggests that the complete loss 
of growth in the triple mutant is in fact due to the loss of the NR-A and Nap 
systems, and not loss of the NR-Z system. To elucidate whether availability of 
another electron acceptor would rescue growth in the mutants which showed 
growth inhibition in the GN media, fumarate was added to the medium. It was 
concluded that the addition of fumarate made no difference to the previous 
results and did not rescue growth in NR-A and Nap mutants. 
Growth profiles of all of the nitrate reductase system mutants which had been 
constructed were assessed, in nitrate replete anaerobic conditions, using GN 
minimal medium. Over a 24 hour period, it was established that there was no 
discernible difference between the growth of the wild type and ∆narZYWV single 
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deletion mutant. The ∆napDA single deletion mutant and the ∆narZYWV∆napDA 
double deletion mutant grew at a similar rate as wild type for 10 hours, but 
thereafter, the decline in bacterial density occurred more quickly than for the wild 
type. In the case of the ∆narGHJI single deletion mutant and the 
∆narGHJI∆narZYWV double deletion mutant, growth was considerably curtailed 
over the initial 10 hour period. However, growth also continued for the next 14 
hours, albeit at a very slow rate. Growth was most severely inhibited in the 
∆narGHJI∆napDA double deletion mutant, and the triple 
∆narGHJI∆narZYWV∆napDA deletion mutant. This suggests that the loss of the 
narGHJI  operon and the napDA operon accounts for most if not all of the effect 
observed in the triple mutant, and concurred with the earlier finding. In contrast, 
loss of the narZYWV operon makes little if any contribution to inhibiting the 
growth of Salmonella in a minimal medium containing nitrate. 
To ascertain any effects of an extra time period with replete nitrate, a similar 
assay was done over twice the initial time period. Over two days, the growth 
pattern for the wild type and the ∆narZYWV∆napDA double deletion mutant were 
very similar. Over the first twelve hours, the growth for the ∆narZYWV  and 
∆napDA single deletion mutants were very similar to each other, although 
markedly slower than for the  wild type and the ∆narZYWV∆napDA double 
deletion mutant. However, between 12 and 36 hours, the differences between 
these four strains were lost so that after 48 hours there is no significant difference 
between the bacterial densities in any of them.  
Noticeably, the other four mutants (∆narGHJI single deletion mutant, the 
∆narGHJI∆narZYWV and the ∆narGHJI∆napDA double deletion mutants and the 
∆narGHJI∆narZYWV∆napDA triple deletion mutant)all failed to thrive or grow. 
This also confirmed that of the three nitrate reductase systems, narGHJI has the 
major effect on growth in minimal medium replete with nitrate.  
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As Salmonella survives the harsh environment within mammalian macrophages, 
the fitness of the nitrate reductase mutants to grow and replicate in a medium 
which closely mimics the intracellular environment of the Salmonella Containing 
Vacuole (SCV) within macrophages was tested. Many intracellular pathogens are 
specially adapted to withstand the rigours of the harsh environment found within 
macrophages (Lavigne, O'Callaghan et al. 2005), and particularly with in the 
phagosome itself. Indeed, several, such as Toxoplasma, Leishmania, 
Mycobacterium, Legionella and including Salmonella spp., are exquisitely 
adapted to actually thrive in such surroundings (Amer and Swanson 2002). The 
phagosome content is mildly acidic and also low in magnesium ions (Mg2+) 
(Rathman, Sjaastad et al. 1996; Buchmeier, Blanc-Potard et al. 2000). In 
addition, neutrophils usually kill bacteria within phagosomes where superoxide 
and cytoplasmic constituents are contained. Myeloperoxidase is one such 
enzyme constituent, which converts chloride and hydrogen peroxide to 
hypochlorous acid (HOCl), which is strongly microbicidal (Winterbourn, Hampton 
et al. 2006).The macrophage intracellular environment is likely also to be at least 
microaerobic being bathed in the serum of oxygenated blood. Therefore, the 
assay was carried out aerobically. No difference between the growth patterns 
observed for the SL1344 single, double or triple nitrate reductase mutant when 
compared to the SL1344 wild type strain in MM5.8 medium was observed. This 
suggested that Salmonella has such a range of strategies to deal with the rigours 
of the macrophage attack that deletion of the known nitrate reductase systems 
does not compromise its survival under this set of challenging conditions.  
Other work has shown that both Pseudomonas aeruginosa and E. coli suffer from 
motility and swarming defects when the activity of their Nar nitrate reductase  or 
Hmp respectively is compromised (Schreiber, Krieger et al. 2007; Stevanin, Read 
et al. 2007). In motility assays carried out to assess any effect of this on 
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Salmonella, my results show that loss of the nitrate reductase systems in S. 
Typhimurium does not compromise motility.  
To conclude, the NarGHJI of Salmonella mediates the assimilatory reduction of 
nitrate, as shown by the failure to thrive of the ∆narGHJI deletion mutant in 
anaerobic GN medium.This is in agreement with work on M. tuberculosis (Malm, 
Tiffert et al. 2009). However, Nap is also able to compensate to some extent for 
the loss of NarGHJI in these conditions, since only growth of the 
∆narGHJI∆napDA double deletion mutant accounted for the complete 
attenuation of growth observed in the triple mutant. This allies with work on E. coli 
(Potter, Millington et al. 1999; Mohan 2007)and in M. tuberculosis (Sohaskey 
2008). This outcome was not improved by making another electron acceptor 
(fumarate) available. None of the deletions of nitrate reductases affected the 
motility of Salmonella, and this is at odds with the findings of previous work on P. 
aeruginosa (Schreiber, Krieger et al. 2007)and  E. coli (Stevanin, Read et al. 
2007). However, the triple mutant was shown to be more invasive in human 
epithelial cells than wild type, whether or not the SPI-1 TTSS had been induced 
prior to infection. This finding lead to in vivo work covered in the next chapter 
being  carried out to see whether this phenomenon was carried through into a 
mouse model of infection. As has been alluded to already, the nitrate reductases 
are instrumental in the production of both NO and N2O – perhaps this had some 
bearing on the invasiveness of Salmonella. Certainly, it is likely that the 
production of reactive nitrogen species both by the host and the nitrate 
reductases may be detrimental to other constituents of the microbiome (Henard 
2011). Perhaps they also exert a damping effect on the progress of Salmonella 
into epithelial cells, which would otherwise result in a much more robust defence 
by the host and possible evacuation of the infective dose of Salmonella before a 
foothold could be gained, and a systemic infection initiated. 
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5.1 Introduction 
If the role of the three nitrate reductase systems of Salmonella, NR-A, Nap and 
NR-Z, is to be fully elucidated, testing of all aspects of successive environmental 
adaptations of Salmonella which must take place in order for successful infection, 
colonization and invasion is vital. S. Typhimurium uses SPI-1 to invade epithelial 
cells (Shea et al., 1996) and Alston et al (unpublished data)have found that the 
SPI-1 genes are co-expressed with other genes of the nap operon (unpublished 
data) as raised above. Alston et al also found that a nap operon deletion mutant, 
tested for its ability to invade epithelial cells, showed a 20-30% attenuation of 
invasive capability compared with SL1344 wild type, which suggests that the nap 
operon could play a role in the early process of Salmonella infection. Since it is 
known, as described previously, that SPI-1 expression is a pre-requisite for the 
invasion process in Salmonella, this may suggest that the nap operon is also 
material to that process. The nap operon encodes one of the three nitrate 
reductase systems of Salmonella, Nap. It was therefore reasoned that the 
mutants to be tested for this project should include those components of the Nap 
operon involved in the construction of the periplasmic nitrate reductase. In 
addition, both of the other known nitrate reductase systems were deleted, 
comprising narGHJI and narZYWV. The possibility that there is a direct link 
between invasion and nitrate reduction is interesting, and invasion assays of 
epithelial cells provide a good starting point to explore any connection which 
exists.  
 
5.2 Invasion Assays - Epithelial Cells 
The invasion assays were carried out in human epithelial cells, HeLa, using a 
multiplicity of infection (MOI) of 1:1. The MOI relates the number of bacterial cells 
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to the number of epithelial cells which are present in an invasion assay, as a 
ratio. These assays therefore used an inoculum calculated to contain one 
bacterial cell for every epithelial cell present in the well. Higher MOIs may cause 
lysis of epithelial cells which would not normally occur in vivo (Maruyama et al., 
2007; Monack et al., 2001). HeLa cells are an immortal human cell line which 
provide a well-defined and extensively tested model for the infection of 
mammalian cells using S. Typhimurium strains (Garcia-del Portillo, Zwick et al. 
1993; Hardt, Chen et al. 1998; Steele-Mortimer, Meresse et al. 1999). 
To ensure that an appropriate control was also used in these assays, a 
Salmonella ∆rpoE deletion mutant was also tested. Although this mutant has no 
direct involvement to this study, it is nevertheless relevant to use it as a control. It 
has been shown that a ∆rpoE mutant becomes challenged within the intracellular 
environment, and is less able to replicate within epithelial or macrophage cells 
than a comparable wild type strain (Humphreys, Stevenson et al. 1999; Cano, 
Martinez-Moya et al. 2001; Helaine, Thompson et al. 2010). RpoE is therefore 
vital to the virulence of Salmonella spp. 
 
5.2.1 Results of invasion assays, in the absence of SPI-1 
induction 
Figure 27 shows the ability of the bacteria to invade the epithelial cell monolayer 
initially, in this case, even without prior induction of the SPI-1 type three secretion 
system.  Each of the double nitrate reductase mutants vary little from the wild 
type in their invasive capability; however, the triple mutant is over one third more 
invasive than the wild type. The ability of the bacteria to replicate within the 
epithelial cells once they have gained ingress, which is achieved through the 
deployment of the SPI-1 type three secretion system (TTSS), is illustrated in 
Figure 28.The baseline measurement was assessed after two hours following the 
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initial infection and it is generally accepted that the number of internalized 
bacteria at this timepoint accurately reflects the numbers of bacteria which invade 
from the inoculum, and before any measurable replication of bacteria has taken 
place (Finlay, Heffron et al. 1989; Gahring, Heffron et al. 1990; Kusters, Mulders-
Kremers et al. 1993).Following internalization, the bacteria need to equilibrate 
before they switch to a fully replicative phenotype.This follows the acidification 
and shrinking of the phagosome to fit around the internalized bacterium to form 
the SCV. Subsequently, induction of the SPI-2 TTSS within the SCV results in 
translocation of effector proteins into the SCV several hours after the initial 
internalization, and which allow replication of the bacteria to ensue (Haraga, 
Ohlson et al. 2008). 
Six hours following the infection, the epithelial cells were lysed and their bacterial 
contents released and enumerated;  this confirmed that all the strains tested were 
able to replicate within the HeLa cells, and hence develop increased bacterial 
numbers over time, following the initial inoculation of the monolayer with bacteria, 
compared to the bacterial numbers present within the epithelial cells two hours 
following infection. 
Figure 28 summarisesthe fold change which was measured in bacterial numbers 
of SL1344 wild type and double and triple nitrate reductase and rpoE deletion 
mutants, within HeLa human epithelial cells given an extra four hours following 
the infection. All the strains tested replicated within the HeLa cells, although the 
∆rpoE deletion mutant, used as a control, was the least able to increase its 
bacterial numbers. This was expected, since as explained earlier, replication of 
this mutant is known to be inhibited intracellularly.  Overall, there was no 
difference between the replicative ability of any of the nitrate reductase mutants 
compared to the SL1344 wild type strain. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 27 – Invasion levels in SL1344 wild type and double and triple nitrate 
reductase deletion mutants
The results have been adjusted to account for variations in the initial inoculum applied to 
the epithelial cell monolayer
separate experiments. 
 
 in HeLa human epithelial cells without SPI
.  Error bars show the Standard Error of the Mean
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Figure 28 – The fold change in bacterial numbers of SL1344 wild type and double and triple 
nitrate reductase and rpoE deletion mutants, within HeLa human epithelial cells in four 
hours. The ∆rpoE deletion mutant
Mean for three separate experiments.
 
 was used as a control. Error bars show the Standard Er
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5.2.2 Results of invasion assays of HeLa cells with SPI-1 
induction 
 
As was discussed earlier, entry of Salmonella  into epithelial type cells of the 
gastrointestinal tract is enhanced through the use of the SPI-1 TTSS apparatus. 
Consequently, it was decided to carry out further invasion assays to test the 
nitrate reductase mutant strains and the ∆rpoE mutant, compared to the SL1344 
Wild type strain, having first induced the expression of the SPI-1 system by 
subculturing overnight cultures of the bacteria in LB-S, an accepted method to 
induce SPI-1 production (Ibarra, Knodler et al. 2010; Garcia-Calderon, 
Casadesus et al. 2007; Temme, Salis et al. 2008).  
In Figure 29, each of the double nitrate reductase mutants vary little from the wild 
type in their invasive capability. However, the triple mutant is a little less than one 
third more invasive than the wild type, and this reflects the result shown in Figure 
27 which was carried out without prior SPI-1 induction.  
The difference in bacterial numbers of SL1344 wild type and double and triple 
nitrate reductase and rpoE deletion mutants, within HeLa human epithelial cells 
over time is shown in Figure 30. All the nitrate reductase deletion strains tested 
replicated and increased their bacterial numbers within the HeLa cells over time; 
consequently, they show increased bacterial numbers six hours after the initial 
inoculation of the monolayer with bacteria, compared to the bacterial numbers 
present within the epithelial cells two hours following infection. However, the 
∆rpoE deletion mutant exhibited a reduction in bacterial numbers compared to 
the two hour timepoint, suggesting that not only was this mutant unable to 
replicate normally, it may have even been dying off. This finding is supported by 
other work (Cano, Martinez-Moya et al. 2001), in which lack of the RpoE 
alternative sigma factor caused considerable reduction in intracellular viability of 
S. Typhimurium. 
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Figure 30 alsoshows the fold change in bacterial numbers of SL1344 wild type 
and double and triple nitrate reductase and ∆rpoE deletion mutants, within HeLa 
human epithelial cells in four hours. All the nitrate reductase deletion mutant 
strains had replicated within the HeLa cells. In the case of the triple deletion 
mutant, replication levels were about 65% higher than in the wild type strain.  
However, in the case of the ∆rpoE deletion mutant, used as a control, the 
bacterial numbers dropped over time, as indicated in Figure 30. Overall, there 
was no difference between the replicative ability of any of the double nitrate 
reductase mutants compared to the SL1344 wild type strain. 
  
 
 
 
 
 
 
 
 
 
 
Figure 29 - Invasion levels in SL1344 wild type and double and triple nitrate 
reductase deletion mutants, in HeLa human epithelial cells with SPI
The results have been adjusted to account for variations in the initial inoculum applied to 
the epithelial cell monolayer. 
separate experiments. 
 
Error bars show the Standard Error of the Mean
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Figure 30 – The fold change in bacterial numbers of SL1344 wild type and double 
and triple nitrate reductase and 
epithelial cells in four hours. 
bars show the Standard E
 
 
∆rpoE deletion mutants, within HeLa human 
The ∆rpoE deletion mutant was used as a control
rror of the Mean for three separate experiments.
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5.2.3. Gentamycin Protection Assays in RAW264.7 Murine 
Macrophages 
 
Unlike the requirement for an operative SPI-1 apparatus to enhance ingress into 
the cells, the situation with macrophage cells is different to that which occurs in 
epithelial cells and which has been alluded to in Section 5.3.2 above. Since 
macrophages are phagocytic in nature, there is no need for the bacteria to 
manipulate the cellular cytoskeleton to gain access, since the role of the 
macrophage is to envelope and ingest the bacterium, with a view to destroying it. 
In consequence, it is not necessary to induce SPI-1 production in assays using 
macrophage cells. However, in most other respects, the protocol for macrophage 
protection assays is broadly similar to that used for the epithelial cell invasion 
assays carried out previously.  
Figure 31 illustrates the fold change in bacterial numbers of SL1344 wild type and 
nitrate reductase single operon deletion mutants, within RAW264.7 murine 
macrophages between 2 and 24 hours post-infection. All the nitrate reductase 
deletion mutant strains replicated within the macrophages, and overall, there was 
no difference between the replicative ability of any of the nitrate reductase 
mutants compared to the SL1344 wild type strain.  
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 31 - The fold change in bacterial numbers of SL1344 wild type and nitrate 
reductase single operon deletion mutants, within RAW264.7 murine macrophages 
between 2 and 24 hours. 
separate experiments. 
 
Error bars show the Standard Error of the Mean
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5.3 Infection of Balb/C mice 
5.3.1 Introduction 
Having exposed what potentially appeared to be a hyperinvasive phenotype in 
the triple nitrate reductase deletion mutant ∆narGHJI∆narZYWV∆napDA, it was 
decided that further testing of this possibility was justified, by using an in vivo 
model. The activity of the nitrate reductase system has been linked to virulence 
for other bacterial species which are also pathogens of humans, for example M. 
tuberculosis (Weber, Fritz et al. 2000) and P. aeruginosa (Palmer, Brown et al. 
2007; Van Alst, Picardo et al. 2007). The observation we made of possible 
hyperinvasiveness using Salmonella had been made during the invasion of 
epithelial cells, but not entry to macrophages. A major difference between the 
process of invasion of epithelial cells, and ingress into macrophages, is that to 
enter epithelial cells, Salmonella employs the products of the SPI-1 TTSS, which 
subverts normal host cell activity so that the epithelial cells behave more  like 
phagocytic cells and ingest  the bacteria. This facility is not required to gain entry 
to macrophages, which are naturally phagocytic, and seek out and ingest foreign 
particles, including bacteria, without the need for bacteria to cajole them into 
doing so. Since the only way in vivo in which bacteria would have to gain entry 
through the employment of the SPI-1 machinery would be via the oral route of 
infection, experiments were conducted using this method in Balb/C mice, to 
further test this phenomenon. 
 
5.3.2 Oral Infection Assays 
Population levels of SL1344 wild type bacteria were compared to the bacterial 
numbers of the  SL1344∆narGHJI∆narZYWV∆napDA triple nitrate reductase 
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deletion mutant, following oral infection of Balb/C mice. During the early stages of 
infection, in the stomach, intestine and colon, there was little to choose between 
the wild type and mutant levels of viable bacteria present. However, once the 
infection had progressed to the systemic phase, as demonstrated in the caecum, 
Peyer’s patches, spleen and liver, the mutant demonstrated increased numbers 
of bacteria, and hence virulence, compared to the the wild type strain. This 
finding is illustrated in Figure 32. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 32 Population levels of SL1344 wild type compared to 
SL1344∆narGHJI∆narZYWV
following oral infection of Balb/C mice. 
bars). Error bars show the Standard Error of the Mean
 
∆napDA triple nitrate reductase deletion mutant, 
Wild type (blue bars)Triple 
 for three separate experiments.
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5.3.3 Intraperitoneal Infection Assays 
5.3.3.1 Competitive Index experiments 
Previously, the LD50 method, in which the number of bacteria required to kill half 
of the infected model animals is critical, has been widely used as an indicator of 
virulence or of attenuation. However, since this also shows the collective effects 
of lethality, (i.e. not all mouse death may be due to the effects of the bacterial 
inoculation or infection), it is rather insensitive, and it is not possible to use it to 
show where in the infection process the gene of interest may be deployed 
(Beuzon and Holden 2001). Scoring of the symptoms of infection displayed by 
the infected animals, although part of the experimental protocol, is used to ensure 
that there is no unnecessary suffering of the animals. It is too subjective a 
measure, being based in the judgement exercised by the practitioner, for firm 
conclusions to be drawn from it. 
Use of the Competition Index (CI) however, provides a more robust illustration of 
virulence since it reflects bacterial numbers instead of mouse survival rates 
(Beuzon and Holden 2001). The CI method requires the administration of a 
combined inoculum containing equal numbers of both wild type and mutant 
strains. Administration of the inoculum is achieved via an intra-peritoneal 
injection. After a suitable time interval, the animals are sacrificed and the bacteria 
recovered from particular organs (liver and spleen) which are known to harbour 
the infective bacteria post-infection. Viable counts of these bacteria can then be 
enumerated, and identified by selective screening using their antibiotic 
susceptibility. The CI calculation illustrates the relative virulence ratio (RVR) 
between two bacteria strains. It compares the ratio of the mutant strain to the wild 
type strain in the output number of recovered bacteria, divided by the ratio of the 
two strains to each other in the original inoculum (Monk, Casey et al. 2008). A 
value of 1 indicates no change in the RVR. 
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Both the spleen and liver of infected animals contained more bacteria of each of 
the mutant strains than the wild type strain, using the single nitrate reductase 
mutants, as shown in Figure 33. When animals were infected intraperitoneally 
with the triple nitrate reductase deletion mutant, 
SL1344∆narGHJI∆narZYWV∆napDA, the same trend was maintained and the 
numbers of the mutants which could be isolated from both tissue types, liver and 
spleen, were higher for the mutant than for the wild type strain, illustrated in 
Figure 34. However, the results of the CI calculations made suggest that the RVR 
is no different between the wild type and any of the mutant strains tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 33 - Competitive Index comparison of SL1344 wild type and SL1344 
∆narGHJI, ∆narZYWV
numbersin the spleen 
reductase deletion mutant (pale green 
for wild type (dark blue bars) and for each single mutant (dark green bars).
show the Standard Error of the Mean
 
Spleen RVR              
Liver RVR                 
 
, and ∆napDA single operon deletion mutants.
are shown for wild type (pale blue bars) and each single nitrate 
bars). In the liver, bacterial numbers are illustrated 
 for three separate experiments. 
0.89                                1.58                               1.77
0.81                                0.17                               0.62
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Figure 34 - Competitive Index comparison of SL1344 wild type and SL1344 
∆narGHJI∆narZYWV∆napDA
numbers in the spleen and liver are shown for wild type and the triple nitrate reductase 
deletion mutant (dark green bar).
three separate experiments.
 
Liver RVR  0.94 
 triple nitrate reductase deletion mutant. 
 Error bars show the Standard Error of the Mean
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5.4 Discussion 
S. Typhimurium uses SPI-1 to invade epithelial cells, (Shea et al., 1996) and 
Alston et al. have found that the SPI-1 genes are co-expressed with other genes 
of the nap operon (unpublished data) as detailed previously. Alston et al 
previously tested the ability of a nap operon deletion mutant to invade epithelial 
cells, and found an apparent 20-30% attenuation of invasive capability compared 
with SL1344 wild type (Alston et al., unpublished data). This suggests that the 
nap operon plays a role in the early processes of Salmonella infection. Since the 
nap operon encodes one of the three nitrate reductase systems of Salmonella, 
Nap, this suggested a direct link between invasion and nitrate reduction.  
Invasion assays of epithelial cells provided a good starting point to explore any 
connection, and were carried out using human epithelial cells, (HeLa), using a 
multiplicity of infection (MOI) of 1:1. This was intended to be physiologically 
relevant; higher MOIs may cause lysis of epithelial cells which would not normally 
occur in vivo (Maruyama et al., 2007; Monack et al., 2001). 
The control used, a Salmonella ∆rpoE deletion mutant, has no direct link to this 
study, but has been previously shown to be less able to replicate within epithelial 
or macrophage cells than a comparable wild type strain (Humphreys, Stevenson 
et al. 1999; Cano, Martinez-Moya et al. 2001; Helaine, Thompson et al. 2010). 
RpoE is consequently of use here for comparison purposes. 
Experiments were conducted with and without priming of the SPI-1 TTSS by 
induction. Salmonella switches on this machinery in response to environmental 
cues in readiness for invasion of epithelial cells in vivo. It was found that while the 
double mutants varied little from the wild type in terms of their invasive ability, the 
triple mutant was about two-thirds more invasive. However, once inside the 
epithelial cells, it was shown that there was no significant difference between the 
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replicative ability of any of the nitrate reductase mutants compared to the SL1344 
wild type strain.  
As was discussed earlier, entry of Salmonella  into epithelial type cells of the 
gastrointestinal tract is achieved through the use of the SPI-1 TTSS apparatus. 
Consequently, further invasion assays to test the strains in this study were 
carried out having first induced the production of the SPI-1 system. Once again, it 
was found that the triple mutant was around one-third more invasive than the wild 
type, while the double mutants varied very little from the wild type invasion levels. 
Also, replication of the bacteria once inside the epithelial cells was maintained at 
a level commensurate with that in the wild type for all the mutant strains. 
In macrophages, there is no requirement for an operative SPI-1 apparatus to 
enhance ingress into the cells, since the phagocytic nature of the macrophage 
means that it will actively seek to engulf the bacteria. No difference between 
numbers of wild type and mutant bacteria which gained ingress to macrophages 
was observed.  There was also no significant difference in the replicative ability of 
the mutants compared to wild type once inside macrophages. 
Population levels of SL1344 wild type bacteria were compared to the bacterial 
numbers of the  SL1344∆narGHJI∆narZYWV∆napDA triple nitrate reductase 
deletion mutant, following oral infection of Balb/C mice. In the initial stages of the 
infection, during the passage and occupation of the murine stomach, intestine 
and colon by the bacteria, there was little difference between the numbers of the 
mutant strain bacteria which were isolated and the wild type strain. However, 
following advancement of the infection to the systemic phase, which follows 
invasion and sequestration of the bacteria within macrophages, as demonstrated 
by the numbers of viable bacterai isolated from the caecum, Peyer’s patches, 
spleen and liver, the mutant demonstrated increased virulence over the wild type. 
The removal of all three nitrate reductase systems may have also reduced the 
levels of NO and N2O which are normally produced endogenously by these 
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systems. This would in turn have reduced the environmental challenge to these 
bacteria, so that more were able to expend energy in survival and replicative 
functions, increasing their numbers present in the systemic samples.  
Interpretation of these data lead to the conclusion that nitrate reductase mutants, 
of the Nar and Nap operon systems, are not compromised in their ability to 
employ the SPI-1 TTSS to invade epithelial cells of the mammalian 
gastrointestinal tract. However, once they have gained access, they may well be 
able to replicate more efficiently within the macrophages of their host, so 
increasing the bacterial load within tissues and hence the virulence of the 
infection. This was also evidenced by the (admittedly slightly subjective) 
observations made of the condition of the animals during the experiments. All the 
animals, regardless of the strain with which they had been inoculated required to 
be sacrificed by day 5, due to their poor condition and to prevent unnecessary 
suffering. However, it was observed and noted that those inoculated with the 
mutant strain appeared to be slightly more unwell in appearance than those 
which had been given the wild type strain. It was also observed that the changes 
in the mice with the mutant infection occurred more dramatically in the final day 
and hours of the experiment, lending weight to the possibility that having gained a 
higher critical mass of bacterial load, due to an increased propensity for 
replication, the effects snowballed and would result in a swifter demise had the 
infection been permitted to run its natural course.  
SPI-1 mutants are still able to infect the host following intraperitoneal (IP) 
infection to the same extent as wild type Salmonella (Galan 1996; Ochman, 
Soncini et al. 1996). Further, SPI-1 is not necessary for intracellular survival and 
the systemic phase of any infection. However, SPI-1 mutants fail to infect the 
host following oral infection, and also are not able to invade enterocytes in vitro 
(Lucas and Lee 2001). This supports the premise that SPI-1 is required for 
invasion via the gut epithelium. Since I found that nitrate reductase mutants are 
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still able to invade via the gut epithelium, it is possible to extrapolate that loss of 
the nitrate reductase systems does not also compromise expression of the 
components required for production and assembly of the SPI-1 TTSS. 
Consequently, I conclude that despite the findings of Alston et al that genes of 
the nap operon are coexpressed with those of the SPI-1 TTSS, it is not because 
they are required for the efficient deployment of SPI-1. 
It seems that the nitrate reductase systems do, however, ameliorate the 
replicative capacity of Salmonella within macrophages, since loss of the systems 
causes an increase bacterial replication. The mechanisms which cause a 
reduction of replication are worthy of further investigation, since it might be 
possible to further exploit them in the design of effective treatments for the 
illnesses caused by Salmonella infections. I would propose that the reduction in 
the endogenous NO production may provide an interesting place to start. The 
nitrate reductase systems appear to place a brake on the ability of Salmonella to 
overwhelm the host defences. This may help to ensure that the infection lasts 
long enough to ensure that it is passed on before the host is destroyed. Several 
pathogens are known to control their potential for destruction of their host to 
ensure their own survival. Consideration of the evolutionary advantage which is 
or may be available to organisms which control their virulence leads to the 
conclusion that there is a close relationship between virulence and the effect on 
host mortality (Lenski and May 1994; Koch 2007) 
In this regard, other previous work has shown also that the SL1344 
∆norV∆nrfA∆hmpA triple deletion mutant was not attenuated after intraperitoneal 
infection of mice, or in cultured murine macrophages (G. Rowley, unpublished 
data). This is a mutant which should experience a reduced capacity to detoxify 
NO, while the nitrate reductase triple deletion mutant constructed in this study 
may also produce less NO than the wild type. Since neither of these mutants are 
attenuated systemically, perhaps there are either other mechanisms which are 
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working to equilibrate any effect of NO on Salmonella, which have yet to be fully 
explored, or NO is simply not important against Salmonella once it is protected 
within the SCV of mammalian macrophages.  
In summary, these data suggest that what has been identified in the course of 
this work is a highly replicative phenotype in the nitrate reductase mutants of 
Salmonella Typhimurium rather than a phenotype which is capable of highly 
increased invasion levels when ingested via the oral route.   
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Chapter 6 – Regulation of Nitrate Reduction 
Systems 
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6.1 Introduction 
As has already been described, the SPI-1 expression is a vital component of the 
infection process for Salmonella, and a major regulator of SPI-1 expression is 
HilA (Thompson, Rowley et al. 2006). Fis is also involved in SPI-1 expression 
(Wilson, Libby et al. 2001), in that it is required for the expression of HilA (Wilson, 
Libby et al. 2001; Schechter, Jain et al. 2003). Fis activity has also been 
implicated in the virulence of Shigella and enteroinvasive strains of E. coli (EIEC) 
(Falconi, Prosseda et al. 2001) through its interaction with the DNA binding 
protein H-NS. The ferric uptake regulator, Fur, also positively regulates HilA by 
the repression of H-NS (Troxell, Sikes et al. 2010). FNR is another DNA binding 
protein which has been described as a global regulator of Salmonella virulence, 
driven by oxygen sensitivity (Fink, Evans et al. 2007). CRP is a transcription 
regulator related to FNR, and also involved in DNA-binding (Spiro, Gaston et al. 
1990), while the alternative sigma factor RpoS has long been recognised to 
regulate virulence in Salmonella (Fang, Libby et al. 1992). While FNR and CRP 
have also been investigated extensively in E. coli, HilA is exclusive to Salmonella 
since it is linked to expression of the SPI-1 TTSS, machinery which is not 
employed by E. coli. 
To ascertain the extent, if any, of the link between regulation of Salmonella 
virulence and the nap operon, which had been hinted at by the work of Alston et 
al (unpublished), β-Galactosidase assays were carried out using mutants in each 
of these systems, in a Salmonella Typhimurium background strain for comparison 
purposes. 
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6.2 β-Galactosidase Assays 
Β-Galactosidase is encoded by the lacZ gene of the lac operon in E. coli. It is a 
large (120 kDa, >1000 amino acids) protein that forms a tetramer. The enzyme 
cleaves lactose to glucose and galactose by hydrolysis within the cell so that they 
can be used as carbon/energy sources. The synthetic compound o-nitrophenyl-β-
D-galactoside (ONPG) is also recognized as a substrate and cleaved to yield 
galactose and o-nitrophenol which has a yellow colour. When ONPG is in excess 
over the enzyme in a reaction, the production of o-nitrophenol per unit time is 
proportional to the concentration of β-Galactosidase; thus, the production of 
yellow colour can be used to determine enzyme concentration. 
 
6.3 Results 
Figures 35, 36 and 37 inclusive illustrate the results of β-Galactosidase Assays 
carried out under aerobic conditions, and 38 and 39 are concerned with the 
results of anaerobic assays.  
Figure 35 shows that the transcription factor FNR (fumarate nitrate reduction) and 
the alternative sigma factor RpoS both exert positive regulation over NapF, under 
aerobic conditions. The greatest influence is exerted by FNR which drives an 
almost three-fold increase in expression aerobically compared to the wild type. 
The alternative sigma factor RpoS on the other hand doubles the aerobic 
expression compared to wild type. Negative regulation is shown by both Fis and 
Crp, which each reduce expression by around one half. However, it is noticeable 
that the actual number of Miller Units measured is quite small, so the differences 
between them have to be viewed with an element of caution, and their 
significance should not be overestimated.     
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It is interesting that under anaerobic conditions, RpoS undergoes a change in its 
activity; RpoS switches from positive regulation aerobically, to negative regulation 
in the absence of oxygen, and this is exquisitely illustrated in Figure 38. 
Significantly, here it demonstrates almost 100-fold inhibition of expression 
compared to the wild type, which is also to the same level as that exhibited by 
both HilA and Crp. Further, it is of note that the Miller Units measured in this 
assay are much higher, so differences are also much greater, and hence, more 
meaningful. The other negative regulators of NapF under anaerobic conditions, 
confirmed by the results, HilA and Crp, also demonstrate robust negative 
regulation anaerobically, along with, to a lesser extent, Fis. The result for Fis, 
however, is marginal. In the meantime, Fnr exerts the opposite effect of positive 
regulation of NapF in anaerobic conditions; indeed it would curtail expression of 
NapF in its entirety. 
 
In the case of NarG, Figure 36 shows that Fis exerts a high level of negative 
control under aerobic conditions, on S. Typhimurium, which equates to almost a 
four hundred-fold inhibition. In Figure 37, in which the data for the ∆fis variant has 
been removed for purposes of clarity, it is possible to see that Crp also provides a 
(much lower) level of negative control over NarG, while HilA, FNR, and RpoS all 
regulate NarG positively, but at low levels. However, the Miller Units calculated 
here are small numbers, so differences, although replicated in this work, should 
be afforded some caution. Further, reference to Figure 39 indicates that 
anaerobically in S. Typhimurium, Fis exerts a positive regulatory role on NarG, 
the opposite of what was observed under aerobic conditions. Like the effects of 
RpoS on NapF expression, therefore, Fis adopts opposing influences under 
differing conditions of aerobiosis. HilA is the only negative regulator of NarG in 
the absence of oxygen; all the other regulators which were tested displayed 
positive regulation on NarG in these conditions. Anaerobically, HilA demonstrates 
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100-fold enhancement of NarG expression, while Crp and Fis exert negative 
influences of around 10-fold.   
 
In summary, my results indicate that NapF undergoes negative regulation by four 
of the six regulators tested anaerobically, which also includes HilA. NarG is 
negatively regulated only by HilA under the same anaerobic conditions. 
Conversely, in aerobic conditions, both NapF and NarG are negatively regulated 
by the same two of the tested regulators, Crp and Fis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
Figure 35 - Aerobic β
plasmid. Results suggest that FNR and RpoS exert positive regulation over 
Conversely, Crp and Fis demonstrate negative regulation of 
in Fnr, Fis and rpoS background significantly different (student t test, p<
show the Standard Error of the Mean
 
 
 
M
il
le
r
 U
n
it
s
 
 
-Galactosidase assay pMP220 with napF insert, excluding the empty 
NapF (and  
. 
184 | P a g e  
NapF ( and ). 
).  Miller units for NapF 
0.05) to WT.  Error bars 
 
  
 
 
 
 
Figure 36 - Aerobic β
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6.4 Discussion 
My results show that the transcription factor FNR (fumarate nitrate reduction) and 
the alternative sigma factor RpoS both exert positive regulation over NapF, under 
aerobic conditions. This finding supports the findings of other work which 
investigated the respective roles of FNR and RpoS in E.coli strain MG1655 
(Constantinidou, Hobman et al. 2006), though that addressed the transition 
between aerobic and anaerobic conditions. In addition, there is clearly a change 
in activity under anaerobic conditions; RpoS switches from positive regulation 
aerobically, to negative regulation in the absence of oxygen. Other work has also 
shown that RpoS has different roles in both aerobiosis and anaerobiosis in E. coli 
(King and Ferenci 2005). King and Ferenci also postulate that RpoS expression 
may not always confer a clear advantage to the bacteria, whilst admitting that 
RpoS is vital to the virulence of many pathogenic microorganisms, including S. 
Typhimurium (Fang, Libby et al. 1992) 
In the case of NarG, it is clear that Fis exerts a very high level of negative control 
under aerobic conditions, on S. Typhimurium. Further, Crp also provides a (much 
lower) level of negative control over NarG, while HilA, FNR, and RpoS all 
regulate NarG positively, but at low levels. Crp (cAMP Receptor Protein) is 
structurally and functionally related to FNR (Spiro, Gaston et al. 1990), and both 
have been shown to be involved in the switch between aerobic and anaerobic 
metabolism in E. coli (Green, Bennett et al. 1996). In E.coli, Fis is recognised as 
a growth phase dependent regulator (Thompson, Moitoso de Vargas et al. 1987; 
Schneider, Travers et al. 1997). Genome analysis using E. coli has shown that 
there is little variation in the availability of Fis-binding sites between aerobic and 
anaerobic conditions, suggesting that in either condition, Fis activity remains 
fundamentally the same (Cho, Knight et al. 2008). Anaerobically in S. 
Typhimurium, my results indicate that Fis exerts a positive regulatory role on 
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NarG, the opposite of what was observed under aerobic conditions. HilA is the 
only negative regulator of NarG in the absence of oxygen; all the other regulators 
tested would exert positive regulation on NarG in these conditions. NapF, 
however, undergoes negative regulation by four of the six regulators tested 
anaerobically, which also includes HilA. Consequently, the findings outlined here 
lend further weight to the initial observations made by Alston et al that the co-
expression of genes of the Nap operon with those of SPI-1, and that this occurs 
under the control of a putative HilA box. HilA is known to activate SPI-1 genes 
which facilitate invasion of epithelial cells (Bajaj, Hwang et al. 1995). Figure 40 
summarises the different regulatory effects in aerobic and anaerobic conditions 
as measured through the use of β-Galactosidase Assays.      
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Insert Negative 
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No effect Positive 
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Aerobic 
NapF ∆crp 
∆fis 
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∆fnr 
∆rpoS 
NarG 
 
∆crp 
∆fis 
 ∆hilA 
 
∆fnr 
∆rpoS 
 
 
 
Anaerobic 
Nap F ∆hilA 
∆crp 
∆fis 
∆rpoS 
 ∆fnr 
 
NarG ∆hilA ∆rpoS ∆crp 
∆fnr 
∆fis 
 
 
 
Figure 40 - The different effects of regulators in aerobic and anaerobic 
conditions for pMP220 plasmid with NapF and NarG inserts.  
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Chapter 7 – General Discussion 
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As each chapter has already been discussed individually, here I summarise the 
findings made during my endeavours and make suggestions for future studies.  
Salmonella enterica serovar Typhi causes systemic disease in humans. The 
same route of infection as that employed by S. Typhi is also used by S. enterica 
serovar Typhimurium during its infection of mice. This makes the S. Typhimurium 
mouse infection model an ideal one to use in studies investigating the systemic 
disease in humans. 
Nitric oxide is known to be important in the control of infections by a range of 
pathogens, since mice which are unable to produce NO are more susceptible to 
infection (Shiloh, MacMicking et al. 1999). The initial stages of this work focused 
on the importance of NO metabolism in Salmonella in relation to virulence. 
Attention was then turned to how Salmonella deals with some of the ordinarily 
potentially toxic products of NO metabolism, like other reactive nitrogen species 
such as nitrate and the nitrate reductase machinery it employs to neutralise their 
effects. 
 
7.1  NorV, NrfA and HmpA 
Under the conditions which were tested, the SL1344 ∆norV∆nrfA∆hmpA triple 
deletion mutant was no more or less affected than the isogenic parent. Rowley et 
al (unpublished data) had also found no difference between this mutant and the 
wild type strain during trials using intraperitoneal infection techniques in Balb/C 
mice.  Our findings support the hypothesis that other mechanisms for NO 
detoxification exist which are induced during animal infection, and which remain 
to be elucidated. 
S. Typhimurium proliferation increases during an infection if NO production by the 
innate immune system of mice is restricted (Umezawa, Akaike et al. 1997; 
MacFarlane, Schwacha et al. 1999). The ability of mutant strains of Salmonella to 
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downregulate host NO production therefore seems to be favourable and has also 
been demonstrated (Eriksson, Bjorkman et al. 2000). Several pathogens, as part 
of their normal infection strategy, survive intracellularly within their host, so it is to 
their advantage to circumvent attempts by the host immune system to eradicate 
them whilst there. Both S. Typhimurium and Mycobacterium tuberculosis, while 
inducing iNOS production in macrophages, can detoxify both ROS and RNI. S. 
Typhimurium interferes with the recruitment of components required by 
phagocytic host cells to mount their defensive burst (Vazquez-Torres, Xu et al. 
2000). 
Das et al have also shown recently that transporters of nitrogen species are 
crucial for controlling what happens between NO and host defences during the 
resistance of the host to Salmonella infection (Das, Lahiri et al. 2009). Production 
of NO in response to IFN-γ activation of RAW264.7 macrophages is inhibited in 
macrophages infected with wild-type Salmonella, and the nitrite transporter nirC 
was found to be fundamental to this effect (Das, Lahiri et al. 2009). This shows 
that some bacterial species, including Salmonella, can defend themselves from 
NO stress by inhibiting the ability of the mammalian cells containing them to 
produce NO. Consequently, the pathogens prevent the function of one of the 
main resources available to the mammalian immune response. 
Future work which is intimated should include complementation of the strains 
which were developed, together with complete sequencing of them. Also, the 
possible impact of alterations on the polarity of the genes involved should be 
more fully explored by testing for unmarked deletions. 
 
7.2  Nitrate reductases, Nap and Nar 
In both nutrient replete medium (LB) and minimal medium containing glucose 
(MGM), the growth of SL1344 nitrate reductase mutants is similar to that of 
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SL1344 wild type, regardless of whether the conditions for growth were aerobic 
or anaerobic.   
The Cole group has shown that using media with glycerol rather than glucose as 
the carbon source and supplemented with nitrate and fumarate induced 
expression of nrfA in E.coli(Darwin, Hussain et al. 1993). However, 
supplementation of this respiratory electron acceptor is not required for nitrate 
reductases, since they do not depend on fumarate. We adapted the Glycerol 
Nitrate Fumarate (GNF) medium developed by Darwin et al by removing the 
fumarate, to assess the ability of the nitrate reductase mutants to grow in the 
presence of replete nitrate. The nitrate reductase mutants were tested in 
anaerobic conditions using this medium. It was interesting that the SL1344 
∆narGHJI (NR-A nitrate reductase system) single deletion mutant consistently 
and repeatedly showed a significant growth reduction compared to the wild type 
and other two single mutants in this medium. Other work has found that a narG 
mutant of M. tuberculosis also fails to grow in nitrate replete broth media (Malm, 
Tiffert et al. 2009). A comparison was also made between SL1344 Wild Type and 
the ∆narGHJI single and ∆narGHJI∆narZYWV∆napDA triple nitrate reductase 
deletion mutants. Growth inhibition of the single mutant was demonstrated and 
also confirmed that growth of the triple deletion mutant was even more reduced.  
As growth of the triple deletion mutant was even more inhibited than the single 
∆narGHJI mutant, we concluded that more than the NR-A nitrate reductase 
system is involved in nitrate reduction in this medium. From further work, it was 
possible to conclude that loss of both the NR-A and Nap nitrate reductase 
systems together prevents growth almost completely, accounting for the entire 
adverse effect on growth observed in the triple nitrate reductase system deletion 
mutant. Sohaskey and Malm have separately drawn similar conclusions from 
their work on M. tuberculosis and E.coli respectively, both showing that NarGHJI 
mutants were disadvantaged in replete nitrate under anaerobic conditions 
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(Sohaskey 2008; Malm, Tiffert et al. 2009). The NR-A system is therefore 
capable of compensating for the loss of both the NR-Z and Nap systems. This is 
not a reciprocal arrangement, as the Nap system does not compensate 
completely for the loss of the NR-A system. This suggests that the complete loss 
of growth in the triple mutant is in fact due to the loss of the NR-A and Nap 
systems, and not loss of the NR-Z system. The addition of fumarate back into the 
medium made no difference to the previous results and did not rescue growth in 
NR-A and Nap mutants. 
We used MM5.8 medium which is considered a good model for the intracellular 
environment of the SCV inside mammalian macrophages within which 
Salmonella not only survives but also replicates. Many intracellular pathogens are 
specially adapted to withstand the rigours of the harsh environment found within 
macrophages (Lavigne, O'Callaghan et al. 2005), and particularly within the 
phagosome itself. Indeed, several, such as Toxoplasma, Leishmania, 
Mycobacterium and Legionella and including Salmonella spp., are exquisitely 
adapted to actually thrive in such surroundings (Amer and Swanson 2002). In 
Salmonella, we found no difference between the growth patterns observed for the 
SL1344 single, double or triple nitrate reductase mutant when compared to the 
SL1344 wild type strain in MM5.8 medium. This suggests that Salmonella has 
such a wide range of strategies to deal with the rigours of the macrophage attack 
that deletion of known nitrate reductase systems does not compromise bacterial 
survival.  
By carrying out motility assays on the nitrate reductase mutants, we have 
confirmed that loss of the nitrate reductase systems in S. Typhimurium does not 
compromise motility. Previously, other work had shown that both Pseudomonas 
aeruginosa and E. coli suffer from motility and swarming defects when the activity 
of their Nar nitrate reductase or Hmp respectively is compromised (Schreiber, 
Krieger et al. 2007; Stevanin, Read et al. 2007) This was attributed to the loss of 
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flagellae probably due to the onerous metabolic burden placed on the bacteria by 
synthesis of Hmp in the absence of NO rather than due to Nar. 
S. Typhimurium uses SPI-1 to invade epithelial cells, (Shea et al., 1996) and 
Alston et al. have found that the SPI-1 genes are co-expressed with other genes 
of the nap operon (unpublished data) as outlined earlier. We postulated that the 
nap operon is important in the early stages of a Salmonella infection. Since the 
nap operon encodes one of the three nitrate reductase systems of Salmonella, 
Nap, we investigated the possibility of a direct link between invasion and nitrate 
reduction.  Invasion assays of epithelial cells provided a good model to explore 
this connection. 
We found that invasion of the double mutants varied little from the wild type and 
the triple mutant was more invasive. However, once inside the epithelial cells, 
there was no difference between the replicative ability of any of the nitrate 
reductase mutants compared to the SL1344 wild type strain.  
Entry of Salmonella  into epithelial type cells of the gastrointestinal tract requires 
the deployment of the SPI-1 TTSS apparatus. In macrophages, there is no need 
for Salmonella to use SPI-1 to enter the cells, since the phagocytic nature of the 
macrophage means that it will actively seek to engulf the bacteria. We found that 
the triple mutant was more invasive in human epithelial cells than wild type, 
whether or not SPI-1 TTSS had been induced prior to infection.  
This interesting finding was followed up by carrying out work in vivo to see 
whether the increased virulence would also be manifest in a mouse model of 
infection. Oral infection of Balb/C mice was used as the preferred method, since 
this would be closer to the natural in vivo method of infection by Salmonella.  In 
the initial stages of the infection, during the passage and occupation of the 
murine stomach, intestine and colon by the bacteria, there was little difference 
between the numbers of the mutant strain bacteria which were isolated and the 
wild type strain, However, following advancement of the infection to the systemic 
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phase, the mutant demonstrated increased virulence over the wild type. It has 
recently been confirmed that both the membrane bound nitrate reductase (Nar) 
and the periplasmic nitrate reductase (Nap) are instrumental in the endogenous 
production of both NO and nitrous oxide (N2O) (Rowley, Hensen et al. 2012). 
The removal of all three nitrate reductase systems may have consequently 
reduced the levels of NO and N2O which are normally produced endogenously by 
these systems. This would in turn have reduced the environmental challenge to 
these bacteria, so that more were able to expend energy in survival and 
replicative functions, increasing their numbers present in the systemic samples.  
Interpretation of our results lead to the conclusion that nitrate reductase mutants, 
of the Nar and Nap operon systems, are not compromised in their ability to 
employ the SPI-1 TTSS to invade epithelial cells of the mammalian 
gastrointestinal tract.  
SPI-1 mutants are still able to infect the host following intraperitoneal (IP), 
infection to the same extent as wild type Salmonella (Galan 1996; Ochman, 
Soncini et al. 1996). Further, Spi-1 is not necessary for intracellular survival and 
the systemic phase of any infection. However, SPI-1 mutants fail to infect the 
host following oral infection, and also are not able to invade enterocytes in vitro 
(Lucas and Lee 2001). This supports the premise that SPI-1 is required for 
invasion via the gut epithelium. In this study, it was found that nitrate reductase 
mutants were still able to invade via the gut epithelium; it is therefore possible to 
extrapolate that loss of the nitrate reductase systems does not also compromise 
expression of the components required for production and assembly of the SPI-1 
TTSS. Consequently, despite the findings of Alston et al that genes of the nap 
operon are co-expressed with those of the SPI-1 TTSS, the findings from this 
work suggest that it is not because Nap genes are required for the efficient 
deployment of SPI-1. 
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It seems that the nitrate reductase systems do, however, ameliorate the 
replicative capacity of Salmonella within macrophages. Loss of the nitrate 
reductase systems causes an increase in bacterial replication. The mechanisms 
with which the nitrate reductases might suppress replication are worthy of further 
investigation, since it might be possible to further exploit them in the design of 
effective treatments for the illnesses caused by Salmonella infections whilst 
limiting replication. The reduction in the endogenous NO production may provide 
an interesting place to start. The nitrate reductase systems appear to place a 
brake on the ability of Salmonella to overwhelm the host defences. This may help 
to ensure that the infection lasts long enough to ensure that it is passed on before 
the host is destroyed. Several pathogens are known to control their potential for 
destruction of their host to ensure their own survival. Consideration of the 
evolutionary advantage which is or may be available to organisms which control 
their virulence supports the view that there is a close relationship between 
virulence and the effect on host mortality (Lenski and May 1994; Koch 2007) 
In summary, the results of this work suggest that what has been identified is a 
highly replicative phenotype in the nitrate reductase mutants of Salmonella 
Typhimurium rather than a phenotype which is capable of highly increased 
invasion levels when ingested via the oral route.  
Findings from the β-Galactosidase Assays carried out support the findings of 
other work which investigated the respective roles of FNR and RpoS in E.coli 
strain MG1655 (Constantinidou, Hobman et al. 2006). This work confirmed that 
RpoS switches from positive regulation aerobically, to negative regulation in the 
absence of oxygen. Other work has also shown that RpoS has different roles in 
both aerobiosis and anaerobiosis (King and Ferenci 2005). King and Ferenci 
postulate that RpoS expression may not always confer a clear advantage to the 
bacteria, although RpoS is vital to the virulence of many pathogenic 
microorganisms, including S. Typhimurium (Fang, Libby et al. 1992). 
 200 | P a g e  
 
In the case of NarG, it was shown that Fis exerts a high level of negative control 
under aerobic conditions, on S. Typhimurium. Crp also provides a (much lower) 
level of negative control over NarG, while HilA, FNR, and RpoS all regulate NarG 
positively, albeit at low levels. Crp (cAMP Receptor Protein) is structurally and 
functionally related to FNR (Spiro, Gaston et al. 1990), and both are involved in 
the switch between aerobic and anaerobic metabolism in E. coli (Green, Bennett 
et al. 1996). In E.coli, Fis is recognised as a growth phase dependent regulator 
(Thompson, Moitoso de Vargas et al. 1987; Schneider, Travers et al. 1997). 
Genome analysis using E. coli has shown that there is little variation in the 
availability of Fis-binding sites between aerobic and anaerobic conditions, 
suggesting that in either condition, Fis activity remains fundamentally the same 
(Cho, Knight et al. 2008). However, this work indicates that anaerobically in S. 
Typhimurium, Fis exerts a positive regulatory role on NarG, the opposite of what 
was observed under aerobic conditions. HilA is the only negative regulator of 
NarG in the absence of oxygen; all the other regulators tested exert positive 
regulation on NarG in these conditions. NapF, however, undergoes negative 
regulation by four of the six regulators tested anaerobically, which also includes 
HilA. Consequently, the findings outlined here lend further weight to the initial 
observations made by Alston et al of the co-expression of genes of the Nap 
operon with those of SPI-1, and that this occurs under the control of a putative 
HilA box. HilA is known to activate SPI-1 genes which facilitate invasion of 
epithelial cells (Bajaj, Hwang et al. 1995). However, this co-expression it seems, 
is incidental, and is not reflected by any effect on invasion in nitrate reductase, 
and particularly Nap, mutants.  
Other future work to pinpoint whether HilA does indeed regulate expression of 
Nap, employing chIP-on-chip and Electrophoretic Mobility Shift Assay (EMSA) 
techniques, would be beneficial. If Nap were found to be regulated in this way, 
further work would also be indicated to explore why that is advantageous to the 
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organism, and enzyme assays could be useful in this respect. Reference to work 
by the Bäumler group suggests that in a colitis mouse model, the interaction may 
be linked to SPI-1 expression (Winter, Thiennimitr et al. 2010). It would be 
interesting to carry out green fluorescent protein (gfp) fusions to nap and nar, 
followed by confocal microscopy techniques to explore further the conditions 
under which expression of the nitrate and nitrite reductases are switched on or 
off. It would also be useful to conduct further invasion and protection assays 
using colonic cell lines, such as Caco-2 or HT29 human cells. However, since 
these are already compromised by virtue of their tumourigenic and immortal 
nature, even better would be cells of the normal mucosa, such as NCM460, 
although these present more difficulties due to their fussy culture requirements. 
Overall, however, the conclusion reached as a result of the work carried out in 
this study is that the nap operon which encodes the periplasmic nitrate reductase 
in Salmonella does not play a role in the early process of Salmonella infection. 
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